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Sommaire 
 La quantité de données générée dans le cadre d'étude à grande échelle 
du réseau d'interaction protéine-protéine dépasse notre capacité à les analyser et 
à comprendre leur sens; d'une part, par leur complexité et leur volume, et d'un 
autre part, par la qualité du jeu de donnée produit qui semble bondé de faux 
positifs et de faux négatifs. Cette dissertation décrit une nouvelle méthode de 
criblage des interactions physique entre protéines à haut débit chez 
Saccharomyces cerevisiae, la complémentation de fragments protéiques (PCA). 
Cette approche est accomplie dans des cellules intactes dans les conditions 
natives des protéines; sous leur promoteur endogène et dans le respect des 
contextes de modifications post-traductionnelles et de localisations 
subcellulaires. Une application biologique de cette méthode a permis de 
démontrer la capacité de ce système rapporteur à répondre aux questions 
d'adaptation cellulaire à des stress, comme la famine en nutriments et un 
traitement à une drogue. 
 Dans le premier chapitre de cette dissertation, nous avons présenté un 
criblage des paires d'interactions entre les protéines résultant des quelques 6000 
cadres de lecture de Saccharomyces cerevisiae. Nous avons identifié 2770 
interactions entre 1124 protéines. Nous avons estimé la qualité de notre criblage 
en le comparant à d'autres banques d'interaction. Nous avons réalisé que la 
majorité de nos interactions sont nouvelles, alors que le chevauchement avec 
les données des autres méthodes est large. Nous avons pris cette opportunité 
pour caractériser les facteurs déterminants dans la détection d'une interaction 
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par PCA. Nous avons remarqué que notre approche est sous une contrainte 
stérique provenant de la nécessité des fragments rapporteurs à pouvoir se 
rejoindre dans l'espace cellulaire afin de récupérer l'activité observable de la 
sonde d'interaction. L'intégration de nos résultats aux connaissances des 
dynamiques de régulations génétiques et des modifications protéiques nous 
dirigera vers une meilleure compréhension des processus cellulaires complexes 
orchestrés aux niveaux moléculaires et structuraux dans les cellules vivantes. 
 Nous avons appliqué notre méthode aux réarrangements dynamiques 
opérant durant l'adaptation de la cellule à des stress, comme la famine en 
nutriments et le traitement à une drogue. Cette investigation fait le détail de 
notre second chapitre. Nous avons déterminé de cette manière que l'équilibre 
entre les formes phosphorylées et déphosphorylées de l'arginine 
méthyltransférase de Saccharomyces cerevisiae, Hmt1, régulait du même coup 
sont assemblage en hexamère et son activité enzymatique. L'activité d'Hmt1 a 
directement un impact dans la progression du cycle cellulaire durant un stress, 
stabilisant les transcrits de CLB2 et permettant la synthèse de Cln3p. Nous 
avons utilisé notre criblage afin de déterminer les régulateurs de la 
phosphorylation d'Hmt1 dans un contexte de traitement à la rapamycin, un 
inhibiteur de la kinase cible de la rapamycin (TOR). Nous avons identifié la 
sous-unité catalytique de la phosphatase PP2a, Pph22, activé par l'inhibition de 
la kinase TOR et la kinase Dbf2, activé durant l'entrée en mitose de la cellule, 
comme la phosphatase et la kinase responsable de la modification d'Hmt1 et de 
ses fonctions de régulations dans le cycle cellulaire. Cette approche peut être 
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généralisée afin d'identifier et de lier mécanistiquement les gènes, incluant ceux 
n'ayant aucune fonction connue, à tout processus cellulaire, comme les 
mécanismes régulant l'ARNm.  
vi 
 
Abstract 
 The quantity of data generated within the framework of protein-protein 
interaction network large-scale studies exceeds our capacity to analyze them 
and to understand their meaning; on one hand, by their complexity and their 
number, and on the other hand, by the quality of the produced data, which are 
populated with spurious interactions. This dissertation describes new 
applications of a protein-fragments complementation assay (PCA) to screen for 
interactions among all proteins in the budding yeast Saccharomyces cerevisiae. 
This approach is carried out in intact cells, with proteins expressed in their 
native contexts and under their endogenous promoter, thus assuring correct 
post-translational modifications and subcellular localization. A further novel 
application of PCA is described for investigating proteome wide changes in 
response to cellular adaptation to stresses, such as nutrient starvations and drug 
treatments. Finally, as a result of the latter strategy applied to characterizing 
proteome-wide response to the immunosuppressant drug, rapamycin, I describe 
the discovery of an unforeseen mechanism of modulating cell cycle progression 
through control of cyclin mRNA stability. 
 In the first chapter of this dissertation, I present a pairwise screen of 
interactions among proteins resulting from the ~6000 open reading frames in 
Saccharomyces cerevisiae. We identified 2770 interactions among 1124 
proteins. We estimated the quality of our screen by comparing our results to 
curated gold standard data and coverage of known interactions to all previous 
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studies. The majority of our interactions were novel, but overlap with data from 
previous studies was as high as 40%. PCA is based on refolding of the reporter 
protein from complementary N- and C- terminal fragments following 
interaction of the two proteins to which they are fused. Thus, reporter activity is 
sterrically limited to interactions in which the termini of the proteins to which 
the complementary reporter fragments are fused are sufficiently close in space. 
In the case of our reporter, this limit was 8 nm. Thus PCA is a molecular ruler, 
providing information on both direct protein-protein interactions and sterrically 
restricted distances between proteins in complexes. We benchmarked and 
demonstrated correct topological relationships for a number of known 
complexes, including the proteasome, RNA polymerase II and the nuclear pore 
complex. Thus our study provided, for the first time, a topological map of 
complex organization in a living cell. The integration of the results from such 
efforts with those of gene regulation dynamics and protein modifications will 
lead to a fuller understanding of how complex cellular processes are 
orchestrated at a molecular and structural level in the living cell. 
 In chapter 2, I describe the results of an application of PCA to study the 
dynamic rearrangement of the proteome under a specific stress; treatment of 
cells with rapamycin. The results of these efforts were the identification of a 
novel mechanism of cell cycle control at the level of cyclin mRNA. 
Specifically, we discovered that the balance between the phosphorylated and 
dephosphorylated forms of the Saccharomyces cerevisiae arginine 
methyltransferase, Hmt1, regulates both its assembly into a hexamer and its 
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enzymatic activity. The Hmt1 activity modulates cell cycle progression through 
stabilizing the B cyclin CLB2 mRNA. We then used PCA to identify the Hmt1 
regulators under rapamycin treatment. We identified the catalytic subunit of the 
PP2a phosphatase, Pph22, activated by the inhibition of TOR, and the kinase 
Dbf2, activated during entry into mitosis, as the phosphatase and the kinase 
responsible for the modification of Hmt1 and for its regulatory functions in the 
cell cycle.  
I thus, in the end close the circle I began in this summary, going from 
large-scale discovery of protein-protein interactions, to mapping dynamics of 
proteome changes during an adaptation and finally to mechanistic insight into a 
primordial control mechanism in cellular dynamics. The strategies that we 
devised to discover this mechanism can be generalized to identify and 
mechanistically link genes together, including those of unknown function, to 
any cellular process.   
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Overview 
 Proteins are operators in all cellular processes including the cell cycle, 
the central subject of this thesis. Further, matter, energy and information 
transfer through biochemical pathways and their organization, are determined 
by specific protein-protein interactions at every phase of the cell cycle. For 
example, protein interactions during cell cycle progression such as mitosis are 
indispensable for the structure of sub-cellular organelles [1], the transport 
machinery across the various biological membranes [2], the packaging of 
chromatin [3], the network of microtubule filaments [4], the periodic decay of 
mitotically regulated molecules [5], and the cyclin-dependent kinase signal 
transduction [6], the regulation of DNA region by transcription factors [7], to 
name a few. Protein interactions during cell cycle progression have been the 
object of intense research for many years due to their importance in 
development and disease. Aberrant protein bindings are implicated in a number 
of neurological disorders such as Creutzfeld-Jacob, Alzheimer's disease [8] and 
cancer, during all developmental stages and metastasis [9]. Although 
disregulated protein interactions are of interest clinically, the main focus of this 
study is in the finely tuned recruitment of proteins and molecules involved in 
the regulation of cell division. 
 Within cells, proteins interact with other proteins, metabolites and 
nucleic acids. Protein interactions are measured using a variety of assays, 
described in method sections of chapters 1 and 2. These assays are based on 
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new innovations in various fields of biochemistry and biophysics, increasing 
the sensitivity and accuracy in molecular interaction cartography. Recently, 
many techniques were designed with the aim of scaling up to measure 
interactions on a proteome-wide level [10-14]. The false-positive and false-
negative rates for networks generated from such high-throughput methods are 
high, stressing the need for discovering new experimental techniques and new 
methods that will allow to study protein interactions in intact cell, and to 
perform studies in various growth conditions and cellular states with 
endogenously expressed full-length proteins in their native post-translationally 
modified states and cellular locations. This knowledge could be generated to 
understand how genetic or environmental perturbations could be linked to these 
networks in disease development or to uncover how perturbations, such as 
drugs, of individual network components could reduce or eliminate cellular 
dysfunctions. 
 I present here the application in Saccharomyces cerevisiae of a protein-
fragments complementation assay (PCA) reporter of protein-protein 
interactions, that is unique because: (I) it is performed in intact cells and (II) it 
can be used to address dynamic behaviors of protein complexes under non-toxic 
conditions. The goal of this dissertation is to demonstrate the limitations, the 
determining factors in detecting interactions and the strength of this approach in 
yeast and to show how it can be used to make a substantial and unique 
contribution to biology. In the first chapter of this dissertation, I focus on 
describing the PCA in the context of a systematic screen of all pairwise 
3 
 
interactions among ~6,000 yeast proteins. In the second chapter, I applied the 
PCA strategy to understand the mechanism regulating an arginine 
methyltransferase assembly and activity under stressful conditions, such as 
starvation and rapamycin-induced TOR kinase inhibition. These enzyme 
regulations have a direct impact on RNA-binding protein capacities to 
stabilized cyclin transcripts and overall cell cycle progression. As a result, this 
strategy can be generalized to identify and mechanistically link genes, including 
those of unknown function, to any cellular process.  
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1.1.Overview 
 Communication at the level of the organism requires the transduction of 
physical cues or chemical information, such as turgor pressure, toxin presence 
or available nutrient sources, into biochemical signals. Chemical and physical 
signals are processed by specific interactions among heterologous proteins 
through non-covalent or covalent modifications. Some of these molecular 
transducers arose from co-evolution of complementary binding interfaces that 
specifically interact when simultaneously localized in space and time with 
corresponding molecular partners, while accumulating mutations that disfavor 
spurious contacts [15-17]. For example, the Haemophilus influenza SspB 
protein homodimer evolved a symmetrical binding surface consisting of an α-
helix and β-strand forming a hydrophobic cluster between two copies of the 
molecule [18]. The SspB homomeric interface is essential to bind and target for 
degradation truncated peptide resulting from stalled ribosome activity upon 
severe starvation [19]. Computationally design SspB mutations at position 12, 
15, 16 and 101 that optimized the stability between the heterodimer mutants, 
SspBFAFI and SspBLALI, would actually assemble with high stability both into 
SspB homomer and heteromer in solution. In contrast, design mutations at the 
5 
 
same position that optimize the difference in energy between the heterodimer 
and both homodimer mutants, SspBLSLA and SspBYGMF, show a 99% specificity 
for the heteromeric assembly while bearing lower stability [17]. It is reasonable 
to think that, as in the design of SspB mutants, protein complex specificity in 
intact cell is achieved at the cost of stability, rendering in vitro purification 
conditions a constraint to their detection. 
 Proteins interact through their interfaces into stable macromolecular 
structures for which a panel of high-throughput screen strategy were design to 
capture. The quality of an unbiased PPI screen is composed of two distinct 
elements: (I) its completeness and (II) its fidelity to reproduce the real PPI 
network. Protein complexes have been extensively studied by many small-scale 
techniques and have been curated to create catalogues, such as The Munich 
Information Center for Protein Sequences (MIPS). These curated protein 
complexes, such as the nuclear pore, the ribosome, the RNA polymerases, the 
proteosome, to name a few, can represent bona fides interactions between 
proteins that could be considered to estimate false-negative discovery rate in a 
given screen. The completeness of a reported screen can be evaluated by 
verifying the number of observed interactions within this standard. The total 
coverage achieved by a screen is determined by both the limitations and 
sensitivity of the detection method. Therefore, the minimal amount of false-
negatives can be reached at the union of the data from different approaches. 
Equally important, each of these screens should be carried out under conditions 
that maximize the sensitivity of the detection technique. The fidelity of a PPI 
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method, on the other hand, is more difficult to determine. Unfortunately, there 
is no clear dataset of protein that would not physically interact. Therefore, a 
compromise standard set is generated from logical inference; creating 
imaginary “impossible” interactions by selecting pairs of proteins with 
divergent expression profiles or mutually exclusive compartmentalization and 
assuring that none of these imaginary interactions were ever reported in all 
published data. This approach overestimates the number of impossible 
interactions, but provides a means to access the false-positive discovery rate.  
The fidelity of a protein-protein interaction detection technique can be 
increased by systematic removal of artifacts. These can be detected by applying 
appropriate controls to the data, usually by determining technical limitations of 
a technique that recover false interactions. For PCA, there are two potential 
technical causes of false-positive interactions. PCA is based on protein 
interaction-mediated refolding of the reporter fragments to yield an active 
enzyme [20]. It is, however, possible that in some cases spontaneous folding of 
reporter from the fragments can occur. An appropriate control for such cases is 
to probe the proteome with fragments fused to a protein that does not interact 
with any protein in the cell (e.g. GFP) or the fragment itself, expressed alone. In 
our screen, we identified approximately 300 proteins that interact with fragment 
alone, notably highly abundant proteins. A second possibility is that non-
specific interactions could be generated due to trapping of complexes between 
two proteins that normally wouldn’t interact, due to irreversible folding of the 
reporter protein. In fact, we have shown that this is not the case: PCA reporter 
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proteins do reversibly unfold when protein complexes dissociate for several 
reporter proteins, but we had not tested this for the reporter used in this study, 
murine dihydrofolate reductase (DHFR) [21, 22]. We verified the reversibility 
of DHFR PCA folding using the adenosine 3´,5´-monophosphate–dependent 
dissociation of the yeast protein kinase A complex as a test system. This 
heterotetrameric complex has two catalytic and two regulatory subunits. The 
adenosine 3´,5´-monophosphate (cAMP) binds to and promotes conformational 
change of the regulatory subunits that release the catalytic subunits. An 
irreversible reporter folding would retain the catalytic subunit under cAMP 
treatments. This test insured that we would not report interactions resulting of 
irreversible trapping by the fragments. 
 DHFR PCA depends on physical contact between the reporter 
fragments. This could be limited by the distance between the two protein 
termini to which the fragments are fused. This is an opportunity to study protein 
complex membrane spanning protein complex topologies. The structure of the 
RNA polymerase II is appealing as it is determined at 2.8 Ǻ resolution and 
contains the largest described variety of protein subunits [23]. We could 
technically use the linker peptide, separating the subunit of the RNA 
polymerase II and our reporter fragment, as a molecular ruler that could 
theoretically give a resolution of the position of complex subunits at the 
resolution of a single amino acid. Similarly, the reporter fragments cannot 
refold through a membrane. Therefore, we can use the reporter fragments fused 
to the C termini of membrane spanning proteins to test for their close proximity 
8 
 
and also their orientation into the same cellular compartment [24-27]. These 
particularities of the PCA would provide complementary information on the 
nature of proteins and their complexes. 
 The motivation for determining protein interaction networks is to 
establish potential protein functions and relationships. Gene annotation is the 
process of conferring biological information to sequence, consisting of (I) 
predicting encoded gene sequence in the genome and (II) conferring biological 
information upon these genes. Gene function annotation is a challenge, given 
that proteins, in their different states, (e.g. subcellularly localized or post-
translationally modified) can be quite versatile, assuming multiple functions at 
any given time and under different conditions [28]. The difficulty of the gene 
annotation task is reflected in the number of genes that remain to be annotated. 
In the popular eukaryotic model, Saccharomyces cerevisiae, almost 30% of the 
genes are refractory to past annotation efforts [29]. A variety of factors are 
likely to contribute to the relatively large number of non-annotated yeast genes, 
including genetic redundancy, lack of strong phenotype, and the possibility that 
not all genes are real open reading frames (ORF). However, there is a clear 
need for new approaches and strategies for specific problems, including the 
characterization of individual genes and their role in nature. For example, the 
rationale for assigning gene function based on protein interactions relies on a 
“guilt by association” argument, suggesting that physically interacting proteins 
shared common functions known a priori for one of the protein. This argument 
is justified for defined protein complexes, but the accuracy of the argument 
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decreased when (I) there is no a priori annotation for both of the interacting 
proteins, (II) function shared by the two interacting proteins is novel and differ 
from any known a priori relationship between functions (e.g. between a 
transcription factor and a metabolic enzyme) and (III) although the proteins 
physically interact, these proteins shared no functions. These limitations have 
not prevented biologist from using these information as a starting point to 
characterize proteins with unknown functions. For example, using the yeast 
two-hybrid assay, the YDR016C gene was shown to function with the spindle-
pole body as part of the Dam1 complex [11]. It was revealed to be an essential 
component of the DASH complex required for mitotic spindle integrity [30]. 
Assembling proteins of unknown function into networks linked to specific 
cellular processes can thus provide new mechanistic insights and potentially 
provide new therapeutic targets for the development of drugs.  
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Background 
 In the following manuscript that was published in an article format in 
the journal Science, we systematically screened for pairwise protein-protein 
interactions in Saccharomyces cerevisiae using a protein-fragment 
complementation assay (PCA) based on the dihydrofolate reductase (DHFR) 
reporter enzyme. We identified 2770 interactions among 1124 proteins. These 
interactions were mostly novel on the fact that PCA is efficient to detect protein 
interaction within and between protein complexes and that we perform the 
screen on a wider array than previous experiments reported in MIPS and by 
TAP-MS [31]. We demonstrate that PCA can identify protein complex structure 
for a crystallized protein complex, in the case of the yeast RNA polymerase II, 
and globally, originating from all stable crystallized complexes of yeast-
homologous proteins deposited in PDB. Then by comparing likelihood that 
protein interaction can be detected between membrane-spanning proteins and 
the cell compartment location of their C-termini, we demonstrate topological 
relationship between these proteins. Finally, using the cyclic adenosine 3´,5´-
monophosphate (cAMP) dependent dissociation of the yeast protein kinase A 
(PKA) complex as a test system to show full reversibility of the DHFR PCA, 
we insured that the PCA itself does not trap spurious complexes, altering the 
thermodynamics of binding. The in vivo extended network provides insights 
into fundamental cellular processes, including cell polarization and autophagy, 
pathways that are evolutionarily conserved and central to both development and 
human health. 
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1.2. Abstract 
Protein interactions regulate the systems-level behavior of cells; thus, 
deciphering the structure and dynamics of protein interaction networks in their 
cellular context is a central goal in biology. We have performed a genome-wide 
in vivo screen for protein-protein interactions in Saccharomyces cerevisiae by 
means of a protein-fragment complementation assay (PCA). We identified 2770 
interactions among 1124 endogenously expressed proteins. Comparison with 
previous studies confirmed known interactions, but most were not known, 
revealing a previously unexplored subspace of the yeast protein interactome. 
The PCA detected structural and topological relationships between proteins, 
providing an 8-nanometer–resolution map of dynamically interacting 
complexes in vivo and extended networks that provide insights into 
fundamental cellular processes, including cell polarization and autophagy, 
pathways that are evolutionarily conserved and central to both development and 
human health. 
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1.3. Introduction and results 
 The elucidation of protein-protein interaction networks (PINs, or 
interactomes) holds the promise of answering fundamental questions about how 
the biochemical machinery of cells organizes matter, information, and energy 
transformations to perform specific functions [32]. An essential and rarely 
addressed question is whether protein complexes and PINs that are 
reconstructed or reconstituted in vitro or removed from the normal context in 
which they are expressed reflect their organization in living cells. For 
eukaryotes, the test bed for large-scale analysis of PINs is the yeast 
Saccharomyces cerevisiae, where several PIN analyses have been performed 
using yeast two-hybrid screens (Y2H) [10, 11] or tandem affinity purification 
followed by mass spectrometric analyses (TAP-MSs) [12-14]. Each approach 
captures specific features of protein interactions; two-hybrid methods are best at 
measuring direct binary interactions between pairs of proteins, whereas affinity 
purification techniques best capture stable protein complexes. However, neither 
approach measures interactions between proteins in their natural cellular 
context, nor are not easily amenable to studying protein complexes that are 
transiently associated or dynamic under different conditions, that do not survive 
in vitro purification, or that cannot be transported to the nucleus and form 
interactions in the absence of other stabilizing interactions as necessitated in 
Y2H screening. Protein-fragment complementation assays (PCA) provide an 
alternative approach to detect protein-protein interactions (PPIs) in their natural 
context. In the PCA strategy, two proteins of interest are fused to 
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complementary fragments of a reporter protein. If the proteins of interest 
interact physically, the reporter fragments are brought together and fold into 
their native structure, thus reconstituting the reporter activity of the PCA (Fig. 
1A). PCA strategies provide a simple, direct means for the detection of PPIs in 
vivo, and do so with endogenously expressed full-length proteins in their native 
post-translationally modified states and cellular locations [33]. Further, PCAs 
provide spatial and topological information about PPIs. Thus, a large-scale 
PCA screen would provide direct insights into the global structural organization 
of PINs as they exist in the living cell. 
 1.3.1.Genome-wide in vivo screen. 
  We have performed a systematic binary screen for PPIs at a genome-
wide scale in S. cerevisiae using a PCA based on the murine dihydrofolate 
reductase (mDHFR) assay adapted to yeast describe in section 1.5. (Fig. 1A). 
The DHFR PCA is a survival-selection assay based on a mutant of mDHFR that 
is insensitive to the DHFR inhibitor methotrexate but retains full catalytic 
activity and allows detection of PPIs with as few as 25 to 100 complexes per 
cell [24, 34]. We created unique homologous recombination cassettes for all 
5756 consensus genes with both the F[1,2] and F[3] complementary N- and C-
terminal DHFR fragment sequences described in section 1.5..  
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Figure 1 In vivo PCA screen of the yeast PIN. 
(A) Strategy for high-density array screening of the yeast PIN by DHFR PCA. 
Both positive [green circles (MATa/α, CDC19 fused to DHFR fragment [1,2] 
(CDC19-F[1,2]), and MCK1 fused to DHFR fragment [3] (MCK1-F[3]) and 
negative [red circles (MATa/α, CDC19-F[1,2], and CLN3-F[3])] controls are 
included on each plate to ensure that each transfer and selection step has 
occurred correctly. (B) PPV score as a function of raw colony intensity and z 
score (relative colony intensity on plates). This score represents the ratio of the 
number of true positive interactions over the sum of the true positive and false 
positive interactions predicted from the reference sets. (C) The ratio of true 
positives to false positives in the DHFR PCA network compared with other 
large-scale data sets [10, 11, 13, 14, 35, 36]. The achieved PPV is indicated 
above the bars.  
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Successful cassette transformation of S. cerevisiae haploids was achieved for 
4326 (75%) open reading frames (ORFs) with the DHFR F[1,2] fragment in 
MATa and 4804 (83%) ORFs with the DHFR F[3] fragment in MATα strains, 
with a final combined coverage of 5367 (93%) of all ORFs (table S1, http:// 
www.sciencemag.org /content /suppl /2008 /05 /08 /1153878.DC1 
/1153878s_tables.zip). The entire screening process was performed on solid-
phase medium (Fig. 1A and Fig. 2). Briefly, MATa strains (F[1,2] fragment 
fusions) served as baits and were mated individually with all MATα (F[3]) 
strains on high-density arrays. The resulting diploids were transferred to a 
minimal medium [synthetic complete (SC)] plate to select for methotrexate 
resistance (reconstituted mDHFR activity, with native S. cerevisiae DHFR 
inhibited), and colony growth was recorded using automated analysis of digital 
images (Fig. 1A and Figs 3 and 4). PPIs were determined based on the growth 
of the diploid colonies measured by the pixel intensities on the selection plates 
(Figs. 2-4). In total, 3247 individual highly reproducible (Fig. 5) bait screens 
were performed, resulting in more than 15 million individual matings. 
 1.3.2.Data filtering, quality assessment, and overlap with existing PINs. 
  We experimentally accounted for two potential sources of false 
positives in a PCA screen: trapping of nonspecific complexes due to 
irreversible folding of the mDHFR reporter protein, and potential spontaneous 
complementation (folding) of the DHFR PCA fragments.  
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Figure 2: In vivo PCA screen of the yeast protein interaction network. 
Strategy for single bait versus prey array screening of the yeast PIN by DHFR 
PCA. 
  
18 
 
 
Figure 3: Automated extraction of colony intensities on plates. 
The DHFR PCA results were inferred from the growth of diploid colonies on 
plates containing methotrexate. Images of the plates were taken after a 90-hour 
growth period with a 4.0 Mega pixel camera (Powershot A520, Canon). Plate 
images were saved in JPG format at a resolution of 180 dpi and a size of 2,272 
× 1,704 pixels. In order to extract the intensity of the colonies, we used 
available image recognition routines available in the Matlab image analysis 
toolbox and we modified parameters for it to be able to differentiate colonies 
that are in proximity to each other. The quality of the position of the grid and 
the recognition algorithm was examined through visual inspection of all plates.  
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Figure 4: Distribution of colony intensities on plates. 
 (A) Raw intensities prior to filtering. Black lines represent the intensity 
distributions on individual plates. The blue line represents the distribution of 
colony intensities across the entire experiment. The red and green lines 
represent the intensity distribution of the negative and positive controls 
respectively. The second panel shows the distribution of colony intensities 
above 10,000 to illustrate the growth of the methotrexate resistant diploid 
strains. (B) Intensities of colonies below the threshold. (C) Intensities of 
colonies above the threshold after filtering positions corresponding to baits and 
preys that interact with the control fragments.  
20 
 
 
Figure 5: Reproducibility of the screening process. 
 In order to evaluate the reproducibility of the screening process, we repeated 
the screen for 48 baits selected for representing the distribution of number of 
colonies growing above background in the first screen. (A) Example of plates 
that were repeated. Top row, MDH3 and bottom row, MSN5 used as baits. 
Green and red circles represent respectively positive and negative controls. (B) 
Raw colony intensity of experiment two plotted against the raw colony intensity 
of experiment one (Pearson correlation: 0.86, P < 2.2e-16).  
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Figure 6: The DHFR PCA is reversible. 
 (A) Upper panel. cAMP-mediated dissociation of the yeast PKA regulatory 
(Bcy1p) and catalytic (Tpk2p) subunits. Middle panel. Schematic 
representation of an irreversible PCA for PKA and predicted results of the Bcy1 
subunit binding to cAMP-conjugated agarose beads. For the irreversible PCA, 
Bcy1 and Tpk2 dissociate but remain trapped by the folded PCA reporter 
protein. Lower panel. For a reversible PCA, reporter protein fragments unfold 
and dissociate when Bcy1 binds to cAMP-conjugated agarose beads and thus 
Bcy1 remains bound to the resin while Tpk2 is found in the unbound 
supernatant fraction. (B) The DHFR PCA is fully reversible. As reported 
previously [21], the Rluc PCA is reversible; Bcy1 is found in the cAMP-
conjugated agarose fraction while Tpk2 is found in the wash. Precisely the 
same result is found for the DHFR PCA, suggesting that it is reversible, while 
Venus YFP PCA is irreversible.  
22 
 
First, we used the adenosine 3´,5´-monophosphate–dependent dissociation of 
the yeast protein kinase A complex as a test system [21] to show that the DHFR 
PCA is fully reversible, and thus the trapping of complexes is unlikely (Fig.6). 
Second, we screened all the strains against the individual F[1,2] and F[3] 
complementary fragments or fragment-peptide linker sequences. This allowed 
us to eliminate 344 promiscuous, highly expressed proteins (Fig. 7 and table S2, 
http:// www.sciencemag.org /content /suppl /2008 /05 /08 /1153878.DC1 
/1153878s_tables.zip), several of which are also often observed as false-
positives in affinity purifications. We next identified a threshold of colony 
intensity above which we could infer PPI. The Munich Information Center for 
Protein Sequences (MIPS) complexes were used as a standard set of true 
positives, along with 266,858 true negative interactions between proteins 
expressed in different cellular compartments or having negatively correlated 
expression [31, 36]. After several filtering steps describe in section 1.5. and 
benchmarking on the reference PPIs, we obtained a high-quality data set 
containing 2770 interactions among 1124 proteins that reach a positive 
predictive value (PPV) of 98.2% (Fig. 1B and tables S3 and S4, http:// 
www.sciencemag.org /content /suppl /2008 /05 /08 /1153878.DC1 
/1153878s_tables.zip). This resulted in data having precision (number of true 
positives relative to false positives) comparable to the MIPS small-scale 
experiments and all previous large-scale data sets (Fig. 1C and Fig. 8).  
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Figure 7. Distribution of protein abundance. 
 The distribution of protein abundance for cells grown on the same (SC, SD + 
glucose (from [37])) medium used in the DHFR PCA screen of the entire 
proteome (black), proteins of the DHFR PCA network (blue) and proteins 
interaction with the control fragments (yellow). 
  
24 
 
 
 
Figure 8: Quality assessment for the PCA networks and other PPI 
networks. 
 The curve represents the total number of true positive interactions and the total 
number of false positive interactions as a function of the score thresholds for 
defining PPIs in the DHFR PCA screen (ROC curve). Values for published 
datasets are shown as well as values of the final DHFR PCA networks. Sources 
for the other networks are described in the section 1.5.13. 
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The proteins in the DHFR PCA network are highly enriched in cellular 
compartments [for example, organelle membranes (P < 10
−12
), proteasome 
regulatory particles (P < 10
−8
), the nucleolus (P < 10
−7
), and the cell cortex (P < 
10
−7
)] that were less represented in comprehensive TAP-MS results [36] (tables 
S5 and S6, http:// www.sciencemag.org /content /suppl /2008 /05 /08 
/1153878.DC1 /1153878s_tables.zip). The high sensitivity of the DHFR PCA 
assay is reflected in the abundance of the proteins that populated our network, 
which are on average only slightly more expressed than the proteome [the 
median log10(protein abundance) = 2.32 versus 2.28; Wilcoxon rank sum test, 
P= 0.19] and spanning the whole distribution of protein abundance (Fig. 7). 
Because this study was performed in vivo, with a technique never used at this 
scale and in a different medium than previous experiments, we expected that 
many interactions would be previously undiscovered. An examination of major 
databases of PPIs reveals that most of the interactions (~80%) we report are 
among protein pairs for which no data had been previously reported (Fig. 9A). 
However, when considering only PPIs that could be detected by both DHFR 
PCA and the other experiments, we confirmed between 16 and 41% of PPIs 
reported in previous large-scale screens, suggesting excellent concordance 
between the results of our and very different methods (Figs. 9B and 10). 
Further, PPIs derived from PCA represent pairwise interactions, which contrast 
with TAP-MS PINs, which identify clusters and thus complexes of interacting 
proteins. PPIs detected by PCA are therefore either within, between, or outside 
these complexes and thus complement these previous studies.  
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Figure 9: Overlap of the DHFR PCA network with other large-scale 
experiments. 
 (A) Most DHFR PCA PPIs are new, since they score 0 within the distribution 
of the number of times a known interaction has been independently deposited in 
major PPI repositories. Examples of interactions are shown above the bars. (B) 
The overlap of the DHFR PCA network is substantially increased when only 
the interactions that could be discovered are considered, i.e. only identified 
successful baits and preys are considered. Bars indicate the number of PPIs that 
could have been discovered by PCA. In red is the number of interactions that 
were discovered. Percentages indicate the percentage of interactions that were 
discovered by PCA out of the total possible.  
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Figure 10: Overlap of the DHFR PCA network with other large-scale 
experiments. 
 On the left is the overlap between the different networks. On the right are the 
same overlaps, but only for those interactions that could have been detected in 
both experiments; i.e. cases in which the interactions were tested for in both 
experiments. 
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For instance, 10% of the DHFR PCA PPIs map within specific complexes in 
the combined analyses of the two TAP-MS data sets [13, 31], and 36 and 38% 
of the DHFR PCA PPIs are between one protein found in a complex and one 
protein not in the published data set, or two proteins not in the data set, 
respectively. We identified several interactions among complexes (15%), which 
probably mediate the integration of biological processes among PIN modules. 
For instance, PPIs occur among complexes that are more related in their 
functional annotations than would be expected to occur by chance [interacting 
protein pairs had a semantic similarity score of cell compartments (CCs) of 3.44 
versus 1.64, P < 10
−100
; of biological processes (BPs) of 3.48 versus 1.51, P < 
10
−80
; and of molecular functions (MFs) of 3.53 versus 2.3, P < 10
−10
]. For 
example, we see interactions between Dhh1p and Lsm4p, both involved in the 
RNA metabolic process but part of the CCR4 and the RNA-splicing complex, 
respectively. Another example is the interaction between Reg1p and Snf1p: 
subunits of the serine/threonine phosphoprotein phosphatase and SNF1 
complex, respectively, but both involved in the regulation of carbohydrate 
metabolic processes (table S7, http:// www.sciencemag.org /content /suppl 
/2008 /05 /08 /1153878.DC1 /1153878s_tables.zip). Finally, we report 286 
interactions involving one uncharacterized protein with proteins of known 
function (n = 278 interactions) or between two uncharacterized proteins (n = 8) 
[38], which will aid in their functional annotation. 
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 1.3.3.General organization of the yeast DHFR PCA PIN. 
  Because we detected PPIs as they occurred in intact cells, with the 
faithful representation of gene expression timing and protein localization, we 
predicted and observed stronger coregulation of interacting protein pairs 
(Pearson r = 0.2 versus r = 0.1, P << 0.001) than was expected for random 
networks of the same size with the same protein connectivity. This is also 
mirrored in the enrichment of interactions among proteins that share the same 
BPs, MFs, and CCs and a depletion of interactions among genes of different 
categories (Fig. 11 and Fig. 12). PPIs among categories are somewhat more 
enriched in the PCA-determined network as compared with TAP-MS studies. 
For instance, 64, 56, and 63% of DHFR PCA interactions map to different BPs, 
CCs, and MFs, whereas these numbers are smaller in the TAP-MS PINs [58, 
46, and 57% [14] and 51, 49, and 58% [13]]. Much of this increased enrichment 
of the cross-cellular components reflects interactions among proteins that the 
DHFR PCA method covers more of than TAP-MS; these are interactions that 
appear to represent the natural exchange of proteins between, for instance, the 
endoplasmic reticulum, Golgi, mitochondrial envelope, and vacuolar proteins, 
whereas others reflect the organization of complex cellular processes. For 
example, high enrichments in interactions between proteins localized to the bud 
and bud neck with those of the cell cortex, cytoskeleton, plasma membrane, and 
sites of polarized growth reflect the roles of these proteins in several 
compartments during cell division.   
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Figure 11. Interactions are enriched within GO categories. 
 The DHFR PCA network covers several classes of protein function, location, 
and biological process. The colors above the diagonal represent positive and 
negative deviations from the expected number of interactions between two cell 
compartments. A positive z score indicates a larger number of interactions 
within or between two categories as compared with a random network. A 
negative z score indicates a smaller number of interactions than expected. A z 
score of 2 or –2 corresponds to a P value of 0.05, and a z score of 5 or –5 to a P 
value of 5 × 10
–7
. Values below –5 and above 5 were given these minimal and 
maximal values. Entries below the diagonal indicate the observed numbers of 
interactions on a log10 scale.   
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Figure 12: Interactions are enriched within Gene Ontology categories.  
The DHFR PCA network covers several classes of protein function, location 
and biological process. The colors above the diagonal represent positive and 
negative deviations from the expected number of interaction between two 
categories, Biological Process or Molecular function. A positive z-score 
indicates a larger number of interactions within or between two categories 
compared to a random network. A negative z-score indicates a smaller number 
of interactions than expected. A z-score of 2 or -2 corresponds to a P-value of 
0.05 and a z-score of 5 or -5 to a P-value of 5×10
-7
. Values below -5 and above 
5 were given these minimal and maximal values. z-scores were calculated by 
generating 10,000 random networks. Entries below the diagonal indicate the 
observed number of interactions on a log10 scale.  
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We also saw strong compartmentalization of interactions; for example, for 
nuclear and nucleolar proteins, which show enrichment in interactions between 
proteins in these two compartments but strong depletions in interactions with 
those of any other compartment. Equally, patterns of cross-process and 
molecular function categories reflect differences in complexity and organization 
(Fig. 12). For example, among molecular functions, RNA binding is 
specifically enriched in interactions between helicase and translation regulatory 
functions, whereas the more general transporter activity category shows links to 
diverse functions. The observation that PCA interactions detect links among 
functionally related categories is supported by a semantic analysis of the full 
Gene Ontology (GO) hierarchies. Proteins that show interactions with different 
GO Slim annotations have higher semantic similarities in their GO terms than 
expected by chance (CCs, 1.52 versus 0.94, P < 10
−231
; BPs, 2.04 versus 1.35, P 
< 10
−122
; and MFs, 1.89 versus 1.64, P < 10
−8
), and may thus represent 
interactions relating information among these processes and CCs that allows 
their integration into higher-order networks. As we describe below, these 
interactions reveal specific spatial and topological relationships between known 
and previously unknown complexes underlying both known and previously 
unknown cellular processes. 
 
 1.3.4.Global structure and topology of the in vivo interactome. 
  PCA-detected interactions are interpreted differently than purified 
protein complexes or binary (one-to-one) interactions determined in Y2H 
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screens, allowing us to address how protein complexes and PINs are spatially 
and topologically organized in living cells. Whether an interaction can be 
observed depends on the distance between the C termini of two proteins and the 
length of the polypeptide linker separating bait and prey proteins to the PCA 
fragments [24, 34] (Fig. 1A). Given that the linkers used in this study were of 
10–amino acid residues, for a given protein complex we expected to detect only 
binary (direct) or near-binary (indirect, C termini within 82Å, but mediated by 
one or more other proteins) interactions for protein pairs separated by less than 
this distance. We first tested this prediction by exhaustively screening all pair-
wise interactions (n = 45 possible pairs) in the well-known RNA polymerase II 
complex (Fig. 13). We found that we were 5.7 times more likely to detect an 
interaction if the C-termini were within 82 Å (Fisher’s exact test, P = 0.01) 
(Fig. 14B). Interactions that were detected but not predicted could be due to 
alternative assemblies of this complex in intact cells, to changes in their 
configuration under different conditions, or to protein dynamics that cannot be 
interpreted from crystal structures. We then asked whether spatial restraint on 
observable interactions is reflected in the complete DHFR PCA network.   
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Figure 13. RNA polymerase II complex reconstitution through DHFR 
PCA. 
(A) Results of the RNA polymerase II complex PCA network through an 
exhaustive screen for interactions among the ten subunits. Colonies for diploid 
strains that show resistance to methotrexate are indicated with red "+" and for 
those showing no resistance, with blue "-". (B) Mean colony pixel intensity 
values extracted from the high-resolution image in (A) by quantification of total 
colony pixel intensities. (C) t-scores for colony pixel intensities ranging from 0 
to 10 and higher (P < 0.0001) resulting from the comparisons with control 
colonies. (D) Summary of the results of the RNA Pol II DHFR PCA screen 
where edges represent a physical interactions corresponding to a t-score of 4 
and higher (P < 0.05) and nodes are the individual RNA Pol II subunits. Nodes 
colored in yellow, blue and green are respectively RNA Pol II exclusive 
proteins, RNA Pol III exclusive protein and RNA Pol II and RNA Pol III shared 
proteins. 
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Figure 14. The DHFR PCA results provide structural and topological 
insights.  
PCA fragments have to be in proximity to each other in order to fold into the 
active structure of the reporter protein. (A) PCA PPIs versus protein complexes. 
Comparison of the PCA network with databases of curated protein complexes 
(MIPS) and inferred from computational analysis of TAP-MS [31] allows 
classification of four types of PCA interactions: in which both proteins are 
found within a complex (type 1), are inferred to be in two separate complexes 
(type 2), one protein is in a complex and the other is not in the network (type 3), 
or both are absent from the network (type 4) [31]. Columns of numbers indicate 
the number of PCA PPIs observed for each data set and each category. (B) A 
thorough DHFR PCA screen of the RNA polymerase II complex [Protein Data 
Bank (PDB) number 1I3Q] detects predicted interactions among the 10 
subunits. (C) An interaction is 3.5 times more likely to be detected for a pair of 
proteins known to interact if the C termini of these proteins are within 82 Å of 
each other in the case of stable crystallized complexes of yeast-homologous 
proteins deposited in the PDB. (D) Membrane protein topology and PPI 
detection by PCA. A protein interaction is 12 times more likely to be detected if 
the C termini are in the same cell compartment.   
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An examination of homologous protein complexes with solved structures 
showed that we were 3.5 times more likely to detect an interaction between a 
pair of proteins that have C termini closer than 82 Å than for those with longer 
distances between C termini (Fisher’s exact test, P < 0.002) (Fig. 14C). Further, 
we found that the interacting protein pairs possess domains known to mediate 
PPI more often than they would be expected to have possessed by chance (7.3% 
of protein pairs have domains known to mediate PPI versus 0.6%, P << 0.001). 
Thus, the data will be useful for predicting spatial relationships and the bases of 
molecular recognition among proteins, protein domains, and peptide 
recognition motifs. Finally, because the C termini of proteins have to be in 
close proximity and also oriented into the same cellular compartment, PCA 
provides information about membrane protein topology (Fig. 14D) [24-27]. Our 
results demonstrate that the topology of interacting membrane proteins is also 
reflected in the PIN; specifically, that membrane proteins that colocalize to the 
same cellular compartment are 12 times more likely to show an interaction if 
they have a parallel rather than an antiparallel orientation (Fisher’s exact test, P 
< 0.0005) [39]. These PPIs between membrane-associated and soluble proteins 
will serve to predict cross-compartment functional relationships, such as 
interactions of endoplasmic reticulum–associated membrane receptors and 
cytosolic or nuclear effector proteins. 
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1.3.5.Bird’s-eye view of the yeast in vivo PIN.  
 The general predictions described above led us to pose specific 
hypotheses for how protein complexes and networks are organized in living 
cells. Unsupervised hierarchical clustering of the 2770 DHFR PCA interactions 
provides an overview of the in vivo PIN (Fig. 15 and file S1, http:// 
www.sciencemag.org /content /suppl /2008 /05 /08 /1153878.DC1 
/1153878s_data.zip). A number of crystallographically or biochemically well 
characterized complexes are organized as clusters along the diagonal, 
confirming that their organization in cells reflects their predicted structures in 
vitro. Also, substructures of these clusters are consistent with those of 
previously affinity purified subcomplexes. For instance, the nuclear pore 
contains a number of distinct subclusters, three of which clearly correspond to 
known subfractionated complexes (the Nup84 subcomplex includes Nup85, 
Nup120, and Nup145, which are in the network, and Nup84 and Seh1p, which 
are not in the network; a second subcomplex that includes Nup57, Nup49, and 
Nsp1, which are in the network, and Nic96, which is not in the network; the 
Nup82 subcomplex includes Nup159, Nup82, and Nsp1, which interacts with 
Nup166 for its proper localization) [40]. These subcomplexes also represent 
groups of proteins that have been hypothesized to form direct contacts in a 
detailed architectural map of the assembly of the nuclear pore complex [41]. 
Our results now suggest that such substructures exist in intact cells.  
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Figure 15. The DHFR PCA network is modular and interconnected.  
Clustering of the DHFR PCA network reveals numerous known complexes, 
within which the substructure represents known subunits. Proteins that have 
interaction patterns similar to those of other proteins and that interact together 
are grouped along the diagonal.   
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Similarly, the proteasome partitions into subcomplexes that correspond to the 
composition of characterized fractions and of structures that can be visualized 
in intact cells [42]. Complexes described in vitro can therefore accurately 
reflect those seen in vivo by PCA and as reported by whole-cell electron 
tomographic studies of protein complexes [43]. PPIs between complexes that 
reflect the cross-compartmental and cross-functional interactions described 
above (Fig. 11 and Fig. 12) can be visualized as off-diagonal interactions on 
this map (Fig. 15). These represent links among several network modules that 
have been well described and shown to be central to eukaryotic cell biology. 
Our map therefore allows us to identify previously unknown multifunctional 
PINs and to associate and integrate other proteins to these processes (Fig. 16). 
First, we showed that, starting from the Arp2-actin organization network, we 
are able to describe new connectivity among the complex network of 
interactions that integrates actin filament assembly and patch formation with 
secretion and cell-wall synthesis and ultimately with membrane abscission and 
cell separation during cell division. Second, we showed that starting from the 
retromer complex, we can physically integrate the protein-sorting machinery 
and trafficking with the synthesis of autophagosomes, links that were 
previously suggested from genetic and cell-biological observations.  
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Figure 16. The yeast DHFR PCA network provides insights into both cell 
polarity and autophagy. 
 Blue edges denote previously unknown interactions (10) and orange edges 
denote interactions reported at least once in major databases. (A) Network at 
the bud neck. Physical association, detected by PCA between proteins that 
localize to the bud and bud neck (blue) and proteins that localize predominantly 
to the bud neck (orange), and proteins lacking localization data (gray), can be 
used to assemble the structure of a polarity PIN. This PIN shows both known 
interactions and previously unknown coupling between proteins involved in 
actin-filament organization and patch and assembly with proteins acting in 
secretion and cell-wall synthesis. The interactions between protein complexes 
in the PIN reflect the complex transition of proteins between the bud tip and the 
bud neck, which function in cell polarity from bud emergence to cytokinesis. 
(B) Autophagy network. Interactions directly connecting proteins involved in 
autophagy (ATG), vacuolar protein sorting (VPS), and cytoplasm-to-vacuole 
targeting (CVT) (orange) and other proteins (blue) are shown.   
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1.3.6.In vivo network at the bud neck. 
 Successful completion of a mitotic cell cycle, and the creation of a viable 
daughter cell, involves the tight coordination of nuclear events with 
mechanisms that control cell morphology. The formation of a bud is an 
example of this temporal and spatial coordination. The bud is the recipient of 
the segregated material from a mother cell, and ultimately will form the 
daughter cell. DNA, organelles, proteins, and mRNAs are selectively 
transported into the bud from the mother and after cytokinesis are enclosed 
within the daughter cell [44]. After bud-site selection, recruitment and assembly 
of proteins that act in polarized growth and bud emergence occur at the 
incipient bud site. We can construct a network (Fig. 16A) that captures the 
dynamic assembly and localization of “polarisome” proteins and both known 
and previously unknown interactions to proteins that provide input signals from 
the cell-cycle machinery via specific cyclin–cyclin-dependent kinase 1 (Cdk1) 
complexes and the Rho signaling proteins that control polarity and cell integrity 
[45]. These mechanisms organize and polarize the cytoskeleton and the 
secretory apparatus at the bud tip and bud neck during cell-cycle progression. 
Many polarisome proteins that localize to the bud and bud neck (Fig. 16A, 
blue), or predominantly to the neck (Fig. 16A, orange) are found in the PCA 
network. Bem1 plays a central role in bud polarization through its ability to 
build scaffolds, at sites of polarized growth, of an activator (Cdc24) and an 
effector (Ste20) of the Cdc42 Rho-like guanosine triphosphatase (GTPase) [46]. 
Kel1 and Kel2 also act as scaffolds for polarity components at the bud tip and 
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bud neck and were shown to couple to Bem1 and Spa2. Further, the exocyst 
complex functions in the vectoral transport of vesicles from the Golgi to the 
bud and promotes plasma membrane expansion, and the Arp2/3 complex, by 
mediating the assembly of actin patches, promotes membrane recycling through 
endocytosis [47]. An extensive network of proteins containing the Arp2/3 actin-
assembly complex, its activator Las17, and effectors of actin organization is 
represented in our network and recapitulates many known protein interactions 
(Fig. 16A, orange edges), but extends the level of connectivity among 
components (Fig. 16A, blue edges), especially for Sla2, Las17, and Arc40. 
However, Arc40 of the Arp2/3 complex is linked via Rvs161 to the GTPase-
activating protein (GAP) Gyl1, known to function in actin-patch formation and 
polarized exocytosis; Gyl1 is also connected to the exocyst through the Sec4 
GTPase and to Ynr065C (Fig. 16A), a large protein of previously unknown 
function and for which localization data are unavailable. In a further extension 
of this actin patch–assembly complex, we found that Las17 and Myo5, a type I 
myosin that associates with actin patches, interact with Syp1, a protein 
implicated in actin cytoskeletal organization. Further, we showed that Syp1 
physically associates with multiple proteins, including the bud-neck septins 
Cdc11 and Shs1 and the cell-surface sensors Mid2 and Wsc2, which activate 
the cell-integrity pathway through Rom2.Collectively, the interactions among 
distinct complexes seen by PCA represent a potential regulatory network 
involved in bud polarization, bud-neck organization, and cytokinesis, a network 
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that captures the dynamic transitions of polarity and exocyst components 
between the bud tip and the bud neck during the cell cycle. 
1.3.7. In vivo network of autophagy. 
  Autophagy is the process whereby organelles and the cytosol are 
engulfed within membrane vesicles for delivery to the lysosome/vacuole for 
degradation and macromolecule recycling and is involved in development, 
response to stress, and pathogen resistance. Dysfunction of this conserved 
eukaryotic process is associated with neurodegenerative conditions, namely 
Huntington’s, Alzheimer’s, and Parkinson’s diseases, and with cancer [48]. 
Proteins involved in autophagy are rich in interactions in the yeast DHFR PCA 
network (Fig. 16B), including the endosomal sorting complexes required for 
transport (ESCRTs) ESCRT-0 and ESCRT-III, the retromer complex, and other 
known interactions (Fig. 16B, dashed gray circles). Vps32, Vps24, and Vps2 
are three of the four subunits of the ESCRT-III complex that are responsible for 
the sorting of transmembrane proteins into the multivesicular body (MVB) 
pathway. Dysfunction of this complex leads to autophagosome accumulation 
and neurodegeneration in mammals [49]. ESCRT-0 is required for sorting 
ubiquitinated membrane proteins before vacuolar degradation. Vta1 is a 
member of the MVB pathway and is known to bind to Vps60 and Vps4, 
regulating the activity of the latter [49]. Proteins destined for secretion or for 
delivery to intracellular compartments follow the same route and are sorted in 
the trans-Golgi network. In yeast, the lysosomal/vacuolar proteins are sorted 
from other proteins by the carboxypeptidase Y receptor Vps10. These receptors 
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are then returned from the prevacuolar compartments to the trans-Golgi 
network by the retromer complex. The role of the retromer complex in protein 
transport is also crucial in metazoa because, for example, it is essential to the 
formation of important morphogen gradients along body axes [50]. Some of the 
interactions we uncovered shed light on this functional relationship between 
protein sorting and trafficking by the retromer complex and Vps10. For 
instance, we find that Vps10 shows physical interactions with the retromer 
complex, which was previously hypothesized on the basis of genetic 
interactions with Vps35 and Vps26 [51, 52]. These observations also suggest a 
topological relationship between these two proteins that add to our 
understanding of the structural organization of the retromer complex recently 
resolved by crystallography [53]. The interaction between Chc1 (clathrin heavy 
chain 1 human homolog), the clathrin heavy chain involved in protein transport 
and endocytosis, and Vps10 was also hypothesized based on genetic data that 
shows Vps10 is rerouted to the plasma membrane in a chc1 vps1 mutant instead 
of its normal travel to the endosome [54]. We confirm this functional 
relationship and show that it is mediated through a physical interaction. Most of 
the interactions we see are not previously described (75%) (Fig. 16, blue edges) 
and represent a substantial advance in describing the autophagy and cytoplasm-
to vacuole targeting pathways. For instance, Atg27 shows a particularly large 
number of interactions. This protein plays a critical role in the formation of 
sequestering vesicles, including autophagosomes. It localizes to the Golgi 
apparatus, the mitochondrion, and the phagophore assembly site. Despite its 
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importance, it showed no interactions in recent large-scale TAP-MS 
experiments and only one in previous Y2H screens [35]. Recent work affirms 
its involvement in both bulk and specific autophagy, and it is hypothesized that 
Atg27 (along with Atg9, not represented here) labels the membrane source for 
its transport to and the formation of autophagosomes [55]. Our results suggest 
that Atg27 occupies a central role in autophagy because it physically interacts 
with the retromer complex and with many other vacuolar proteins involved in 
the sorting of vacuolar hydrolases; further, these results implicate 
uncharacterized ORFs, such as YML018C, YMR221C and YDR119W, in this 
process. 
 1.4.Conclusions. 
  There remain many insights to be drawn beyond the general details, 
overview, and examples of extended structural and functional networks 
reported here for the in vivo protein interactome, and other dimensions of the 
interactome remain to be explored: How dynamic are these interactions? What 
are the effects of growth conditions on PPI network architecture? The 
functional and integrative genomic tools developed for this study will enable 
analysis of protein-interaction dynamics on any scale to uncover mechanisms of 
biochemical network regulation. A wide variety of PCA reporter enzymes can 
be used to study temporal and spatial dynamics of protein interactions over a 
broad range of time scales (from seconds to many hours) and under the 
influence of natural or artificial perturbations [33]. Further, the topological 
requirements of PCA generate a protein-complex topology map at 8-nm 
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resolution that will provide reference data for studying the spatial dynamics of 
functional protein complexes by immunofluorescence or by monitoring the 
localization of proteins genetically tagged with fluorescent proteins. Finally, 
they will also provide reference constraints for determining the architecture of 
macromolecular assemblies [41]. The integration of the results from such 
efforts with those of gene regulation dynamics and protein modifications will 
lead to a fuller understanding of how complex cellular processes are 
orchestrated at a molecular and structural level in the living cell. 
 
Supplementary Table and File is linked to the online version of the paper at 
www.sciencemag.org/cgi/content/full/1153878/DC1. 
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1.5. Methods  
1.5.1. Adaptation of the mDHFR Protein-fragment Complementation 
Assay for studies in yeast.  
The mDHFR PCA (henceforth DHFR PCA) was previously developed for E. 
coli, plant protoplasts and mammalian cell lines [20, 24, 56]. To adapt the 
DHFR PCA for high-throughput screening in Saccharomyces cerevisiae we 
created a double mutant (L22F and F31S) that is 10,000 times less sensitive to 
methotrexate than wildtype scDHFR, while retaining full catalytic activity [22]. 
The L22F-F31S double mutant was created by introducing by site-directed 
mutagenesis the L22F mutation into the existing F31S mutant DHFR PCA N-
terminal fragment (F[1,2]) previously developed for studies in mammalian cells 
[24]. The mutant was designed so that methotrexate inhibition of the wildtype 
scDHFR activity would be complemented by the activity of the reconstituted 
DHFR PCA reporter. In order for a PCA to minimally perturb the natural 
kinetics of protein-protein interactions and to prevent trapping of non-specific 
complexes, it has to be reversible; the reporter protein has to unfold and the 
fragments dissociate upon the disruption of a protein complex. PCAs based on 
the Gaussia princeps and Renilla reniformis luciferase have been shown to 
have this property whereas those based on GFP variants are irreversible [21, 
22]. To directly assay the reversibility of the DHFR PCA, we used an in vitro 
assay that uses the cAMP dependent dissociation of regulatory (Bcy1) and 
catalytic (Tpk2) subunits of the yeast homologue of serine/threonine kinase 
PKA. In this assay, binding of the Bcy1 regulatory subunit to resin-immobilized 
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cAMP is probed and whether the Tpk2 catalytic subunit is dissociated or 
remains associated with Bcy1 can be assessed [21, 57]. These experiments 
allow us to directly distinguish two possible outcomes of Bcy1:Tpk2 
dissociation (Fig. 6A): i), the PCA is a trap; that is, while a PKA complex may 
dissociate on binding to the cAMP resin conjugate, the PCA fragments do not 
unfold and thus both catalytic and regulatory proteins remain bound to the 
resin; ii), PKA subunits dissociate and the PCA fragments unfold and separate, 
resulting in the release of the catalytic domain from the cAMP resin. In this 
case, the regulatory subunit remains bound to the resin while the catalytic 
subunit would be found in supernatant. We tested the reversibility of the DHFR 
PCA in direct comparison to the Rluc and “Venus” YFP PCAs, which we 
previously showed to be respectively reversible and non-reversible [21]. We 
constructed two sets of yeast expression vectors harboring fusions of Bcy1 and 
Tpk2 to complementary fragments of the Rluc, YFP and DHFR PCAs under 
control of a constitutive TEF promoter. Bcy1 and Tpk2 genes were PCR 
amplified from the S. cerevisiae genome and subcloned into yeast expression 
vectors harboring mDHFR, Renilla luciferase (Rluc) or “Venus” YFP PCA 
fragments fused 3’ to Zip-linker, replacing the Zip sequences (p413-TEF-Zip-
linker-F[3], p415-TEF-Zip-linkers-F[1,2], p413-TEF-Zip-linkerhRluc- F[1] and 
p415-TEF-Zip-linker-hRlucF[2], p413-TEF-Zip-linker-Venus YFP F[1] and 
p415-TEF-Zip linker-Venus YFP F[2]). Approximately 100 ng of each of the 
complementary PCA fragments expression vectors were cotransformed into S. 
cerevisiae BY4743 strain (MATa/α his3/his3 leu2/leu2 lys2/LYS2 
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MET15/met15 ura3/ura3) and positive clones were selected in synthetic 
complete medium (SC) –methionine, -lysine, -uracil and –histidine for 
p413/p416 transformed strains. BY4743 diploid strains harboring plasmids 
encoding the three DHFR, Rluc or “Venus” YFP Bcy1-Tpk2 PCAs were grown 
in 5 ml of synthetic complete medium (SC) (-met, -lys, -his, -leu) to an OD600 
of 1.0, harvested and treated with 200 units of lyticase (Sigma-Aldrich, St-
Louis, MO) for 2 hrs at 30°C to digest the cell wall. We extracted soluble lysate 
and incubated with the cAMP resin followed by a series of washes and then 
probed supernatant and bound fractions with antibodies that can bind to each 
PCA fragment (Fig. 6B). Specifically, the protoplasm was harvested at 500xg 
for 30 minutes at 4°C and resuspended in 0.1% volume of the original culture 
volume of phosphate-buffered saline (PBS) (pH 7.4) + 1% (v/v) Triton-X-100 + 
protease inhibitors (100 µg/ml) PMSF and MiniComplet EDTA free protease 
inhibitor tablets (Roche, Indianapolis, IN) and stored on ice for 30 minutes. The 
lysate was clarified by centrifuging at 12,000xg for 30 minutes at 4°C. The 
soluble fraction of each lysate was separated into two equal aliquots (volume of 
250 µL). The first aliquot was incubated for 15 minutes with 1 mM dibutyryl 
cyclic AMP (DBcAMP) dissolved in water (Biolog, Bremen, Germany) and the 
second aliquot with water only.. 30 μL of 8- (2-Aminoethylamino)adenosine- 
3', 5'-cyclic monophosphate (8-AEA-cAMP) crosslinked to agarose beads 
(Cedarlane Laboratories ltd, Canada, ON) were added to each of the two 
aliquots and incubated at 4°C for two hours. The agarose beads were then 
washed three times successively with equal volumes of phosphate-buffered 
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saline (PBS) (pH 7,4) + 1% (v/v) Triton- X-100 + protease inhibitors and 
pelleted by centrifugation (2500xg) at 4°C. The agarose beads and 25 µL 
aliquots of each discarded wash and of the lysates were boiled for 5 minutes 
with Laemmli sample buffer and loaded onto 10% polyacrylamide gel and 
proteins were resolved by SDS-PAGE. Proteins were transferred from gels onto 
PVDF membranes (BioRAD, CA) by semi-dry electroporation (Hoefer 
SemiPhor, Pharmacia Biotech, San Francisco, CA, USA). The membranes were 
blocked in Tris-buffered saline with 0.2% (v/v) Tween-20 (TBST) + 5% 
(wt/volume) milk for 16 hrs. The blocked membranes were incubated for 2 hrs 
at room temperature with the primary antibodies: anti-Rluc antibodies 
(Mab4410 versus Rluc-F[1], Mab4400 versus Rluc-F[2], (Chemicon, 
Temecula, CA)), anti-dihydrofolate reductase antibodies (D1067 versus DHFR-
F[1,2], D0942 versus DHFR-F[3] (Sigma-Aldrich, St-Louis, MO)) and anti-
GFP antibody (A6455 versus both “Venus” YFP-F[1] and “Venus” YFP-F[2]); 
(Molecular probe, Eugene, OR, USA), 11814460001 versus “Venus” YFP-
F[2]; (Roche, Basel, Switzerland)). The membranes were washed 3 times with 
TBST and incubated for 90 minutes at room temperature with the appropriate 
secondary antibody coupled to horseradish peroxidase: anti-rabbit horseradish 
peroxidase (HRP)-conjugated antibody (#7074; Cell Signaling technology, 
Danvers, MA, USA) for primary antibodies raised in rabbit (D1067, D0942, 
A6455) and antimouse horseradish peroxidase (HRP) conjugated antibody 
(#7076, Cell Signaling technology, Danvers, MA, USA) for primary antibodies 
raised in mouse (Mab4400, Mab4410 and 11814460001), and washed with 
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TBST. The membranes were revealed with the western lightning 
chemiluminescence reagent plus (PerkinElmer, USA) substrate of HRP with 
Kodak Biomax XAR film over 30 seconds and 20 minutes exposure. 
Comparison of the three PCAs (Fig. 6B) showed that Bcy1 remained bound to 
cAMP resin while Tpk2 is found in the supernatant for both Rluc and DHFR 
PCAs whereas both the Bcy1 and Tpk2 subunits remained associated with 
cAMP resin in the case of the “Venus” YFP PCA. Thus, in contrast to the 
irreversible Venus YFP PCA and as already demonstrated for the Rluc PCA 
[21], the DHFR PCA is reversible. 
1.5.2. Creation of universal DHFR PCA fragment templates and creation 
of homologous recombination cassettes. 
 We set out to create two universal oligonucleotide cassettes encoding each 
complementary DHFR PCA fragment and two unique antibiotic resistance 
enzymes to allow for selection of haploid strains that have been successfully 
transformed and recombined with one or the other homologous recombination 
cassettes. The universal cassettes were constructed in three steps as follows: 
First, the ADH terminator (ADHterm) was PCR amplified from S. cerevisiae 
genomic DNA with a forward primer containing a BamHI restriction site prior 
to a 5’XbaI restriction site and a reverse primer containing a BglII 3’ restriction 
site using the high fidelity Accuprime Pfx DNA polymerase (Invitrogen, 
Carlsbad, California). The BamHI/ BglII digested PCR product was subcloned 
into the multicloning site of the pAG25 and pAG32 plasmids (henceforth called 
pAG25ADHterm and pAG32 ADHterm) [58]. Second, the DHFR PCA N-
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terminal (F[1,2]) and C-terminal (F[3]) fragments, each proceeded 5’ by a 
sequence coding for a 10 amino acid (Gly.Gly.Gly.Gly.Ser)2 flexible 
polypeptide linker (henceforth referred to as “linker”) were PCR amplified from 
pMT3 mammalian expression vectors harboring these constructs [24]. These 
PCRs were performed with a forward primer containing a 5’ BamHI restriction 
site and reverse primer containing a 3’ XbaI restriction site. The linker- F[1,2] 
was subcloned into pAG25ADHterm between BamHI and XbaI restriction sites 
3’ to the ADHterm sequence, creating the pAG25-linker-F[1,2]-ADHterm 
cassette. The linker-F[3] was subcloned into the multicloning site of 
pAG32ADHterm between BamHI and XbaI restriction sites creating the 
pAG32 linker-F[3]-ADHterm. Each of the plasmids used for subcloning 
already contained unique antibiotic resistance cassettes that in the resulting 
constructs are 3’ to the ADHterm. Thus, the final DHFR PCA F[1,2] universal 
template consists of pAG25-linker- F[1,2]-ADHterm followed by TEF 
promoter, nourseothricin N-acetyl-transferase (NAT1) that confers resistance to 
nourseothricin and finally a TEF terminator. The final DHFR PCA F[3] 
universal template is the pAG32 linker-F[3]-ADHterm followed by TEF 
promoter, hygromycin B phosphotransferase that confers resistance to 
hygromycin B and TEF terminator. The resulting universal templates were used 
to create homologous recombination cassettes for each of 5,756 budding yeast 
genes by PCR using 5’ and 3’ oligonucleotides consisting of 40-nucleotide 
sequences homologous to the 3’ end of each ORF (prior to the Stop codon) and 
a region approximately 20 nucleotides from the stop codon. Design of 
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recombination cassette and diagnostic PCR primers are described below in 
section 1.5.3. 
1.5.3. Oligonucleotide design and synthesis. 
 The oligonucleotides used for the 3’-tagging of each ORF with recombinant 
DHFR PCA cassettes and the oligonucleotides used to perform diagnostic 
confirmation of successful transformations were designed as follows and are 
available in tables S8 and S9. Coding and downstream sequences of yeast ORFs 
were downloaded from the Saccharomyces Genome Database (SGD) 
(http://www.yeastgenome.org/) on March, 2004. Homologous regions for the 
forward oligonucelotides were 40 nucleotides long and their sequences 
corresponded to a sequence 5’ to the ORF stop codon. The following sequence 
was added to the end of this homologous sequence: 
GGCGGTGGCGGATCAGGAGGC, which anneals to the 3’ end of the TEF 
terminator region of antibiotic resistance cassettes that are 3’ to linker-F[1,2]-
ADHterm in pAG25 and linker-F[3]-ADHterm in pAG32 as described in 
section 1.5.2, creating a specific 61 bp PCR oligonucleotide for each of 5,756 
ORFs. Homologous regions for the reverse oligonucleotides were 40 
nucleotides long and contained the sequence of genomic DNA immediately 3’ 
to the stop codon of each ORF. The following sequence was added 5’: 
TTCGACACTGGATGGCGGCGTTAG, which anneals to the sequence of the 
linker in both linker-F[1,2]-ADHterm in pAG25 and linker-F[3]-ADHterm in 
pAG32, creating a 64 bp oligonucleotide for each of 5,756 ORFs. Diagnostic 
PCR oligonucleotides were designed to correspond to sequences of the non-
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coding strand of DNA in a region from 100 to 1,000 bp downstream of each 
ORF. Using custom made Perl scripts, these regions were searched for short 
sequences (18-25 nucleotides) with the following properties: have a melting 
temperatures from 58 to 62 degrees, have high GC content (> 50%), have a G 
or C at the 3’ end for better annealing of the 3’ end and optimized primer 
extension, have no complementary ends and do not contain palindromes. The 
forward diagnostic oligonucleotide consisted of a region common to both 
homologous recombination cassettes within the terminator of the antibiotic 
resistance marker. The oligonucleotides were custom synthesized (IDT, 
Coralville, IA, USA). Primer mass was determined by mass spectrometry for 
quality control of the synthesis. Primers were delivered lyophilized on 15, 384-
well format microtitre plates. The oligonucleotides were resuspended in sterile 
distilled water at a concentration of 133 µM in their indexed well positions and 
stored at -20°C. An aliquot of the forward and the reverse primers for 
generating each ORF-specific homologous recombination cassette were mixed 
in a 60 µl volume to final concentration of 5 µM of each primer. The primer 
mixtures were used for PCR amplification of the cassette and remaining volume 
was kept at -20°C. 
1.5.4. Creation of homologous recombination cassettes 
The linker-F[1,2]-ADHterm-TEFpromoter-NAT1-TEFterm in pAG25 and 
linker-F[3]-ADHterm- TEFpromoter-HPH-TEFterm in pAG32 were PCR 
amplified with the ORF-specific oligonucleotides (describe in section 1.5.3) to 
create the specific homologous recombination cassettes in assigned positions of 
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384-well PCR plates. The 30 PCR cycles were carried out with the high fidelity 
Accuprime Pfx DNA polymerase, with an annealing temperature of 59°C for 30 
seconds, a 3-minute elongation at 68°C, in a 25 µl total volume reaction. 3 µl 
aliquots of 40 randomly chosen PCR products on each 384-well plate were 
mixed with brilliant blue tainted glycerol, resolved by gel electrophoresis of the 
mixture on a 1% agarose gel stained with ethidium bromide and visualized 
under an UV light for quality control of the PCR amplification. The PCR 
products were directly used for creation of recombinant strains and the 
remaining reaction volume was stored at -20°C. Final homologous 
recombination cassettes are referred to henceforth as F[1,2]- NAT1 and F[3]-
HPH. 
1.5.5. Creation of recombinant strains 
The strains BY4741 (MATa his3 leu2 met15 ura3) and BY4742 (MATα 
his3 leu2 lys2 ura3) were transformed as described in [59] with PCR 
products amplified from the templates described above to create specific 
homologous recombination DNA fragments ( in section 1.5.4). The protocol 
was adapted to large-scale transformation in 96 well plates as follows: 8 µl of 
PCR product was mixed with 10 µl of chemically-competent yeast and mixed 
with 72 µl polyethyleneglycol (PEG) buffer and incubated for 30 minutes at 
room temperature. Cells were then heat shocked for 15 minutes at 42°C in a 
water bath. The transformation buffer was replaced with 250 µl YPD and cells 
were left to recover for 4 hours at 30°C and were then plated on antibiotic 
containing YPD agar plates and allowed to grow for 4 days at 30°C. In all cases 
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the BY4741 (MATa) strain was transformed with the F[1,2]-NAT1 cassettes 
and BY4742 (MATα) with the F[3]-HPH cassettes. The transformed strains 
were grown on YPD agar plates plus appropriate antibiotic agar plates (100 
µg/mL nourseothricin for MATa transformed strains (WERNER BioAgents, 
Jena, Germany) or 250 µg/mL hygromycin B for MATα transformed strains 
(Wisent Corporation, Quebec, Canada). Identification of successfully 
recombinant clones was performed as follows: Putative recombinant clones 
were picked by hand, cell lysis was performed by heat treatment and 
confirmation of the correct location of a genome insertion was determined by 
PCR using the diagnostic primers described above (in section 1.5.3). The yeast 
lysates were placed at indexed positions of the 96-well PCR plates and mixed 
with the ORF specific and cassette specific diagnostic primers. Annealing of 
the diagnostic primers was performed at 56°C and 35 PCR cycles were carried 
out with the regular Taq DNA polymerase, with elongation cycles of 1.5 
minutes at 72°C, in a 50 µl total reaction volume. Aliquots of 30 µl from each 
PCR product position within each 96-well plate were mixed with brilliant blue 
tainted glycerol and gel electrophoresed on ethidium bromide stained 1% 
agarose gels. Correct recombination was confirmed based on sizes of PCR 
products. The success rate for obtaining positive recombinants ranged between 
30 and 90% of diagnosed colonies per 96-well plate. This process was repeated 
for up to six rounds of recombinant colony selection if recombinants were not 
found in the first round. Our efforts resulted in successful creation of 4,326 
MATa strains harboring unique ORF F[1,2]-NAT1 fusions and 4,804 MATα 
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harboring unique ORF-F[3]-HPH fusions. The confirmed strains were glycerol-
stocked in pre-assigned positions of 96-well plates and stored at -80°C with a 
total of 120 plates. 
1.5.6. Optimization of DHFR PCA screening conditions 
 We optimized the DHFR PCA by selecting a subset of 380 MATa strains with 
ORFs tagged with F[1,2] mated to 380 MATα strains with ORFs tagged with 
F[3], for a total of 145,000 crosses (in section 1.5.5). These were selected based 
on the knowledge that the protein products of each ORF expressed as a fusion 
to F[1,2] should interact with the protein product of at least one ORF expressed 
as fusion to F[3] when complementary MATa and MATα strains are mated and 
resulting diploids selected for growth in the presence of methotrexate (positive 
reconstitution of the methotrexate-insensitive DHFR PCA reporter). The known 
protein-protein interactions were obtained from the hand-curated MIPS 
database of protein complexes (http://mips.gsf.de/genre/proj/yeast/) as of 21 
July 2005. We used this array to optimize the protocols for large scale, solid 
phase mating; selection of a methotrexate concentration that assures minimal 
background growth of negative control strains (in section 1.5.8) and maximizes 
growth of DHFR PCA-rescued diploid strains at different temperatures while 
minimizing the incubation time. Briefly, methotrexate concentrations were 
tested between 25 µg/mL and 225 µg/mL (in 25 µg increments) with an optimal 
concentration found at ~ 200 µg/mL. While higher concentrations provided 
more stringent selection, we found that methotrexate had limited solubility 
above this concentration. For all concentrations of methotrexate, we found that 
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the optimal incubation time was 96 hours of growth at 30°C, which were then 
the conditions we used for the large-scale screen. 
1.5.7. Test for detection of structural and topological organization of a 
protein complex 
To test for the capacity of the DHFR PCA to provide structural and topological 
information, we performed a screen for interactions among the subunits of the 
well-characterized RNA polymerase II (RNA Pol II) complex structure, which 
has been determined at high resolution (PDB file 1I3Q) [21]. We constructed 
homologous recombination cassettes for the 10 subunits (RPB2, RPB3, RPB5, 
RPB8, RPB9, RPB10, RPB11, RPC10, RPO21, RPO26) and created MATa and 
MATα strains in which each of these genes are fused to the DHFR PCA 
fragments according to the methods described in Section 1.5.5. We used 
engineered heterodimerizing mutants of the SspB dimer from Haemophilus 
influenzae to serve as a positive control for the DHFR PCA and a negative 
control for interactions with RNA Pol II [17]. Expression plasmids harboring 
these control proteins fused to the DHFR PCA fragments were generated as 
follows: The heterodimerizing SspB mutants, SspBLSLA and SspBYGMF 
were amplified by PCR and subcloned into p413-TEF-Zip-linker-DHFR F[3] 
and p413-TEF-Zip-linkers-DHFR F[1,2], replacing the leucine Zipper (Zip) 
sequence. We replaced the existing His3 metabolic enzyme selection marker 
cassette in p413TEF with nourseothricin N-acetyl-transferase (NAT1) or 
hygromycin B phosphotransferase (HPH) antibiotic selection genes. 
Specifically the cassette encoding (NAT1) from pAG25 was PCR amplified 
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and subcloned between the sequence corresponding to the His3 complementing 
cassette of p413-TEF-SspBLSLA-linkers-DHFR F[1,2]. These plasmids were 
renamed p41NAT. The cassette encoding HPH gene from pAG32 was PCR 
amplified and subcloned between the sequence corresponding to the His3 gene 
cassette of p413-TEFSspBYGMF- linker-DHFR F[3]. These plasmids were 
renamed p41HPH. Final products were transformed into MATa or MATα 
(p41NAT-TEF-SSpBLSLA-linkers-DHFR F[1,2] and p41HPHTEF- 
SspBYGMF-linker-DHFR F[3]) and respectively selected on YPD (+100 
µg/mL nourseothricin) or YPD (+250 µg/mL hygromycin B). The ten MATa 
strains harboring genomic fusions of DHFR F[1,2] fused to the ten RNA Pol II 
subunit genes or the control MATa expressing the SspBLSLA mutant fused to 
F[1,2] were mated in a one-to-one matrix with the ten complementary MATα 
strains harboring genomic fusions of DHFR F[3] fused to the ten RNA Pol II 
subunit genes or the MATα control strain expressing SspBYGMF mutant fused 
to F[3]. The diploid strains were grown on synthetic complete medium (SC) (-
met, -lys, +methotrexate 200 µg/mL) to select for growth of methotrexate 
resistant diploid strains and incubated at 30°C for 120 hours (Fig. 13). The 
plates were then photographed with a high-resolution (4 Mega pixel, Canon) 
digital camera and resulting images were converted to 8-bit grayscale images 
and analyzed with ImageJ 1.36b software (National Institutes of Health, USA), 
measuring pixel intensities of the colonies over a constant area. Results were 
corrected by subtraction of the pixel intensity of a region without colonies to 
remove any background intensity of the plate (Fig. 13A, B). Based on a t-test 
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for differences in growth, we detected 30 of the 50 possible interactions among 
the RNA Pol II subunits (60%), including homodimers while the control 
heterodimerizing mutants of SspB fused to mDHFR fragments showed no 
significant interactions with any of the ten RNA Pol II subunits (Fig. 13C). The 
detected interactions are consistent with observations of physical proximity 
inside the RNA polymerase II complex (Fig. 13D and Fig. 14). 
1.5.8. Large scale PPI screen 
To test pairwise protein-protein interactions between the two collections of 
MATa and MATα strains, each of 3,247 MATa strains harboring ORF-F[1,2]-
NAT1 fusions (henceforth the “baits”) were individually mated with each of 
4,804 MATα strains harboring ORF-F[3]-HPH fusions (henceforth “preys”) 
arrayed on agar plates as described below (Fig. 2). Diploids were subsequently 
selected and plated on medium containing methotrexate to select for positive 
DHFR PCA reconstitution. Although our screen is based on a selection assay 
and thus amenable to a split-pool screening strategy, we performed individual 
crosses to avoid the overrepresentation of highly abundant interacting proteins 
that would result from growth competition within pools of clones. The bait-by-
query-array crosses were performed as follows: First, to generate the prey array, 
the MATα query strains were printed from 96-well glycerol stock plates (in 
Section 1.5.5) to yeast peptone dextrose medium (YPD) agar plates with 
hygromycin B (+250 µg/mL hygromycin B) to a density of 384 colonies per 
plates using a 96 pin robotically manipulated pin tool (0.787 mm flat round-
shaped pins, custom AFIX96FP3 BMP Multimek FP3N, V&P Scientific Inc., 
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San Diego, CA) and allowed to grow for 24 hours at 30°C. The colonies were 
transferred to four YPD agar plates with hygromycin B (+250 µg/mL 
hygromycin B) using a 384 pin robotically manipulated pin tool (0.356 mm flat 
round-shaped pins, custom AFIX384FP8 BMP Multimek FP8N, V&P 
Scientific Inc., San Diego, CA) to a density of 1,536 spots/plate and allowed to 
grow for 24 hours at 30°C. Subsequently, colonies from the four MATα plates 
were transferred onto individual YPD agar plates using a robotically 
manipulated 1,536 pin tool (0.229 mm flat roundshaped pins, custom 
AFIX1536FP9 BMP Multimek FP9N, V&P Scientific Inc., San Diego, CA), 
necessary for the mating procedure with individual MATa bait strains, resulting 
in MATα query strain arrays at a density of 6,244 pin transfers per plate in 
which the 4,804 MATα query strains form colonies at defined positions. In 
addition, positive and negative controls for correct transfer of cells and 
selection conditions were introduced at 48 positions on the array in cross-
shaped patterns that traverse the entire array (See Fig. 5B) The positive control 
strains consisted of 24 MATa/MATα diploids harboring DHFR PCA fusions of 
the MCK1 and CDC19 proteins that are known to interact and for which the 
interactions were confirmed by the DHFR PCA (MCK1-F[3] and CDC19-
F[1,2]) and 24 negative control MATa/MATα diploids for the pair of proteins 
CLN3 and CDC19, which have not been shown to interact by any method and 
show no growth in the DHFR PCA (CLN3-F[3] and CDC19-F[1,2]). 
Remaining positions on the 6,244-position array were empty; no cells having 
been transferred to these positions. For each of the bait-by-prey array crosses 
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(Fig. 1), individual MATa bait strains were grown separately in liquid YPD 
with nourseothricin (+100 µg/mL nourseothricin) to saturation. The MATa bait 
strains saturated culture were concentrated by centrifugation and removal of 
approximately 60% of the supernatant. The MATa bait strain was printed on top 
of previously printed MATα query strains on a YPD containing plates, using a 
robotically manipulated 1,536 pin tool (0.229 mm flat round-shaped pins, 
custom AFIX1536FP9 BMP Multimek FP9N, V&P Scientific Inc., San Diego, 
CA), and incubated at 30°C for 24 hours to allow for mating. The mated 
colonies were selected the next day by transferring all colonies onto YPD agar 
(+ 100 µg/mL nourseothricin, +250 µg/mL hygromycin B). The selected 
MATa/MATα diploids were transferred the next day onto synthetic complete 
medium (SC) (-met, -lys, +methotrexate 200 µg/mL) to select for growth of 
methotrexate resistant diploid strains and incubated at 30°C for 90 hours. 
Individual plates were then photographed with a high-resolution (4 Mega pixel, 
Canon) digital camera and resulting images were analyzed and growing 
colonies quantitated using a shape recognition algorithm (in Section 1.5.9). The 
diploid strains created were heterozygous for the two tagged genes, thus 
minimizing growth defects that may result from reduced activity or abundance 
of the modified gene products and reducing the potential for non-specific 
interactions among highly expressed proteins. Bait screens for which no 
significant growth above background was observed could be due to low 
expression of the proteins under the growth conditions, to interference of the 
mDHFR fragments with the folding or stability of bait and prey proteins, or 
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simply to the absence of expression or interaction of the bait proteins with any 
of the query proteins under the conditions tested 
1.5.9. Control experiments for spontaneous, interaction-independent 
DHFR protein fragment complementation. 
 Large-scale PPI screens often contain a large fraction of false-positive 
interactions, either because of experimental noise or from artifacts specific to 
the detection method. The latter is the most problematic because false-positive 
interactions are often reproducible and have strong signal to background ratios. 
This problem therefore must be dealt with experimentally. Previous large-scale 
PPI studies (e.g., [13, 14, 60]) indeed reported that a number of proteins show 
promiscuous patterns of interactions. These interactions are typically arbitrarily 
eliminated from filtered datasets. The source of spurious results in PCA could 
be due to spontaneous complementation (folding) of the DHFR PCA fragments 
into active enzyme in the absence of any physical interaction between bait and 
prey proteins. Specifically, some proteins fused to a PCA fragment, (e.g. 
F[1,2]) could complement the other PCA fragment, F[3], without necessarily 
interacting with the protein to which this second fragment is fused, i.e. 
interacting with the F[3] fragment alone. In a screen such as ours, these proteins 
could promiscouously interact with many proteins and thus produce a large 
fraction of false positive interactions. To test for this possibility, we constructed 
a set of control baits that consist of the 10-amino acid linker 
(Gly.Gly.Gly.Gly.Ser)2 fused to each of the complementary F[1,2] or F[3] 
DHFR fragments or F[1,2] or F[3] fragments alone. These control baits were 
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used to challenge the prey array and a newly constructed MATa F[1,2] array 
created with the same procedure described in Section 1.5.7. The fragments have 
to be expressed from plasmids that harbor both linker-fragment fusions or 
fragments alone and contain resistance cassettes compatible with our screening 
strategy, transformed into complementary strains and mated against the 
individual arrays as described in section 1.5.8. The control constructs were 
generated by PCR amplifying linker-fragment fusions or fragments alone from 
the universal PCA template constructs (in Section 1.5.2) constructed in pAG25 
(linker-F[1,2]-ADHterm) and pAG32 (linker-F[3]-ADHterm). We used forward 
primers containing a 5’ XbaI restriction site upstream of sequence coding for 
the linker sequence or individual DHFR PCA fragments and reverse primers 
coding for the 3’ region of the individual fragments upstream of a 3’ XhoI 
restriction site-coding sequence. These were used to subclone the XbaI- and 
XhoI-digested PCR products into the expression vector p413TEF between the 
XbaI and XhoI of the multicloning site 3’ of the constitutive TEF promoter. 
The existing His2 metabolic enzyme section marker cassette in p413TEF 
needed to be replaced with NAT1 and HPH antibiotic selection genes to be 
consistent with our screening strategy as follows: The cassette encoding 
nourseothricin N-acetyl-transferase from pAG25 [58] flanked by the TEF 
promoter in 5’ and terminator 3’ was amplified with TEF promoter forward 
primer and TEF terminator reverse primer. These primers insert an NdeI 
restriction site into the 5’ region of the PCR product and a NsiI restriction site 
in the 3’ region. The resistance cassette was subcloned into the control 
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expression plasmids between the NdeI restriction and NsiI restriction sites that 
flank the His3 complementing cassette. These plasmids are henceforth referred 
to as p41NAT for the NAT1 gene, conferring resistance to the antibiotic 
nourseothricin of transformed yeast. The control fragment plasmids expressing 
a F[3] fusion were further digested with BstXI and BsmI to subclone the HPH 
gene from pAG32 [58], located between BstXI and BsmI, encoding 
hygromycin B phosphotransferase, which confers resistance to the antibiotic 
hygromycin B of transformed yeast. The expression of the control fragments 
was confirmed by Western blot using a rabbit anti- DHFR polyclonal antibody 
that specifically recognizes an epitope in the N-terminal F[1,2] fragment 
(Sigma D1067, 1:6000 (Sigma-Aldrich, St-Louis, MO)) F[1,2] or an anti-
DHFR polyclonal antibody that specifically recognizes an epitope in the C-
terminal F[3] fragment (Sigma D0942, 1:5000 (Sigma-Aldrich, St-Louis, MO)) 
(Data not shown). 
1.5.10. Data acquisition, colony quantification and documentation, and 
statistical analyses. 
Positive protein-protein interactions were interpreted from growth of the diploid 
colonies on methotrexate-containing medium as described above (in Section 
1.5.7). Complete acquisition and analysis of each plate proceeded as follows: 
First, images of the diploid methotrexate selection (MATa bait/MATα prey) 
array plates were taken after 96 hours of growth (as described above, Section 
1.5.7) with a 4.0 Mega pixel camera (Powershot A520, Canon). Plate images 
were saved in JPG format at a resolution of 180 dpi and a size of 2,272 x1,704 
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pixels. Second, all of the 3,301 plates (3,247 plates for the 3,247 different baits, 
48 repeated plates and 6 plates for the control experiments) were manually 
inspected during the image analysis step and positions too close to the plastic 
edges of the plate and therefore uninterpretable were eliminated by setting the 
intensities of the first and the last colonies on the first row of the array to 0. At 
this stage we eliminated 44 plates from the final analysis because they 
displayed growth of colonies at empty positions, likely resulting from grid 
misalignment or contamination. In order to accurately identify bait ORF/prey 
ORF coordinates on the array and to extract the intensity of the colonies, we 
developed image recognition routines from the Image Processing Toolbox of 
Matlab (The MathWorks, Natick, Massachusetts). Each plate contained a set of 
positive and negative control colonies as described in Section 1.5.7, arranged in 
parallel X-patterns across the plates (Fig. 1A), which allowed us to identify 
misalignment or mispositioning of the colony arrays on each plate due to 
variation in the robotic pinning process. The first step of the image analysis was 
to determine expected centers of the colonies arrayed in 96 columns and 64 
rows. In order to adjust for variation in plating and possible rotation of an 
image during image acquisition we manually defined the coordinate center of a 
first and a last colony in a first row of the array and of the last colony of the 
first column using Matlab build-in tools for accepting user input. Using the 
coordinates of these centers the image was rotated so that each column and row 
of colonies lies on a straight line. Next, images were adjusted using the same 
parameters and centers of all colonies were calculated. For each subsequent 
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plate, manual reselection of colony centers was performed for colonies or 
positions at the extremities of a plate if array coordinate position centers 
deviated significantly from those of an earlier plate. Image analysis was 
performed in the same order as the images were acquired and thus deviations in 
the positioning of plate images occurred among groups of plates and were 
easily identified. However, we usually found that series of images taken on the 
same day (~100 plates per day were processed) did not have to be readjusted. 
Results of positional array adjustment and detection of colony centers were 
manually checked for all images taken during the large-scale screening (3,307 
plates in 6,144 position format plus spontaneous complementation control 
experiments (in Section 1.5.8) and repeats of 48 bait/prey repeat plates. While 
the procedure described above defines approximate colony centers, we used a 
modified version of a previously described algorithm to accurately locate them 
[61]. The assumption of the algorithm is that pixels have higher intensity values 
at colony centers. Thus, the algorithm processes columns and rows of pixels 
one at a time and finds areas of maximal pixel intensity. Intersection of 
columns and rows where corresponding sets of pixels have the highest 75th 
percentile values are used to find approximate colony centers. We modified this 
algorithm in order to handle an array of 6,144 colonies per plate (96 well format 
was used in the original work). Next, we used an automated Matlab procedure 
to calculate colony areas and intensities on each plate as follows (Fig. 2) (please 
refer to Matlab documentation for detailed description of functions used for the 
analysis): 1), images were corrected for possible non-uniform illumination as 
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described in (http:// www.mathworks.com / products / image / 
demos.html?file= / products / demos / shipping / images / ipexrice.html) and 2), 
small objects that correspond to gel background, bubbles, plate edges or other 
anomalies were removed using the imopen function with the disk 
morphological structuring excluding elements of a radius smaller than 2 pixels 
(radius of 4 pixels was used on plate edges), 3) images were converted into 
binary format using the im2bw function with a threshold calculated by the 
graythresh function. In this format, pixels that correspond to colonies were set 
to 1 and background pixels to 0. Thus, connected components of binary images 
with pixel values equal to 1 (calculated with bwlabel and regionprops 
functions) corresponded to colonies. Identity (row and column number on the 
plate array) of each colony was calculated by comparing approximate colony 
centers (calculated as described above) and centers of these connected regions. 
Intensity of each colony was then extracted from the original image. If there 
was no overlap between colonies (i.e. there were no colonies that touched each 
other) these 3 steps were sufficient for the analysis. However, in a small 
number of cases, large colonies overlapped between adjacent positions and had 
to be deconvoluted. One of the simplest ways of discriminating intersecting 
circular objects is to calculate the distance transform for a binary image 
followed by a watershed transform. The watershed transform finds "catchment 
basins" ( which represent circular colonies) and "watershed ridge lines" (which 
correspond to an edge where colonies touch each other) in an image by treating 
it as a surface (see Image Analysis watershed segmentation demo for details 
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http://www.mathworks.com/company/newsletters/news_notes/win02/watershed
.html). As a result of the watershed transform, pixels that lie on the border 
between objects can be identified. These border pixels are set to zero on the 
original binary image, thus separating overlapping colonies and step 3 is 
repeated in order to analyze separated colonies. If the size of a connected region 
identified in step 3 was larger than expected for a single colony (on average, 
400 pixels) or a connected region could not be matched to a position on the 
array (fusion of several colonies will result in centering of a connected region to 
deviate from an approximate colony center) the following steps were 
performed: 4), extraction of a rectangular subpart of an original image that fully 
contains a connected region that is suspected to contain fused colonies, 5), 
apply a distance transform. The distance transform calculates for each pixel its 
distance from the nearest nonzero pixel in a binary image. In the case of two 
intersecting circular objects it will produce a set of values with a maximum 
value at the centers of the objects. We found that calculating an accumulation 
array by the Circular Hough transform and superimposing its local maximum 
on a distance transform array further improved the detection of circular 
colonies. Hough transform is another method for detecting circular objects. It’s 
a voting procedure that assigns a value to a pixel if it can be a center of a circle. 
As a result, central pixels in circular objects receive higher values. So step 6), 
superimpose local maxima of the accumulation array of Circular Hough 
transform onto a matrix produced by step 5. 7), apply the watershed transform. 
8), in cases where a number of objects that were separated using steps 4 to 5 
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was different from the number of possible centers detected by the Circular 
Hough transform, we performed a watershed transform on the original grey 
scale image that corresponds to the connected regions requiring deconvolution. 
Raw colony intensities are available on the Michnick Lab website 
(http://michnick.bcm.umontreal.ca/). 
1.5.11. Analysis of colony intensity distributions and benchmarking. 
Raw colony intensity (sum of pixel values from a grayscale) distribution was 
approximately lognormal and centered around 4,300 (Fig. 4). This distribution 
showed a steep decrease in frequency at around 10,000, after which it showed 
an increase in frequency. This second distribution represents the population of 
diploid colonies able to grow on methotrexate. This is also where we saw a 
clear distinction between the positive (median: 38,361) and negative control 
intensity (median = 5,192) distributions. We therefore reasoned that the 
threshold above which we could infer a protein-protein interaction (PPI) should 
be located at around an intensity of 20,000 (see below). It is important to note 
that controls were diploid strains printed directly onto the plates and that these 
control strains did not go through the solid phase mating procedures. This 
explains why several colonies were smaller than the negative controls. These 
likely represented variability in diploid cell transfers. In order to determine the 
accuracy of our data, we first had to eliminate data for ORFs that showed 
interactions with control fragments (spontaneous fragment complementation; in 
Section 1.5.8). To do this, we calculated z-scores for control plates and used 
cutoffs for accepting an interaction based on a visual inspection of distributions 
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of plate scores. Cutoffs were conservatively assigned based on visual inspection 
of the control plate distribution by identifying all colonies with larger intensities 
than the background distribution. We identified 344 such proteins (table S1), 
which are enriched for those associated with ribosomes (P < 2x10
-65
) (table S2) 
and are highly expressed compared to the proteome (median log10(Abundsd ) = 
3.27 vs 2.28 for the proteome, Wilcoxonrank test: P < 2.2x10
-16
; Fig. 11). 
Similar highly abundant proteins are also often observed as false-positives in 
spurious interactions in affinity purifications in particular several ribosomal 
proteins and others like Cdc19p, Eno2p, Tef2p and Tef3p [14]. Global analysis 
of the network created by these proteins revealed that they show highly 
structured and similar patterns of PPIs, suggesting that they could also be 
identified by computational analysis. Proteins that show correlated patterns of 
interaction with that of the controls but that were not identified in this control 
experiment could then be eliminated as well (see below). After eliminating 
positions from the plates corresponding to these proteins, we determined the 
threshold above which we could confidently infer PPIs as follows: First, we 
used the MIPS catalog of protein complexes 
(ftp://ftpmips.gsf.de/yeast/catalogues/complexcat/complexcat_data_18052006) 
as of 18 May, 2006 as a source of True-positive (TP) interactions (n = 11,005 
among 1,236 proteins), 503 of which could be potentially detected in our screen 
(bait and prey strains exist in our collection for each protein and crossing of 
each strain resulted in growth of at least a colony, suggesting that the DHFR 
fragment-tagged ORFs are expressed and can interact with other proteins). This 
73 
 
set of manually annotated MIPS complexes serves as a benchmarking standard 
for networks enriched for soluble proteins such as TAP-MS [36] and also in 
studies of helical membrane protein PINs (n = 79) [61]. A true-negative (TN) 
set of PPI was obtained from [36] and consists of pairs of proteins that are part 
of distinct complexes and are expressed in different cellular compartments or 
have anticorrelated patterns of gene expression. This set contains 266,858 
interactions, 6,377 of which could potentially be detected in our screen as 
described for the TPs. These two sets of PPIs allowed us to determine at what 
colony intensity we could confidently infer a PPI. In order to control for plate-
to-plate variation in overall growth intensity and the non-random distribution of 
the number of interactions among plates, we combined two criteria [62] to 
determine a threshold above which to call the growth of a colony: The first 
criterion was the absolute intensity (a sum of pixel intensities on a grey-scale) 
of the colonies and the second, a score derived from the distribution of 
intensities on the plates:  
z-score(x) = (x-µx)/σx 
 where x is the intensity of a given colony, µx is the average intensity of the 
plate and σx is the standard-deviation of the mean. This allowed us to eliminate 
colonies that had high intensity values due to the high background growth of 
colonies on some plates. This combination allowed us to maximize coverage of 
true-positive PPI at a high Positive Predictive Value (PPV) comparable to 
small-scale experiments, where PPV is defined as the ratio of inferred True 
Positive interactions over the sum of the inferred True and False Positives. This 
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was achieved with a pixel intensity of 23,000 and a z-score = 2.4. After 
removing false-positive interactions based on the control experiments (n = 344) 
and benchmarking on the MIPS gold standard, our final, high quality dataset 
includes data that reached a PPV score of 97.7%, implying that 97.7% of these 
interactions are predicted true-positives based on this high quality data. These 
cutoff results in data having precision comparable to all previous large-scale 
data sets including those that reaches the same precision as small-scale protein 
interaction studies (Fig. 1C, Fig. 8). At this cutoff and PPV score of 97.7% we 
observed 5,672 interactions. A further analysis revealed 83 highly connected 
proteins that mediate 2,902 interactions. Eight of these proteins constantly 
demonstrated a higher growth pattern than other MATα strains (type 1). The 
remaining 75 proteins showed an unusually large number of common 
interactions. 23 proteins had a similar pattern of interactions to proteins that 
showed growth in the negative control experiments (type 2). Some of them, for 
example ARO8 and VAS1, were not among the 344 proteins identified as 
interacting with controls because their growth was just slightly below one of the 
two threshold cutoff values used to analyze control plates. The remaining 52 
proteins showed a distinct pattern of common interactions (1,830 interactions) 
also typical of the 344 proteins that showed positive growing colonies in the 
negative control experiments. Given the ambiguity or control-like behavior of 
these results, all 2,902 interactions were removed from the final dataset. Our 
final, filtered dataset contained only 3 FP and 163 TP interactions. To 
determine the statistical significance of these results, we generated 10,000 
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random networks by randomly assigning the same number of interactions 
between the same set of proteins as in our final dataset to estimate the 
distribution of random scores, and a z-score for the observed score from this 
distribution. After applying a multi-step filtering procedure, the DHFR PCA 
network was derived from 24% of these bait screens. On average, a random 
network had 2.7 TP and 33.8 FP interactions. Our observed results are thus 
unlikely to have been found by chance alone (TP : P = 0, FP = P < 10
-7
) and do 
not reflect a bias in the composition of our network with respect to the TP and 
TN data sets used here. A total of 3,113 colonies were found above the PPV 
threshold of 98.2%, which represents 2,770 unique interactions after subtracting 
interactions observed in both MATa bait (ORF1-F[1,2])/MATα prey (ORF2-
F[3]) and MATa (ORF2-F[1,2])/MATα prey (ORF1-F[3]) (tables S3 & S4). 
40% of the interactions that could have been detected in reversed crosses were 
detected, consistent with previous observations showing that interactions may 
be detected by the DHFR PCA when the individual proteins are fused to either 
F[1,2] or F[3] fragments, but not necessarily if the fragments are swapped 
between the two proteins [63]. This proportion was 50% in the RNA pol II 
small-scale experiment (Section 1.5.7), which suggests that we are near the 
upper bound with the large-scale screen. However, interactions that were 
observed in both directions (n = 343) can be considered as being of higher 
confidence given that their intensity scores on the plates is slightly higher on 
average (51, 216 versus 38,995), despite the fact that these two sets of proteins 
have only marginally different levels of protein abundances (median 
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log10(Abund): 2.38 vs 2.32, P = 0.01). This is also reflected in the similarity of 
their Gene Ontologies. Pairs of proteins that were shown twice to interact 
during the screen have higher semantic similarity on average in terms of 
Biological Process, Molecular Function and Cellular Compartment than the 
same number of interactions taken randomly from the interactions detected in 
one direction only (BP : 3.45, BP random : 2.65, P < 10
-12
 ; MF : 3.88, MF 
random : 3.12, P < 10
-5
 ; CC: 2.76, CC random: 2.21 ; P < 10
-7
). PCA is 
efficiently able to detect interactions among membrane proteins with high 
specificity [64, 65], which contrasts with methods that have comprehensively 
studied protein interactions [10, 11, 13, 14, 35]. About one quarter of all genes 
in most genomes contain putative transmembrane (TM) helices [61]. They 
therefore likely represent an important fraction of the interactome and yet we 
have little knowledge of their patterns of interactions. The DHFR PCA network 
therefore represents important steps in that direction. As a consequence of the 
difficulty to identify protein-protein interactions among membrane proteins, 
these are not well represented in public databases. Two papers established 
genome-wide protein interaction networks for membrane proteins: 1) Miller et 
al. [26] using the split-ubiquitin assay, and 2) Xia et al. [61], using 
computational prediction. These studies both acknowledged the challenge that 
the identification of protein-protein interactions among membrane proteins 
represents. Miller et al. identified 1,985 putative interactions among 536 
proteins. Xia et al. predicted 4,145 interactions among 1,048 putative helical 
membrane proteins that they identified using computational methods. As 
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membrane proteins are less represented in high-quality datasets such as the 
MIPS (6% of proteins membrane proteins and 1% of interactions are among 
membrane proteins) which may limit our ability to identify false-positive 
interactions, we took special care in trying to identify potential spurious 
interactions involving membrane proteins. First, the control experiment with the 
fragments and the linkers alone revealed 19 (out of 344) putative helical 
membrane proteins that show spontaneous fragment complementation. Further, 
we eliminate 83 proteins that showed similar patterns of interactions, which is a 
characteristic of proteins showing spontaneous complementation with other 
proteins. This analysis further identified 45 membrane proteins that are likely to 
mediate spontaneous complementation of the DFHR fragments and these were 
removed from the dataset. In the final network, 232 of the putative membrane 
proteins identified by [61] show interactions in our PCA screen out of 1,124 
proteins, which represents a slight enrichment compared to the entire genome. 
We identified 2,770 high quality interactions among 1,124 proteins in our 
screen. The average degree of a protein (number of interactions) is therefore ~ 
1.6. Our network contains 232 helical membrane proteins that make 662 protein 
interactions among them, for an average degree of ~2.8. This is not much 
higher than for the network as a whole. This may represent an increased power 
of the PCA to detect pairwise interactions among 15 membrane proteins, which 
are less spatially constrained than proteins that are member of large complexes. 
In order to assess the quality of the fraction of the DHFR PCA network that 
represents the among helical membrane protein interactions, we examined the 
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overlap between our final dataset and that of the two previous membrane 
protein PINs. First, we found that we detected 51 of the 662 interactions 
predicted by [61]. Randomizations (10,000) of our network reveals that we 
expect an overlap of only 5 interactions between these two datasets by chance 
alone, which represents an enrichment of 10 fold over the random expectation 
(P < 10
-94
). Similarly, 27 of the our 662 interactions were also identified using 
the split-ubiquitin method [26]. Only 1.9 interactions are expected to be in 
common between these two datasets, which represents an enrichment of 15 fold 
over the random expectation (P < 10
-75
). Finally, we found that while 
controlling for the sharing of cellular compartment of interacting protein pairs, 
interacting protein pairs remain significantly enriched for semantic scores of 
Molecular Function and Biological processes (i.e. similarity of gene ontology 
categories), and this for the whole set of protein interactions (MF: 3.76, MF 
random: 2.48, P < 10
-74
; BP: 3.34, BP random: 2.14, P < 10
-144
) and for the set 
of helical membrane proteins interactions (MF: 3.89, MF random: 2.84, P <10
-
18
; BP: 2.86 , BP random: 2.15, P < 10
-15
). 
1.5.12. Analysis of high-quality PPI in comparison to protein abundance, 
gene ontology enrichment and three-dimensional structures. 
1.5.12.1. Analysis of PPI versus protein abundance 
 Protein abundance for yeast grown under the same conditions (SC medium) as 
used in the DHFR PCA screen or YEPD and based on FACS analysis of GFP- 
tagged proteins was obtained from [37]. 
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1.5.12.4. Analysis of Gene Ontology enrichment. 
 We examined whether the final set of proteins constituting the DHFR PCA 
network contained an overrepresentation of proteins involved in specific 
biological processes, with certain molecular functions or that localize to 
specific cell compartments. Gene Ontology enrichments were calculated using 
the method implemented in GOstat (R library) [66, 67]. This approach utilizes a 
conditional hypergeometric algorithm that considers the hierarchical 
relationships of gene ontology definitions to decorrelate the results. More 
precisely, due to their hierarchical organization—a GO term inherits all 
annotations from its more specific descendants. Gene Ontology categories are 
not exclusive and are thus locally correlated. This method considers this 
organization to limit the redundancies in the results. The algorithm considers 
more specific to more general terms. When testing the significant enrichment of 
a GO term, it removes genes that are annotated to a significantly enriched node 
from all its ancestors (more general term). The universe of genes (reference list 
to which the network proteins are compared) used for the comparisons was the 
entire genome, as we aimed at identifying what categories of proteins were 
overrepresented relative to the entire proteome. A conservative P-value cutoff 
of 0.00001 was used for these analyses. 
1.5.12.5. Correlation of gene expression profiles. 
 Correlation of gene expression between pairs of ORFs (Pearson correlation) 
was calculated from gene expression profiles from more than 1,000 expression 
profiles compiled in [68]. The distribution of correlation coefficients for 
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random networks of the same size and degree distribution were estimated from 
1,000 random networks. 
1.5.12.4. Structural analysis of PPI 
 Structural domain annotations for all S. cerevisiae proteins were obtained from 
SGD in September 2007. The identity of domains known to mediate PPI were 
obtained from [69]. These data are derived from the mapping of protein 
domains onto 3D structures of resolved protein complexes deposited in the 
Protein Data Bank by [70, 71]. Domains mediating PPIs are those that are 
found at the interface of interacting proteins. The fraction of protein pairs in the 
DHFR PCA network that each have a domain that is known to mediate PPIs 
was estimated by combining these data with the domain identity obtained from 
SGD. The random expectation of the fraction of interacting proteins pairs that 
have one domain each that mediate PPI was estimated by generating random 
networks, as described above. Distances among C-termini of known protein 
complexes were determined as follows: The identity of yeast proteins that have 
homologs in the Protein Data Bank (PDB) was obtained from SGD. On June 
2007, 46,320 PDB files corresponding to biological units of cellular organisms 
were obtained from PDB, among which 13,966 contained yeast homologs. The 
first biological unit was used (.pdb1) if more were available. We extracted the 
distances between the C-termini of all pairs of chains within each complex. We 
then went through each complex and determined whether: 1), they contain more 
than one chain homologous to any of the proteins that are part of the DHFR 
PCA network, 2), we recorded all of the possible pairs of interactions within 
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those complexes and 3), we merged all the interactions together and if a pair of 
chains was recorded more than once, we kept the one with the shortest distance 
between the C-temini of these two proteins. Finally, we examined whether this 
interaction was seen or not in the DHFR PCA screen. We considered 
interactions as not being seen only if it could have been detected, i.e. the pair of 
proteins showed at least one interaction as bait and prey or as prey and baits. 
This left us with 175 interactions from 129 distinct PDB entries. 
1.5.11.6. Membrane topology and PPI determined by DHFR PCA. 
 Protein membrane topology was obtained from [39]. We reasoned that the C-
termini of interacting proteins have to be oriented into the same cellular 
compartment in order for DHFR PCA to occur; for instance both in the cytosol 
or both in the lumen of the endoplasmic reticulum. Kim et al. [39] established 
the location of the C-termini of 546 proteins of which 448 have their C-termini 
oriented towards the cytosol. We examined all possible pairs of proteins among 
these 546 proteins and determined which of these are localized in at least one 
common cellular compartment using microscopic evidence for yeast proteins 
fused to green fluorescent protein [72]. It is important to note that we don’t 
know if any of these pairs should actually show an interaction. For these 
possible interactions, we counted how many of each type we detected and did 
not detect, considering only those for which interactions could have been 
observed as described above (i.e. strains exist in which both proteins are fused 
to one or the other DHFR PCA fragments and show interactions). 
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1.5.13. Comparison of DHFR PCA to previously determined PPI. 
 In order to examine whether the DHFR PCA interactions had been reported 
previously, we obtained the following databases: Biogrid (www.thebiogrid.org/, 
version 2.0.29), mips-MPact (http://mips.gsf.de/genre/proj/mpact, version 
18052006) and DIP (http://dip.doembi. ucla.edu/, June 2007). Entries in 
Biogrid with experimental systems defined as: "Synthetic Lethality" , "Dosage 
Rescue", "Synthetic Growth Defect", "Synthetic Rescue", "Epistatic MiniArray 
Profile", "Dosage Lethality", "Phenotypic Enhancement", "Phenotypic 
Suppression" and "Dosage Growth Defect" were not considered. Mpact entries 
were considered only if they had the tag “902.01.01.02.01”, which indicates 
physical interactions. We separately considered the combined TAP-MS data 
from [36] (data used were those with Purification Enrichment scores of 3.19 
and above as defined in [36]), as it overlaps considerably with what has been 
deposited in Biogrid by [13] and [14]. We considered only one citation for an 
interaction reported in Collins et al. (2007), even if it had been reported by one 
of, or both of the two original studies. Finally, we considered only interactions 
associated with PubMed ids, because these can be tracked to their original 
experimental evidence. We considered different ids as being independent 
evidence. Although this may inflate the confidence in some interactions, it 
should not affect the identification of new interactions as described in our 
screen. 
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1.5.14. Overlap with previous large-scale studies. 
 In order to calculate the overlap between our screen and previous results 
derived from large-scale experiments and a catalogue of manually annotated 
complexes we computed a number of interactions common to our screen and 
each of the datasets described below. We first calculated the overlap between 
DHFR PCA PPI and all interactions reported in a previous study (Figs. 12 & 
13; numbers in circle indicate the total number of interactions detected in a 
particular dataset (since affinity-purification based methods cannot detect 
homomeric interactions, only heteromeric interactions were used for the 
analysis)). None of the datasets reports a complete set of interactions between 
all yeast proteins and thus low overlap between different data sets may be 
because different datasets cover different sets of yeast proteins. Therefore, we 
performed a normalization of the number of interactions based on how many 
proteins are in common between two datasets and how many same interactions 
could be detected (Fig. 10). Numbers in the PCA circles indicate how many 
interactions reported in a particular dataset could be detected by our screen (an 
interaction can be detected only if one of interacting partners showed a signal as 
bait and another as prey or vice-versa in our final network). Numbers in circles 
that correspond to a reference dataset indicate how many interactions from our 
final network could be detected by a reference dataset. When only interactions 
that could be detected by both experiments are considered, the overlap between 
DHFR PCA and reference datasets reaches as high as 50%. Reference datasets 
and criteria for normalization are described below: 1), MIPS catalogue of 
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manually annotated complexes. Downloaded from 
ftp://ftpmips.gsf.de/yeast/catalogues/complexcat/complexcat_data_18052006. 
Complexes detected by large-scale experiments were filtered out from this file 
and interactions were assigned between all proteins that belong to the same 
complex. An interaction is considered to be possible if both interacting partners 
are present in the MIPS catalogue. 2), Krogan et al. [14] The core dataset was 
obtained from supplementary table 7, that lists successfully identified baits and 
preys obtained from supplementary tables 2 and 3. An interaction is considered 
to be possible only if one of the proteins is present in the baits list and another 
is in the preys list. We don’t consider a co-occurrence of both proteins in the 
prey list since the core dataset of this study contained only bait-prey pairs. 3), 
Gavin et al. [13] The network of interactions was obtained as deposited in 
Biogrid. This study used a statistical framework for deriving a high confidence 
set of interactions that makes possible interactions between two prey proteins. 
Therefore for normalization, we considered an interaction to be possible if for a 
pair of interaction partners, a bait-prey or prey-prey pair exists in the raw 
purification data (downloaded from http://yeast-complexes.embl.de). 4) Collins 
et al. [36] We used high confidence data with a PE score cutoff of 3.19. 
Normalization was performed as described above for Gavin et al. using a 
combination of both Krogan and Gavin raw datasets.5), Ito et al., Uetz et al. 
[35] Interactions detected by yeast two-hybrid assays. Interaction was 
considered possible if one of the interacting partners is among proteins that 
showed an interaction when tagged with a binding domain and another is 
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among proteins that showed interactions when tagged with an activation 
domain.6), Miller et al. [26] Interactions tested using the split-ubiquitin 
reporter. The data were extracted from supplementary Table 1. An interaction is 
considered possible if a corresponding pair of Cub-PLV and NubG ORF is 
present in the dataset. 
1.5.15. Clustering of high confidence interactions. 
 2,534 heteromeric high confidence interactions were clustered as described in 
[73]. For clustering purposes and during calculation of the association matrix, a 
value for self-association of a protein was set to 1. Hence, observed homomeric 
interactions could not be distinguished from those used for clustering purposes. 
Since two proteins that belong to the same complex may not be interacting but 
rather kept together by a common interacting partner, an association matrix 
based on the number of links that connect two proteins can be used for 
clustering [74]. We found that for the sparse PPI matrix derived from DHFR 
PCA data, this procedure resulted in a tight and natural clustering of 
interactions among subunits of known complexes. Briefly, the network was 
organized into an association matrix with entries for pairs of proteins that range 
between 0 and 1. Values were calculated as 1/d2, where d is the shortest path in 
the network between these two proteins. A hierarchical agglomerative 
averagelinkage clustering with the uncentered correlation coefficient as the 
distance matrix was then applied to the association matrix [74]. The data were 
then visualized using iVici (File S1, http://michnick.bcm.umontreal.ca/ivici/) 
[75]. Only direct interactions are shown on a complete map (Fig. 15). On the 
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insets, direct interactions are bright red, while indirect interactions (2 or 3 links 
between two proteins) are shown as two consecutively darker shades of red, 
respectively. The clustered network is available in Supplementary File S1. This 
file can be opened and visualized using iVici [75], a platform independent 
software available at (http://michnick.bcm.umontreal.ca/ivici/). 
1.5.16. GO enrichment. 
 The GO slim map was obtained from SGD 17 February 2007. For every pair of 
annotation terms associated with a biological process, cellular compartment and 
molecular function we calculated enrichment/depletion in the number of 
interactions in our high confidence dataset compared to the number expected by 
chance. First, we calculated the number of interactions that are detected 
between proteins associated with a specific pair of GO terms. Next, we 
constructed 10,000 randomized networks of interactions between the same set 
of proteins as in our high confidence network and with the same number of 
interactions per proteins. The randomized networks contain only interactions 
that could be detected in our screen (as described for the normalized overlap 
calculations). For each randomized network, a number of interactions between 
proteins associated with a specific pair of terms were calculated and a z-score 
was derived by comparison of these numbers with a corresponding number of 
interactions detected by our analysis. High z-scores correspond to significant 
enrichment in interactions comparing to random while negative z-scores values 
correspond to significant depletion. 
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  For pairs of interacting proteins that lack a common GO slim 
annotation term we calculated a GO semantic score, which is another measure 
of a functional relationship between proteins. The semantic score takes into 
account a specificity and hierarchy of a parent term that is common to a pair of 
proteins. Thus, pairs of proteins that are more closely related have higher scores 
[76]. The results were compared with semantic scores calculated for random 
networks generated as described above.  
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2.1. Overview 
 While canonical pathways and regulatory networks provide a 
representation of molecular interactions in the cell that appears immutable, real 
regulatory pathways are anything but static. Rather, they reconfigure 
dynamically as a function of the specific molecular context in which they 
operate. This was shown initially in yeast and more recently in mammalian 
cells [77-79]. The cellular response to environmental stress is associated with 
massive rewiring of protein complexes and of genetic interactions that they 
tolerate [28]. These lines of mechanistic causality propagate in the protein 
network resulting in coherent morphological dynamics and cellular responses. 
Cells have evolved different strategies to coordinate these cellular network 
rearrangements including: (I) transcriptional programs launched by common 
transcription factors, (II) post-translational modifications, such as 
phosphorylation by protein kinases that alter and activate substrates required for 
cellular responses, (III) active molecule sequestration in subcellular 
compartments, and (IV) molecule-targeted decay, to name a few [80] (Fig. 17). 
For example, treatment of yeast with rapamycin has pleiotropic effects on 
cellular processes. In the cell, rapamycin binds to the ubiquitous and abundant 
protein FKBP12 and the rapamycin-FKBP12 complex in turn forms a ternary 
complex with the Target Of Rapamycin (TOR) kinase and inhibit its enzymatic 
activity [81]. Inhibition of TOR by rapamycin promotes effects through down-
regulation of translation by preventing TOR phosphorylation and activation of 
the protein S6 kinase and in turn phosporylation and activation of the S6 
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ribosomal protein. Rapamycin also prevents direct phosphorylation of initiation 
factor (eIF) 4E binding protein 1 (4E-BP1) by TOR, which prevents 4E-BP1 
binding to and inhibition of eIF-4E that reduce mRNA translational rates [82, 
83]. In parallel, PP2A phosphatase is activated following release of its catalytic 
subunit, Pph22, from the TAP42 complex when rapamycin-FKBP binds to 
TOR kinase [84]. The phosphatase catalytic subunit is released when Tap42, a 
direct substrate of TOR kinase in yeast, is dephosphorylated. The Pph22 
activation also occurs during the mitosis transition and under a variety of 
stresses, such as nitrogen starvation and carbon source limitation, in a TOR 
dependant manner [84-88]. It is interesting that all of these conditions have 
drastic effects on cell cycle progression. In this chapter I describe experiments 
that link TOR and nutrient limitation to a novel mechanism of control of cell 
cycle progression at the level of mRNA stability. 
 
All cells arise from division of existing cells. The cell reproductive 
mechanisms are separated into distinct processes leading to cell cycle 
completion. In budding yeast, first, cell contents are duplicated, and second, 
they are distributed asymmetrically between the newborn daughter cell and the 
mother cell. Most of the cell components are replicated continuously 
throughout the cell cycle, resulting in doubling of cell size by the end of the 
cycle. The genetic material, conversely, is doubled once per cycle. This occurs 
during a discrete stage of DNA synthesis or S phase (Fig.18). The separation of 
mother cell constituent into individual daughter cell occurs in a brief stage 
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called mitosis or M phase. The S and M phases are separated by two distinct 
gaps providing additional time for cell growth and for regulatory events to take 
place. The first gap phase, G1, occurs before S phase, whereas, G2 takes place 
prior to M phase. During the G1 phase, cells are accumulating mRNAs and 
proteins in preparation for the subsequent steps leading to mitosis. G1 phase 
ends when a cell commit for mitosis in a checkpoint called START and move 
into S phase. Similarly, G2 phase is characterized by a rapid growth and protein 
accumulation period during which the cell readies itself for mitosis.  
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Figure 17: Network representation of a protein interaction regulatory 
cascade. 
 Protein, denoted as nodes in a network (red and green circles), represent 
several entities (gene, mRNA, and protein) and events (transcription, 
translation, degradation, translocalization, scaffolding, protein post-translational 
modifications and conformational changes) that simultaneously happen in space 
and time. Although a series of regulatory events can be represented as a node in 
the network, the dynamics of the entities and the biological processes that make 
up the node cannot be symbolize in the same manner. 
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Figure 18: The events of the eukaryotic cell cycle  
94 
 
Cells in G1 regulatory period become committed to either continued division or 
exit from the cell cycle, entering a prolonged state called G0 [89]. During the 
G0 stage, cells are maintaining a minimal metabolic and structural state 
allowing survival in extreme conditions, until stress conditions are alleviated 
and cell cycle can be resumed. G2 is a regulatory period during which cells 
ensure DNA integrity and adequate adaptation status to maximize daughter cell 
viability [90]. The central components that control division are an enzyme 
family called the cyclin-dependant kinases (Cdks) [6]. These kinases bind to 
sets of phase specific cyclins, conferring specificity and acute kinase activity 
for substrates, thereby initiating cell cycle events. These molecules are the 
limiting factors in cell cycle progression and their regulation is therefore a main 
focus [91]. 
 
 The keystone process in the cell cycle oscillation is ultimately the cyclin 
concentrations, the rate-limiting elements. The quantity of each cyclin is 
regulated through their synthesis, whose expression is stimulated by various 
transcription factors such as SCB-binding factor (SBF) and MCB-binding 
factor (MBF), and through their degradation, promoted by both Cdc20-and 
Cdh1- Anaphase promoting complex (APC), and Grr1-Skp, Cullin, F-box 
containing complex (SCF). In fact, activation of SBF and MBF transcription 
initiates key cell cycle events, including budding, DNA synthesis, and spindle 
pole body duplication. The SBF complex activates transcription mainly through 
a cis-acting sequence element; called Swi4/6 cell cycle box (SCB). Genes 
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activated by SBF include those encoding G1 cyclins; CLN1 and CLN2. The 
MBF complex recognizes the Mlu1 cell cycle box (MCB) element and activates 
G1-specific transcription of the S-phase cyclin genes, CLB5 and CLB6. In 
contrast, the APC and SCF complexes are ubiquitin ligases that conjugate 
ubiquitin onto cyclins and target them for proteolysis. The APC controls 
metaphase-anaphase transition with its activator Cdc20. Its activity is required 
for sister chromatids separation. APC with the other activator, Cdh1, is also 
involved in the G1 phase and controls levels of mitosis regulating proteins. SCF 
controls G1/S through G2/M transitions. The complex promotes cell cycle 
progression and cell growth by targeting G1/S cyclins to degradation. 
 
 Both cyclin mRNA synthesis and cyclin protein degradation are crucial 
for the cell cycle progression and delays required for adaptations. However, the 
molecular mechanisms regulating the cyclin amounts per cell can take a variety 
of forms. It is not clear whether post-transcriptional regulation could control 
availability of mRNA for translation. It is now well established that 
transcription and nuclear mRNA processing and cytosolic stability are coupled, 
as mRNA maturation, such as capping, splicing and polyadenylation, mRNA 
export and stability are initiated on nascent transcripts [92, 93]. It was shown 
that Npl3, Hrp1, Nab2 and other heterogeneous nuclear RNA binding proteins 
(hnRNPs) specify the translational control, mRNA decay and mRNA 
localization shuttle between the cytoplasm and the nucleus [94-97]. Their early 
binding to RNA secondary structure folded co-transcriptionally in the nucleus 
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is essential for their impact on RNA fate [98]. For example, CLB2 mRNA is 
localized to the bud tip in a manner dependent of RNA binding protein Khd1 
[99] and is stabilized when associated with Dbf2 kinase [93]. Similarly, CLN3 
mRNA is localized into Whi3 protein foci, inhibiting its translation [100]. 
Distinctively, CLB6 mRNA is degraded early in unperturbed S phase, but 
stabilized during replication stress and DNA damage [101]. In fact, it was 
shown that Npl3, Nab2, Hrp1 and Tho2 bind to all of the cyclin transcripts [96]. 
The exact mechanisms by which these cyclin and possibly other transcripts are 
regulated remains to be determined. 
 
 Post-translational modifications of hnRNPs modulate their capacity to 
bind to and regulate transcripts. For example, specific arginine residue 
methylation occurring on Nab2, Npl3, Tho2 and Hrp1 by the only arginine 
methyltransferase in yeast, Hmt1, directly regulates their RNA binding function 
[94, 95, 102]. This enzyme exists as a functional homohexamer as shown by 
both affinity chromatography and high-resolution X-ray crystallography [103]. 
S-Adenosyl-L-methionine (SAM) acts as methyl group donor co-factor for 
methylation of hnRNPs and other proteins on consensus sequences surrounding 
an arginine residue (-(G/F)(G/R)GRGG(G/F)-). These modifications may alter 
their activity, interactions or stability [94-97]. Hmt1 is thought to be regulated 
at the level of transcription and transcript production is altered under different 
conditions [104]. There is, however, no evidence that changes in transcript level 
result in changes in Hmt1 protein synthesis or enzyme activity in the cell. In 
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this chapter, I present evidence that Hmt1 assembly and induction of catalytic 
activity is directly controlled by phosphorylation. 
 
 Completion of this thesis work required that I adapt and apply recent 
conceptual and technical advances in the study of cell cycle and RNA 
measurements. New understanding of cell cycle regulation have resulted from 
recognition of two things: first, the importance of dissecting populations of 
cells into those having different lengths of mitotic phases (e.g. newborn 
daughter versus mother cells), second, the use of fluorescent reporters and 
single cell analysis to define specific regulatory cues in time [105, 106]. 
Equally, to understand the role of mRNA regulation in cell reproduction control 
and to set the stage for studying upstream regulatory pathways, requires the 
ability to follow the spatial and temporal dynamics of single molecules mRNA 
following transcription [9, 93].  
 
Ultimately, we need strategies to identify upstream regulatory pathways 
that control mRNA dynamics during the cell cycle. In this chapter I describe a 
strategy I developed to identify proteins that regulate oscillating mRNAs during 
mitosis based on proteome-wide measurements of change in protein-protein 
interactions in vivo following perturbations of the cell by rapamycin, a 
compound known to delay the cell division at G2/M [107]. I then used single 
mRNA molecule tracking techniques combined with genetic and biochemical 
analyses, to infer mechanistic details regulating transcript turnover and 
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translational availability. The same strategy could be applied to identify 
proteins involved in any cellular process.   
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Background 
 In the following manuscript that was submitted in an article format to 
the journal Cell, we used single cell, single molecule FISH to measure absolute 
quantities of CLB2 mRNAs in response to a nutrient-limiting mimic stress, treatment 
with rapamycin. Surprisingly, CLB2 transcript failed to accumulate in early M-phase in 
rapamycin-treated cells, leading us to investigate its regulation by hnRNPs and the 
arginine methyltransferase, Hmt1. By quantitative fluorescence microscopy, we 
showed that rapamycin causes sequestration of hnRNPs to the nucleus preventing their 
localization to cytosol, where they are indispensable to mRNA stabilization. Genetic 
and protein-protein interaction screens, combined with biochemical analysis revealed 
that the protein kinase Dbf2 competes with phosphatase PP2A (Pph22) for 
phosphorylation, and cooperative phosphorylation-induced oligomerization and 
activation of the arginine methyltransferase, Hmt1. Hmt1 in turn methylates hnRNPs 
to promote their co-transcriptional association with mRNA and nuclear export. 
Rapamycin inhibition of TOR induces the recruitment of the PP2A phosphatase 
catalytic subunit Pph22 to Hmt1 and dissociation of Dbf2, favoring dephosphorylation 
and inactivation of the arginine methyltransferase. Based on these results, we propose a 
general model of how CLB2 transcript accumulation and therefore early M-phase 
transition can occur under normal and stress conditions. We discuss how the unique 
mechanism of cooperative Hmt1 activation generates a modulator of RNA stability in 
which small variations in PP2A activity leads to sharp changes in Hmt1 activity while 
Dbf2 activity remains at constitutive levels. We propose that this may be a general 
mechanism to modulate the rate of cell cycle progression in response to alterations in 
environmental conditions.  
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2.2. Highlights 
 CLB2 mRNAs fail to accumulate in cells treated with rapamycin 
 CLB2 transcript decay depends on phosphorylation and cooperative 
activation of Hmt1 
 Dbf2 and Pph22 regulate Hmt1 phosphorylation, oligomerization and 
activation 
 Entry into M-phase is sharpened by Hmt1-dependent stabilization of 
CLB2 transcripts 
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2.3. Introduction 
 
 Transcriptional programs and therefore mRNA expression patterns are 
constantly adapting to intrinsic and extrinsic cellular cues including cell cycle 
control mechanisms. We have little understanding of how posttranscriptional 
regulation of mRNA contributes to control of mitosis [108, 109]. Temporal and 
spatial patterns and levels of transcript expression are governed by 
transcriptional mechanisms, as well as mRNA binding proteins and degradation 
machinery [110]. While transcription is generally thought to result in linear 
accumulation of transcripts, the rate of mRNA decay can change exponentially 
in response to external stress signals [111]. mRNA decay machinery is 
modulated by decay regulatory proteins that bind to untranslated regions 
(UTRs) or the open reading frame (ORF) of mRNAs, thereby inducing or 
preventing mRNA degradation [112, 113]. Most of the mRNA decay 
machinery is located in the cytosol where mature mRNA degradation is 
performed (Reviewed in [114]). Early factors, such as the heterogeneous 
nuclear RNA binding proteins (hnRNPs), bind co-transcriptionally to mRNA to 
promote mRNA export and stability; their association with nascent mRNA is 
partially dependent upon post-translational arginine methylation [96]. However, 
the contribution of mRNA degradation regulators, mRNA degradation 
machinery and the pathways that link external and internal signals to regulation 
of mRNA stability remain subjects of intense investigation. 
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 Recent advances in single cell, single molecule fluorescent in situ 
hybridization (FISH) studies have provided insights into mRNA regulatory 
mechanisms [93, 115, 116]. Notably, a novel mechanism was reported that 
controls stabilization of the mRNA of G2/M transition regulators, the cyclin 
Clb2 and Swi5 in the budding yeast S. cerevisiae [93]. CLB2 and SWI5 mRNA 
accumulates in the cell starting at early until late M-phase when it is rapidly 
degraded [117]. Trcek et al. demonstrated that the degradation of CLB2 and 
SWI5 transcripts was regulated by co-transcriptional recruitment of the mitotic 
exit regulating kinase Dbf2 to the CLB2 and SWI5 promoters. Dbf2 bound 
directly to CLB2 and SWI5 mRNA and they proposed that the interaction 
regulates mRNA degradation in a CCR-NOT complex dependent manner. 
Other proteins are recruited to the CLB2 locus, including the hnRNP 
components Hrp1 and Npl3 in a methyltransferase dependent and independent 
manner, respectively [96], promoting mRNA stability and nuclear mRNA 
export.  
 
 The novel function of Dbf2 in regulating cell cycle-specific 
transcription begs the question of how such functions might be regulated by 
external signals to control cell cycle progression. For instance, delay or arrest in 
early M-phase are induced by various cellular stresses, including protein 
synthesis inhibition, osmotic shock, DNA damaging agents, Target of 
rapamycin (TOR) inhibition by rapamycin and nutrient starvation [107, 118-
120]. We know little about how M-phase delay or arrest is caused by these 
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treatments and whether it may occur at the level of mRNA or protein synthesis 
or degradation. 
 
 As with other cellular stresses, rapamycin will delay or arrest different 
phases of the cell cycle, but the details of how this occurs are not clear [107]. 
Rapamycin prevents TOR phosphorylation of substrates by first forming a 
binary complex with the endogenous protein Fkbp12, and this complex then 
forms a ternary complex with TOR [81]. Inhibition of TOR by rapamycin 
promotes pleiotropic effects through down-regulation of translation by 
preventing TOR phosphorylation and activation of the protein S6 kinase and in 
turn phosporylation and activation of the S6 ribosomal protein. Rapamycin also 
prevents direct phosphorylation of initiation factor (eIF) 4E binding protein 1 
(4E-BP1) by TOR, which prevents 4E-BP1 binding to and inhibition of eIF-4E 
[82, 83]. In addition, TOR pathway was involved in nitrogen starvation and 
carbon source limitation sensing and was, therefore, utilized as a tool to mimic 
these processes. In fact, Gln3 and Ure2, transcription factors responsible for 
nitrogen starvation and sugar limitations adaptations, translocalizations and 
gene expression targets upon starvations and rapamycin treatments suggest 
direct regulation by the TOR pathway [121]. Simultaneously, the translation 
regulation by Gcn2 and vacuolar organization induced by Npr1 upon starvation 
are revealed to be targeted by rapamycin-induced TOR inhibition [122, 123]. 
TOR kinase affects normal G1 cell cycle progression and rapamycin causes 
reduction of G1 cyclin transcripts and translation in cells, likewise observed 
105 
 
during nitrogen starvation [124, 125]. Interestingly, however, the TOR pathway 
delays early M-phase cell cycle progression in a translation-independent 
manner, since the delayed transition is unaffected in cells treated by ribosomal 
inhibitors or in mutant strains that exhibit reduced initiation of translation 
[107]. Based on these observations and previous mentioned evidence of Trcek 
et al., we hypothesized that a TOR-regulated pathway controls G2 cyclin 
stability post-transcriptionally, via mechanisms that regulate mRNA 
degradation [93]. 
 In this work, we used single cell, single molecule FISH to measure 
absolute quantities of CLB2 mRNAs in individual cells in response to 
rapamycin treatments. Surprisingly, CLB2 transcript failed to accumulate in 
early M-phase in rapamycin-treated cells, leading us to investigate its regulation 
by hnRNPs and the arginine methyltransferase, Hmt1. By quantitative 
fluorescence microscopy, we showed that rapamycin causes sequestration of 
hnRNPs to the nucleus preventing their localization to cytosol, where they are 
indispensable to mRNA stabilization. Genetic and protein-protein interaction 
screens, combined with biochemical analysis revealed that the protein kinase 
Dbf2 competes with phosphatase Pph22 for phosphorylation, and cooperative 
phosphorylation-induced oligomerization and activation of the arginine 
methyltransferase. Hmt1 in turn methylates hnRNPs to promote their co-
transcriptional association with mRNA and nuclear export. Rapamycin 
inhibition of TOR induces the recruitment of the PP2A phosphatase catalytic 
subunit Pph22 to Hmt1 and dissociation of Dbf2, favoring dephosphorylation 
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and inactivation of the arginine methyltransferase. Based on these results, we 
propose a model of how CLB2 transcript accumulation and therefore early M-
phase transition can occur under normal and stress conditions. 
2.4.Results 
 
2.4.1. CLB2 mRNA fail to accumulate in early M-phase in cells treated 
with rapamycin 
 
 We counted single transcripts in individual cells using single cell, single 
molecule FISH [9]. To achieve this, multiple oligonucleotides complementary 
to the CLB2 and ACT1 mRNAs (actin positive control), labeled with 4-5 
fluorescent dyes, were hybridized to paraformaldehyde fixed yeast cells and 
signal emitted from individual mRNAs detected by wide field fluorescence 
microscopy [93, 126]. Total cellular mRNA distribution was further monitored 
using an oligo dT probe detecting all cellular polyA mRNA (Fig. 19A). 
Individual CLB2 and ACT1 mRNAs within individual cells detected as 
diffraction limited spots were counted [93]. To monitor CLB2 accumulation 
over the cell cycle, cells were arrested in G1 by treatment with -factor and 
then released into the cell cycle by the removal of -factor.   
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Figure 19: CLB2 mRNA fail to accumulate in early M-phase in cells treated with rapamycin.  
(A) Accumulation of mRNA following release of cells from G1 phase arrest by 
removal of -factor. Rapamycin (200 nM) was added to one of the 
synchronized cultures 20 minutes after -factor release to prevent premature 
rapamycin-induced G1 arrest. A mix of cy3 labeled CLB2 mRNA probes (in 
yellow), cy3.5 ACT1 mRNA probes (in red) and poly(A) containing mRNA 
probes (in gray scale) were combine to reveal single mRNA of individual cells 
by FISH in cells fixed every 20 minutes following -factor release or 
rapamycin treatment. Cell nucleus was stained by DAPI (in blue) contained in 
cover slip mounting medium. (B) Detection and counting of fluorescent 
mRNAs and single probes was performed for 25 cells treated with rapamycin 
(200 nM) or ethanol vehicle at each time points for CLB2 mRNAs (left panel) 
and ACT1 mRNAs (right panel). Scale bar: 1 µm.  
108 
 
Cells were treated with 200 nM rapamycin or ethanol vehicle (Control) 20 
minutes after -factor release to prevent rapamycin-induced G1 arrest [107]. 
Cells were harvested and fixed every 20 minutes for one cell cycle and after 
120 minutes following -factor release (t = 0). Fixed cells were hybridized to 
mRNA probes and CLB2, ACT1 and poly(A) mRNA were quantified (Fig. 
19B). During the first 40 minutes following -factor release, control cells 
harboured an average of 5 CLB2 mRNA copies per cell, independent of 
whether they were treated with rapamycin or not. Cells entering early M-phase 
(60 minutes) accumulated an average of 18 CLB2 mRNA molecules and 
continued to accumulate copies into M-phase (80 minutes) reaching a 
maximum of about 23 molecules per cells before returning to basal copy 
numbers at 120 minutes. In contrast, rapamycin treated cells did not accumulate 
new CLB2 mRNAs, remaining at an average of 5 molecules per cell throughout 
the recorded period. This conditional build up of transcripts in cells during early 
M-phase was specific to CLB2 mRNA as ACT1 mRNA remained constant in 
control and rapamycin-treated cells. 
 
2.4.2.Rapamycin causes sequestering of hnRNPs in the nucleus 
 
 To investigate the cause of CLB2 transcript accumulation in cytosol in 
early M-phase and failure to accumulate in cells treated with rapamycin, we 
first reasoned that rapamycin could affect mRNA nuclear export and 
cytoplasmic related mRNA stabilizing activities. It has already been 
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demonstrated that deletion of genes coding for hnRNP components causes 
accumulation of mRNA in the nucleus and reduced mRNA stability [127, 128]. 
Thus we first tested whether correct nuclear and cytosolic localization of 
hnRNP components occurs in cells treated with rapamycin. We used diploid 
strains that express one of each the endogenous hnRNP protein Nab2, Npl3 and 
Hrp1 as fusions to GFP and, simultaneously, express endogenous Nup49 as a 
fusion to dtTomato as a nuclear membrane marker. Strains were treated with 
rapamycin or ethanol vehicle for 6 hrs before being adhered on ConA-coated 
glass bottom 96-well plates and imaged (Fig. 20A). In control cells, the GFP 
signal intensities for all three hnRNP components were mostly localized within 
the nucleus with some cytosolic signal. However, cells treated with rapamycin 
exhibited significantly reduced cytoplasmic GFP signal intensities. We 
quantified GFP signal intensities over the nucleus, the cytoplasm and the whole 
cell, and normalized the quantity by area, for 100 cells per strain treated with 
rapamycin or vehicle control (Fig. 20B). While GFP signal densities stayed 
relatively unaffected in the nucleus, we observed a significant decrease for each 
hnRNP in the cytoplasm. The intensities of GFP that we observed in the 
cytoplasm of rapamycin treated cells were within the range of auto-fluorescence 
of wildtype cells. The nuclear sequestration that we detected in rapamycin 
treated cells were specific to the hnRNP components Nab2, Npl3 and Hrp1, and 
did not affect the localization of the mRNA export receptor Mex67, nor did it 
change the distribution of different karyopherins, including Sxm1, Kap123, 
Crm1, Los1 and Pse1 (Fig. 21A). 
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Figure 20: hnRNPs are sequestered in the nucleus in rapamycin treated cells.  
(A) Yeast cells endogenously expressing hnRNPs fused to GFP (in green) and 
Nup49 fused to dTomato (in red), as nuclear membrane marker, were treated 
with 200 nM rapamycin or ethanol vehicle for 6 hrs. Cells were adhered on 
ConA-coated glass bottom 96-well plates, imaged and images were overlayed. 
(B) GFP intensities for hnRNPs fused to GFP were quantified and area 
normalized for 100 cells for each strain treated with rapamycin (200 nM) or 
ethanol vehicle (in yellow). Cellular GFP signal was further segmented into 
nucleus (in blue) and cytoplasm (in red) based on Nup49 nuclear membrane 
marker. Scale bar: 1 µm. See also Figure 21.  
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Figure 21: Other karyopherins and mRNA nuclear export elements are homogenously affected in 
rapamycin treated cells.  
(A) Yeast cells endogenously expressing hnRNPs fused to GFP (in green) and 
Nup49 fused to dTomato (in red), as nuclear membrane marker, were treated 
with 200 nM rapamycin or ethanol vehicle for 6 hrs. Cells were adhered on 
ConA-coated glass bottom 96-well plates, imaged and images were overlayed. 
(B) GFP intensities for hnRNPs fused to GFP were quantified and area 
normalized for 100 cells for each strain treated with rapamycin (200 nM) or 
ethanol vehicle (in yellow). Cellular GFP signal was further segmented into 
nucleus (in blue) and cytoplasm (in red) based on Nup49 nuclear membrane 
marker. Scale bar: 1 µm. 
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2.4.3.Rapamycin does not affect Hmt1 activity through changes in 
expression or localization 
 
 Both efficient association and localization of the hnRNP components 
are dependent on specific methylation by the arginine methyltransferase, Hmt1 
[95, 129, 130]. Since rapamycin inhibits general translation we reasoned that 
simply a reduction in Hmt1 expression and therefore reduced methylation 
activity could account for nuclear sequestering of hnRNP components. Using a 
yeast strain expressing endogenous Hmt1 fused to GFP, we treated cells with or 
without rapamycin for 6 hours. Hmt1 expression was quantified as GFP 
fluorescence intensity by FACS (Fig. 22A). Contrary to expectation, cells 
treated with rapamycin exhibit approximately an order of magnitude increase in 
Hmt1 expression per cell.  
 
 Although Hmt1 expression increases upon rapamycin treatments, it is 
possible that Hmt1 activity must be localized to either cytosolic or nuclear 
compartments in order to act on hnRNPs. We thus examined the effects of 
rapamycin on Hmt1 localization in the same strains as above, treated with or 
without rapamycin for 6 hours. Rapamycin caused an increase of Hmt1 in both 
compartments (Fig. 22B,C). Thus, neither changes in expression nor 
localization of Hmt1 induced by rapamycin can account for changes in hnRNP 
localization.  
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Figure 22: Both modifications and homo-oligomeric affinities are lost on Hmt1 in cell treated with 
rapamycin.  
(A) Yeast cells endogenously expressing Hmt1 fused to GFP were treated with 
200 nM rapamycin (in red) or ethanol vehicle (in blue) 6 hrs. GFP intensities 
per cell in culture treated with rapamycin or ethanol vehicle were record in a 
LSRII FACS for 30, 000 cells and distribution were displayed in bar graph. (B) 
Yeast cells endogenously expressing Hmt1 fused to GFP (in green) and Nup49 
fused to dTomato (in red), as nuclear membrane marker, were treated with 200 
nM rapamycin or ethanol vehicle for 6hrs. Cells were adhered on ConA-coated 
glass bottom 96-well plates, imaged and images were overlayed. (C) GFP 
intensities for Hmt1fused to GFP were quantified and area normalized for 100 
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cells for each strain treated with rapamycin (200 nM) or ethanol vehicle (in 
yellow). Cellular GFP signal was further segmented into nucleus (in blue) and 
cytoplasm (in red) based on Nup49 nuclear membrane marker. (D) Flow chart 
of modified TAP tag purification for Hmt1 homomeric complexes. Diploid 
strain expressing Hmt1 fused to the TAP tag from the first locus and Hmt1 
fused to DHFR F[3] from second locus are treated with rapamycin (200 nM) or 
ethanol vehicle for 6 hrs. After washes and TEV protease elution, presence in 
immunoprecipitate of cleaved Hmt1-TAP and Hmt1-DFHR F[3] revealed 
condition specific oligomerization assembly. (E) Diploid yeast cell 
endogenously expressing Hmt1-TAP on first locus and Hmt1-DHFR F[3] on 
second locus were treated with 200 nM rapamycin or ethanol vehicle for 6 hrs. 
For each condition, cells were harvest, lysed and proteins were purified to be 
applied on IgG resin. IgG immunoprecipitates was eluted by TEV protease 
cleavage of the Hmt1-TAP. IgG immunoprecipitates and cell lysates were 
analyzed by immunoblotting for levels of Hmt1-TAP, co-immunoprecipitated 
and levels of Hmt1-DHFR F[3]. (F) Hmt1 N-terminal first 20 amino acids 
contain conserved serine, threonine and lysine residues across fungi. (G) 
Phosphorylation prediction perform by NetPhos 2.0, target serine 9 and tyrosine 
23 to be phosphorylated and conserved across fungi. Scale bar: 1 µm.  
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2.4.4.Rapamycin prevents homo-oligomerization and activation of Hmt1 
 
 Hmt1 arginine methyl transferase activity only occurs when it is a dimer 
or higher order homo-oligomer [103]. Thus we next tested whether rapamycin 
could prevent homo-oligomerization of Hmt1. We devised a simple in vivo 
assay to detect oligomeric states based on affinity and immuno-affinity 
detection of dual immunogenic peptide-tagged Hmt1 (Fig. 22D). We generated 
a strain in which a TAP tag sequence was integrated 3’ at one locus of Hmt1 
and an antigenic C-terminal peptide sequence of mouse dihydrofolate reductase 
(DFHR F[3]) 3’ to the Hmt1 coding sequence on the second locus. Following 
treatment of the strain with rapamycin or vehicle control, we performed IgG 
immunoprecipitation (against Protein A domain of the TAP tag) of Hmt1-TAP, 
eluted and ran samples on SDS-PAGE followed by immunoblot with an 
antibody against either DHFR F[3] or the TAP calmodulin-binding peptide 
(CBP) (Fig. 22E). We observed that Hmt1-TAP co-immunoprecipitated Hmt1-
DHFR F[3] in control, non-treated cells. However, in cells treated with 
rapamycin, Hmt1-TAP no longer co-immunoprecipitated with Hmt1-DHFR 
F[3]. These results suggest that rapamycin prevents the homo-oligomerization 
and therefore activation of Hmt1 activity. 
 
 
116 
 
2.4.5.Hmt1 phosphorylation is essential for its homo-oligomerization 
 
 We observed that a fraction of Hmt1 migrated more slowly on SDS-
PAGE in the control cells (Hmt1*) but this species is not evident in rapamycin-
treated cells (Fig. 22E). We reasoned that the slower-migrating species of Hmt1 
could be phosphorylated and that perhaps phosphorylation is required for its 
oligomerization and set out to identify potential sites of phosphorylation. A clue 
was provided by the crystal structure [103]. Hmt1 was crystallized as an active 
hexamer. However, the Hmt1 that was crystallized was, in fact, expressed as a 
mutant in which the first 20 amino acids were deleted and positions 21 and 22 
were muted from Gln-His to Asp-Tyr. This mutant Hmt1 was chosen because it 
was more soluble and produced crystals of higher diffraction quality than 
wildtype Hmt1 [103]. We hypothesized that the first 20 amino acids could 
contain regulatory elements, perhaps phosphorylation sites that control homo-
oligomeric assembly. Since these regulatory elements are necessary for Hmt1 
activity, they should be evolutionarily conserved. We performed an alignment 
of Hmt1 homologues across the ascomycetes fungi (Fig. 22F). We identified 
five conserved potential phosphorylation sites within or around the first 20 
amino acids of which Ser 9 and Tyr 23 showed the strongest prediction to be 
phosphorylated by NetPhos 2.0 [131] (Fig. 22G).  
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 We investigated the possibility that Hmt1 homo-oligomerization 
depends on phosphorylation, of Ser 9. We adapted the TAP tag 
immunoprecipitation assay (Fig. 23A) to include a step to deplete 
phosphorylated species in purified protein complexes by treatment with alkaline 
phosphatase (AP) following immunoprecipitation of Hmt1-TAP (Fig. 23A). 
Protein was applied on IgG resin and treated with active alkaline phosphatase 
or treated with sodium vanadate to inactivate alkaline phosphatase for 1 hour 
before a final wash. We eluted and separated IgG immunoprecipitate on SDS-
PAGE to reveal co-immunoprecipitated Hmt1-DHFR F[3] (immunoblot with 
anti-DHFR) or Hmt1-TAP (with the CBP antibody) (Fig. 23B). We observed 
that alkaline phosphatase-treated Hmt1-TAP immunoprecipitates no longer co-
purified with Hmt1-DHFR F[3]. However, simultaneous treatment of 
immunoprecipitates with sodium vanadate prevented alkaline phosphatase-
induced monomerization of Hmt1. These results suggest that oligomerization of 
Hmt1 requires phosphorylation of at least one subunit. 
 To specifically determine if Ser 9 is required for Hmt1 phosphorylation 
and sufficient to mediate oligomerization of Hmt1, we generated 
phosphomimetic (Hmt1S9E) and non-phosphorylatable (Hmt1S9A) mutants. 
We generated diploid strains as above to express wildtype Hmt1 Hmt1wt-TAP, 
Hmt1S9E or Hmt1S9A from the first locus and Hmt1wt-DFHR F[3], 
Hmt1S9E-DFHR F[3] or Hmt1S9A-DFHR F[3] from the second locus and 
performed our immunoprecipitation assay (Fig. 23B).  
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Figure 23: Hmt1 phosphorylation of serine 9 is essential and required for Hmt1 oligomerization, 
methyltransferase activity and resulting CLB2 mRNA accumulation in early M-phase and hnRNP 
nuclear exports. 
 (A) Flow chart for Hmt1 homomeric immunoprecipitation in diploid yeast cell 
endogenously expressing Hmt1wt, Hmt1S9E or Hmt1S9A fused to TAP tag on 
first locus and Hmt1wt, Hmt1S9E or Hmt1S9A fused to DHFR F[3] on the 
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other locus. IgG immunoprecipitate was treated with alkaline phosphatase or 
alkaline phosphatase with sodium vanadate before the last wash preceding 
elution by TEV protease cleavage of Hmt1-TAP. Presence in 
immunoprecipitate of cleaved Hmt1-TAP and Hmt1-DHFR F[3] revealed 
phospho-dependent oligomerization (B) Diploid yeast cell endogenously 
expressing Hmt1wt, Hmt1S9E or Hmt1S9A fused to TAP tag on first locus and 
Hmt1wt , Hmt1S9E or Hmt1S9A fused to DHFR F[3] on the other locus were 
grown in YPD. For each strain, cells were harvested, lysed and proteins were 
purified applied to IgG resin. Cell lysates (lane Ly), last washes preceding TEV 
protease elution of TAP tag protein fusion (lane W) and IgG 
immunoprecipitates (lane IP) were analyzed by immunoblotting for levels of 
TAP tag protein fusion, levels and co-immunoprecipitated DHFR F[3] tag 
protein fusion. (C) Strains endogenously expressing Hmt1wt, Hmt1S9E or 
Hmt1S9A were arrested in G1 phase by alpha-factor and released in cell cycle. 
Synchronized cultures were treated with rapamycin (200 nM) or ethanol vehicle 
20 minutes after alpha-factor released to prevent premature rapamycin induced 
G1 arrest. A mix of cy3 labeled CLB2 mRNA probes (in yellow), cy3.5 ACT1 
mRNA probes (in red) and poly(A) containing mRNA probes (in gray scale) 
were combine to revealed single mRNA of single cell by FISH in cell fixed 
every 20 minutes for each culture. Cell nucleus was stained by DAPI (in blue) 
contain in cover slip mounting media. (D) Detection and counting of 
fluorescent mRNAs and single probes was performed for 25 cells treated with 
rapamycin (200 nM) or ethanol vehicle in each time points per strains for CLB2 
mRNAs (in upper panel) and ACT1 mRNAs (in lower panel). (E) Yeast cells 
endogenously expressing hnRNPs fused to GFP (in green), Nup49 fused to RFP 
(in red), as nuclear membrane marker, and overexpressing Hmt1wt or 
Hmt1S9E were treated with rapamycin (200 nM). Cells were adhered on ConA-
coated glass bottom 96-well plates, imaged and overlayed. (F) GFP intensities 
for hnRNPs in Hmt1wt or Hmt1S9E overexpressing background strains were 
quantified and area normalized for 100 cells for each strain treated with 
rapamycin (200 nM) or ethanol vehicle (in yellow). Cellular GFP signal was 
further segmented into nucleus (in blue) and cytoplasm (in red) based on Nup49 
nuclear membrane marker. (G) Methylation assay was perform with TAP-
tagged proteins immunoprecipitated with IgG sepharose beads from 
asynchronous cultures, fractionated on SDS-PAGE and immunoblotted with 
anti-CBP (left panel). Npl3-TAP and Nab2-TAP immunoprecipitates were 
treated with enrich Hmt1wt-TAP (lane 1), Hmt1S9E-TAP (lane 2) or 
Hmt1S9A-TAP (lane 3) immunoprecipitates in the presence of [methyl-
3
H]SAM, fractionated on SDS-PAGE and detected by autoradiography (right 
panel). Scale bar: 1 µm. See also Figure 24.  
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We observed that both alkaline phosphatase treated and sodium vanadate-
inactivated alkaline phosphatase treated Hmt1S9E-TAP immunoprecipitates co-
purified with Hmt1wt-DHFR F[3], which demonstrates that phosphomimetic 
mutation of Ser 9, by itself, is sufficient to elicit oligomerization of Hmt1 in the 
absence of phosphorylated protein species. 
 
  In contrast, alkaline phosphatase treated Hmt1S9A-TAP 
immunoprecipitates no longer interacted with Hmt1wt-DHFR F[3], but, 
interestingly, both Hmt1wt-DHFR F[3] forms co-purified in sodium vanadate 
inhibited alkaline phosphatase treated Hmt1S9A-TAP immunoprecipitate. 
Therefore, only a third or less of phosphorylated Hmt1 is required to mediate 
the homo-oligomerization. 
 
  We were able to co-purify both Hmt1S9A-DHFR F[3] and Hmt1S9E-
DHFR F[3] in Hmt1S9E-TAP immunoprecipitates both in the presence and in 
the absence of alkaline phosphatase. In addition, Hmt1S9A-TAP 
immunoprecipitates co-immunoprecipitated Hmt1S9E-DHFR F[3], both in the 
presence and absence of alkaline phosphatase activity. These results suggest 
that both unphosphorylated and phosphorylated Ser 9 Hmt1 subunits can 
oligomerize with a phosphorylated Hmt1 subunit. Thus phosphorylation of at 
least one Hmt1 monomer may be sufficient to induce dimerization and in turn, 
nucleate an enzymatically active hexamer.  
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  Finally, we observed that Hmt1S9A-TAP immunoprecipitates did not 
co-purify Hmt1S9A-DHFR F[3], both in presence and absence of alkaline 
phosphatase. This result demonstrates that Ser 9 is required for Hmt1 
phosphorylation and essential for Hmt1 oligomerization but that Hmt1S9A is a 
constitutive monomer in cells that express this mutant alone. 
 
2.4.6.Phosphorylation of Hmt1 is required to regulate CLB2 mRNA 
stability 
 Based on our observations thus far, we hypothesized that rapamycin 
causes a reduction of CLB2 mRNA stability through a mechanism requiring 
Hmt1 complex dephosphorylation and disassembly, with consequent loss of 
methyltransferase activity. This results in nuclear sequestering Hmt1-
methylation dependent hnRNPs. Based on this hypothesis, we predicted that 
Hmt1S9E, would be a constitutively active homo-oligomer that would promote 
CLB2 mRNA stability that is insensitive to rapamycin treatment. In contrast, we 
predicted that Hmt1S9A would be an inactive, constitutive monomer and that 
CLB2 mRNA would fail to accumulate in early M-phase, whether cells were 
treated or not with rapamycin. Therefore, as above, CLB2, ACT1 and poly(A) 
tail containing transcripts were counted in single cells, by single molecule FISH 
in strains of different mutant backgrounds [9] (Fig. 23C, Fig. 24A).  
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Figure 24: Hmt1 phosphorylation of serine 9 is essential and required for Hmt1oligomerisation, 
methyltransferase activity CLB2 mRNA accumulation in early M-phase and hnRNP nuclear 
exports.  
(A) Strains endogenously expressing Hmt1wt, Hmt1S9E or Hmt1S9A were 
arrested in G1 phase by alpha-factor and released in cell cycle. Synchronized 
cultures were treated with rapamycin (200 nM) or ethanol vehicle 20 minutes 
after alpha-factor released to prevent premature rapamycin induced G1 arrest. A 
mix of cy3 labeled CLB2 mRNA probes (in yellow), cy3.5 ACT1 mRNA 
probes (in red) and poly(A) containing mRNA probes (in gray scale) were 
combine to revealed single mRNA of single cell by FISH in cell fixed every 20 
minutes for each culture. Cell nucleus was stained by DAPI (in blue) contain in 
mounting media. (B) Yeast cells endogenously expressing hnRNPs fused to 
GFP (in green), Nup49 fused to RFP (in red), as nuclear membrane marker, and 
overexpressing Hmt1wt or Hmt1S9E were treated with rapamycin (200 nM) or 
ethanol vehicle. Cells were adhered on ConA-coated glass bottom 96-well 
plates, imaged and overlayed. (C) Yeast cells endogenously expressing 
karyopherins and mRNA nuclear export elements fused to GFP (in green), 
Nup49 fused to RFP (in red), as nuclear membrane marker, and overexpressing 
Hmt1wt or Hmt1S9E were treated with rapamycin (200 nM) or ethanol vehicle. 
Cells were adhered on ConA-coated glass bottom 96-well plates, imaged and 
overlayed. (D) GFP intensities for karyopherins and mRNA nuclear export 
elements in Hmt1wt or Hmt1S9E overexpressing background strains were 
quantified and area normalized for 100 cells for each strains treated with 
rapamycin (200 nM) or ethanol vehicle (in yellow). Cellular GFP signal was 
further segmented into nucleus (in blue) and cytoplasm (in red) based on Nup49 
nuclear membrane marker. Scale bar: 1 µm.  
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Cells endogenously expressing Hmt1S9E or Hmt1S9A were synchronized with 
α-factor and treated with rapamycin or vehicle 20 minutes after α-factor release. 
Cells were harvested and fixed every 20 minutes for 80 minutes and at 120 
minutes following -factor release. Fixed cells were hybridized to mRNA 
probes and CLB2, ACT1 and poly(A) mRNA were quantified and compared to 
wildtype strain (Fig. 23D). Cells expressing Hmt1S9E exhibited elevated CLB2 
mRNA throughout the cell cycle, in both rapamycin or vehicle treated cells. We 
counted an average of 12 CLB2 molecules during G1. The CLB2 mRNA 
accumulated until late M-phase to a maximum of 20 transcripts, which is 
comparable to quantities in vehicle treated wildtype strain in the same cell cycle 
phase. However, cells expressing Hmt1S9A failed to accumulate CLB2 mRNA 
throughout the cell cycle in both rapamycin and vehicle treated cells. We 
counted around 6 CLB2 transcripts in these cells, independent of cell cycle 
phase and rapamycin treatment. These observations were specific for CLB2 
transcripts as ACT1 mRNA remained constant in control and rapamycin-treated 
cells in both mutant strains, similar to results in wildtype cells (see Fig. 22B). 
 
2.4.7.hnRNP nuclear sequestering is dependent on Hmt1 phosphorylation 
 
 Since CLB2 mRNA is stabilized in Hmt1S9E expressing cells, we 
investigated whether Hmt1S9E expression alone is sufficient to prevent 
rapamycin-induced nuclear sequestration of hnRNP proteins. We generated 
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diploid strains harbouring an expression vector for wildtype HMT1 (Hmt1wt) or 
HMT1S9E that simultaneously expressed one of each hnRNP components 
(Nab2, Npl3 and Hrp1) fused to GFP and Nup49 fused to dtTomato as a nuclear 
membrane marker. Strains were treated with rapamycin or ethanol vehicle for 6 
hrs before being adhered onto ConA-coated glass bottom 96-well plates and 
imaged (Fig. 23E, Fig. 24B). In rapamycin-treated Hmt1wt cells, the GFP 
signal for all three hnRNP components were sequestered in the nucleus. 
However, Hmt1S9E cells treated with rapamycin exhibited significant 
cytoplasmic GFP signal (Fig. 23F). These Hmt1S9E associated effects were 
specific to Nab2, Npl3 and Hrp1. Other karyopherins, including Sxm1, Kap123, 
Crm1, Los1, Pse1 and Mex67 (Fig. 24C), showed similar levels of expression 
in cytosol and nucleus that changed proportionately in both compartments 
following rapamycin treatment, in strains expressing either Hmt1wt or 
Hmt1S9E (Fig. 24D). 
 
2.4.8.Methyltransferase activity of Hmt1 is regulated by its 
phosphorylation 
 
 To determine whether Hmt1S9E and Hmt1S9A could methylate 
substrates in vitro, we performed a methylation assay for yeast purified Nab2 
and Npl3 with radiolabeled methyl donor, S-Adenosyl-L-[methyl-
3
H]methionine (
3
H-SAM) in the presence of yeast purified Hmt1wt-TAP, 
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Hmt1S9E-TAP or Hmt1S9A-TAP. The expression and stability of each TAP 
fusion protein was verified by western blot analysis of the methylation reactions 
using the CBP antibody (Fig. 23G). Proteins were resolved on SDS-PAGE, and 
labeling was revealed by fluorography. Both purified Nab2 and Npl3 were 
substrates of Hmt1wt and Hmt1S9E in vitro. However, Hmt1S9A did not 
methylate these substrates. These results confirm that Hmt1wt-TAP and 
Hmt1S9E-TAP are functional methyltransferases, whereas the catalytic activity 
of monomeric Hmt1S9A is abolished. 
 
2.4.9.Rapamycin-dependant Hmt1 protein-protein interactions include 
potential kinases and phosphatases 
 
 We thus far determined that hnRNP localization and CLB2 mRNA 
stability depends on phosphorylation of Hmt1. We next needed to identify a 
kinase that could act on Hmt1. Equally, we hypothesized that there must exist a 
non-canonical TOR pathway with rapamycin-dependent phosphatase activity 
that dephosphorylates and inactivates Hmt1. Thus, we reasoned that we needed 
to identify kinases and phosphatases that interact with Hmt1 in a rapamycin-
dependant manner. To identify potential candidates as well as any other 
rapamycin-dependent Hmt1 protein-protein interactions, we used the DHFR 
survival-selection Protein-fragment Complementation Assay (PCA) [20, 24, 34, 
64]. This assay has been used to access the protein-protein interaction network 
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of S. cerevisiae for approximately 92% of its proteins, in vivo and expressed at 
endogenous levels [132]. We, performed the DHFR PCA screen between 
strains endogenously expressing Hmt1 fused to DHFR fragment F[1,2] and 
complementary fragment DHFR F[3] fused to a collection of 5,250 ORFs 
[132]. Diploid yeast strains were printed onto plates containing methotrexate 
DHFR PCA selective medium and sublethal rapamycin concentration (2 nM) or 
vehicle. Clones in which an interaction occurs between Hmt1 and another 
protein results in complementary fragments of DHFR, to which they are fused, 
being brought together in space where they refold and reconstitute 
methotrexate-resistant DHFR activity. Thus, simple readout of an interaction 
between two proteins is survival and proliferation of cells. Colonies were 
allowed to grow for 5 days at 30°C and resulting plate images recorded with a 
high-resolution digital camera. Images were analyzed to extract pixel intensity 
over colony area in both rapamycin and vehicle-containing selective media 
(Table S1). We calculated a fold-change in interaction for each tested Hmt1 
pair-wise interaction of the collection based on the Log2 ratio of colony 
intensities of rapamycin versus vehicle treated cells (Fig. 25A). We observed 34 
proteins whose interaction with Hmt1 changed by at least 8-fold. These proteins 
were highly enriched in biological processes such as RNA 3'-end processing 
(p<10
-6
), post-translational protein modification (p<10
-4
) and mRNA processing 
(p<10
-3
) (Table S2).  
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Figure 25: Dbf2 kinase and Pph22 phosphatase regulate Hmt1 phosphorylation state and related 
activity on CLB2 accumulation during early M-phase differentially in rapamycin treated cells. 
 (A) Diploid yeast strains endogenously expressing Hmt1 fused to DHFR F[1,2] 
PCA fragment and complementary PCA fragment DHFR F[3] fused to a 
collection of 5250 (91%) ORFs were screen on solid-agar DHFR PCA selective 
media supplemented with sub-lethal rapamycin (2 nM) dose or ethanol vehicle. 
Plates were incubated 120 hrs at 30ᵒC, photographed and analyzed with 
ImageJ, measuring integrated pixel intensity over each colony area. The fold 
change of protein interaction reported by the DHFR PCA colonies growth in 
each condition was computed and the distributions of fold changes were 
displayed in a histogram. 12 of the 34 strongest changes were presented on top 
of the appropriate fold change range for both reduced (in blue) and increased 
(in red) interaction intensities in rapamycin treated reporter strains. (B) Diploid 
yeast cell endogenously expressing Hmt1-TAP on first locus and Hmt1-DHFR 
F[3] on second locus in PKH2∆, DBF2∆, PKH3∆, FPR1∆ or BY4743 
background strains were treated with ethanol vehicle for 6 hrs. In parallel, 
diploid yeast cell endogenously expressing Hmt1-TAP on first locus and Hmt1-
DHFR F[3] on second locus in PPH22∆, NEM1∆, FPR1∆ or BY4743 
background strains were treated with rapamycin (200 nM) for 6 hrs. For each 
strain, cells were harvest and lysed to be applied on IgG resin. IgG 
immunoprecipitates was eluted by TEV protease cleavage of the Hmt1-TAP. 
IgG immunoprecipitates and cell lysates were analyzed by immunoblotting for 
levels of Hmt1-TAP, co-immunoprecipitated and levels of Hmt1-DHFR F[3]. 
(C) Diploid yeast cell endogenously expressing Hmt1-TAP and Dbf2, Pph22 or 
Hmt1 fused to DHFR F[3] or overexpressing a control SspBLSLA-DHFR F[3] 
were treated with rapamycin (200 nM) or ethanol vehicle for 6 hrs. For each 
strain, cells were harvest, lysed and proteins were purified to be applied on IgG 
resin. IgG immunoprecipitates were eluted by TEV protease cleavage of the 
Hmt1-TAP. Cell lysates (lane Ly), IgG immunoprecipitates (lane IP) and last 
wash (lane W) were analyzed by immunoblotting for levels of Hmt1-TAP, co-
immunoprecipitated and levels of DHFR F[3] fused protein. (D) In vivo 
analysis of the steady state level of Hmt1 complex with itself with Dbf2 and 
Pph22 reported by Rluc PCA as a function of rapamycin incubation of 6 hrs. 
Protein interaction reported by Rluc PCA were controlled over spontaneously 
interacting partner SspBLSLA-SspBYGMF, non-interacting partner Dbf2-Pph22 
and spontaneous Rluc PCA fragments reconstitution. Error bars, s.e.m. (n=3). 
(E) Strains endogenously expressing Pph22F232S and Dbf2N305A were 
arrested in G1 phase by alpha-factor and released in cell cycle. Synchronized 
cultures were treated with rapamycin (200 nM) or ethanol vehicle 20 minutes 
after alpha-factor released to prevent premature rapamycin induced G1 arrest. A 
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mix of cy3 labeled CLB2 mRNA probes (in yellow), cy3.5 ACT1 mRNA 
probes (in red) and poly(A) containing mRNA probes (in gray scale) were 
combine to revealed single mRNA of single cell by FISH in cell fixed every 20 
minutes for each culture. Cell nucleus was stained by DAPI (in blue) contain in 
cover slip mounting media. (F) Detection and counting of fluorescent mRNAs 
and single probes was performed for 25 cells treated with rapamycin (200 nM) 
or ethanol vehicle in each time points per strains for CLB2 mRNAs (in upper 
panel) and ACT1 mRNAs (in lower panel). Scale bar: 1 µm. See also Figure 26.  
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Among these, the hnRNP proteins Nab2, Npl3 and Hrp1 showed reduced 
interaction with Hmt1 in reporter strains treated with rapamycin, along with 
several kinases, including Dbf2, Pkh2 and Pkh3. We also observed interaction 
of Hmt1 with two phosphatases, Nem1 and Pph22, but in these cases, the 
interactions increased in rapamycin. We thus next tested these kinases and 
phosphatases as potential regulators of Hmt1 phosphorylation. 
 
2.4.10.Hmt1 phosphorylation and oligomerization are regulated by Dbf2 
kinase and Pph22 phosphatase 
 
 We first tested Dbf2, Pkh2 and Pkh3 as potential Hmt1 kinases and 
Nem1 and Pph22 potential Hmt1 phosphatase in a genetic screen for both their 
requirements for Hmt1 phosphorylation and oligomerization. To do so, we 
generated diploid strains as above to express Hmt1wt-TAP, from one locus and 
Hmt1wt-DFHR F[3] from the other locus in knockout strains DBF2∆, PKH2∆, 
PKH3∆, FPR1∆ and BY4743 wildtype strains treated with vehicle for 6 hrs or 
NEM1∆, PPH22∆, FPR1∆ and BY4743 background strains treated with 
rapamycin for 6 hrs and performed our immunoprecipitation assay (Fig. 25B). 
The FPR1 gene encodes the yeast FKBP12 proteins, which interacts with 
rapamycin to form a ternary inhibitory complex with TOR kinase [81]. Thus, 
the FPR1∆ strain is insensitive to rapamycin, thus serving as a control for TOR 
pathway activation. We observed that Hmt1-TAP phosphorylation was 
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abolished in the DBF2∆ strain and Hmt1-TAP immunoprecipitates no longer 
co-purify Hmt1-DHFR F[3]. This result is specific to the DBF2∆ strain as 
PKH2∆, PKH3∆ and FPR1∆ all retained Hmt1-TAP phosphorylation and 
Hmt1-DHFR F[3] co-immunoprecipitating in Hmt1-TAP immunoprecipitates 
similar to the wildtype strain. Repeating the experiments with the phosphatase 
candidates, we found that rapamycin treated PPH22∆ strains retained Hmt1-
TAP phosphorylation and co-purified Hmt1-DHFR F[3] in Hmt1-TAP 
immunoprecipitates. The FPR1∆ strain showed similar results, insensitive to 
rapamycin. These results suggest that Dbf2 and Pph22 are directly or indirectly 
essential for Hmt1 phosphorylation and dephosphorylation, respectively. 
 
 We verified the Hmt1-Dbf2 and Hmt1-Pph22 physical interactions by 
Hmt1-TAP immunoprecipitation. We generated diploid strains as above to 
express Hmt1wt-TAP and DFHR F[3] fused to Dbf2, Pph22, Hmt1 and a 
control protein from Haemophilus influenzae, SspBLSLA, and performed our 
immunoprecipitation assay from strains treated with rapamycin (200 nM) or 
vehicle (Fig. 25C). We observed that Dbf2-DHFR F[3] and Hmt1-DHFR F[3] 
co-immunoprecipitated Hmt1-TAP immunoprecipitates in cells treated with 
vehicle only and that Pph22-DHFR F[3] interacted with Hmt1-TAP 
immunoprecipitates only in cells treated with rapamycin. These results were 
specific for Hmt1, Dbf2 and Pph22 as SspBLSLA-DHFR F[3] did not 
immunoprecipitate with Hmt1-TAP in cells treated or not with rapamycin. 
These results and those of the DHFR PCA suggest that both Pph22 and Dbf2 
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interact directly with Hmt1 in cells treated with rapamycin and vehicle, 
respectively. 
 
 To determine whether Dbf2 kinase could phosphorylate Hmt1 in vitro, 
we performed a kinase assay for yeast purified Hmt1wt, Hmt1S9E and 
Hmt1S9A with radiolabeled [γ-32P]ATP in the presence of insect cell purified 
Dbf2-Mob1 or Dbf2N305A-Mob1 kinase dead mutant [133]. Proteins were 
resolved on SDS-PAGE, and 
32
P incorporation was revealed by fluorography 
(Fig. 26A). Hmt1wt was phosphorylated in vitro by Dbf2-Mob1. Absence of 
32
P incorporation in Dbf2N305-Mob1 kinase dead mutant showed specific 
phosphorylation by Dbf2 and not a co-purified kinase during protein 
purification both in insect cells and yeast cells. In contrast, Hmt1S9E and 
Hmt1S9A did not incorporate 
32
P in both Dbf2-Mob1 and Dbf2N305A-Mob1 
kinase dead mutant. These results indicate that Hmt1 can be a direct substrate 
of Dbf2 and that Ser 9 is required for the unique Dbf2 phosphorylation site on 
Hmt1. 
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Figure 26: Dbf2 kinase and Pph22 phosphatase regulate Hmt1 phosphorylation state and related 
activity on CLB2 accumulation during early M-phase differentially in rapamycin treated cells.  
(A) Dbf2 kinase assay was perform with Hmt1wt, Hmt1S9E and Hmt1S9A 
mutants TAP-tagged proteins immunoprecipitated with IgG sepharose beads 
from asynchronous cultures. Each Hmt1 species were treated with insect 
purified Cdc15 activated Dbf2-Mob1 kinase complex or Dbf2N305A-Mob1 
kinase-dead mutant in the presence of [γ-32P]ATP, fractionated on SDS-PAGE 
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and detected by autoradiography.(B) Yeast cells endogenously expressing Dbf2 
or Pph22 fused to GFP were treated with 200 nM rapamycin (dotted line) or 
ethanol vehicle (plain line) 6 hrs. GFP intensities per cell in culture treated with 
rapamycin or ethanol vehicle were record in a LSRII FACS for 30, 000 cells 
and distribution were displayed in bar graph. (C) Strains endogenously 
expressing Pph22F232S and Dbf2N305A were arrested in G1 phase by alpha-
factor and released in cell cycle. Synchronized cultures were treated with 
rapamycin (200 nM) or ethanol vehicle 20 minutes after alpha-factor released to 
prevent premature rapamycin induced G1 arrest. A mix of cy3 labeled CLB2 
mRNA probes (in yellow), cy3.5 ACT1 mRNA probes (in red) and poly(A) 
containing mRNA probes (in gray scale) were combine to revealed single 
mRNA of single cell by FISH in cell fixed every 20 minutes for each culture. 
Cell nucleus was stained by DAPI (in blue) contain in mounting media. Scale 
bar: 1 µm.  
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2.4.11.Rapamycin induces cooperative disassembly of Dbf2-Hmt1 and 
Hmt1-Hmt1 complexes but graded assembly of Hmt1-Pph22  
 
 We measured the levels of the Hmt1-Hmt1, Hmt1-Dbf2 and Hmt1-
Pph22 complex with another in vivo PCA based on the Renilla reniformis 
luciferase (Rluc) as a reporter that allows for direct detection of interactions 
among proteins expressed endogenously without significantly altering their 
binding kinetics [21, 134]. Direct measurements of the steady state levels of the 
Hmt1-Hmt1 and Hmt1-Dbf2 protein complexes showed a switch-like 
dissociation of the complex in cellular response to rapamycin with Hill 
coefficients of 3.7 ± 1.7 and 3.6 ± 0.4, respectively, and half-maximum 
effective concentration (EC50) of 34.8 pM and 36.1 pM (Fig. 25D). The Hmt1-
Pph22 protein complex revealed a non-cooperative binding in response to 
rapamycin with Hill coefficient of 1.4 ± 0.5 and half-maximum effective 
concentration (EC50) of 538.4 pM. These protein complex dynamics were 
specific as the constitutive SspBLSLA-SspBYGMF interaction did not change over 
all rapamycin concentrations tested. As controls for spontaneous 
complementation of the Rluc fragments, we tested the fragments alone or fused 
to non-interacting protein, Dbf2-Pph22, and observed only background 
luminescence [21, 134]. 
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 We reasoned that changes in abundance of Dbf2 and Pph22 in response 
to rapamycin could contribute to changes in measured steady-state interactions. 
Using yeast strains expressing endogenous Dbf2 or Pph22 fused to GFP, we 
treated cells with or without rapamycin for 6 hours. The cells were analyzed by 
FACS for integral GFP intensities per cell (Fig. 26B). The quantities of both 
Dbf2 and Pph22 were constant in cells treated with rapamycin or vehicle. These 
results suggest that other molecular events trigger change in Dbf2 and Pph22 
binding to Hmt1. 
 
2.4.12.Dbf2 activity increases and Pph22 activity decreases CLB2 mRNA 
stability 
 
 To establish the roles of Dbf2 kinase and Pph22 phosphatase activities 
on CLB2 mRNA stability, we reasoned that a strain harbouring a Dbf2N305A 
kinase-dead mutant would result in CLB2 mRNA destabilization and a strain 
expressing a Pph22F232S temperature-sensitive mutant should allow for CLB2 
mRNA accumulation in rapamycin treated cells. Therefore, CLB2, ACT1 and 
poly(A) tail containing transcripts were counted in individual cells by single 
molecule FISH in strains exogenously expressing these mutants. We 
synchronized the Dbf2N305A or Pph22F232S strains with α-factor and treated 
them with rapamycin or vehicle for 20 minutes after α-factor release. 
Dbf2N305A mutant cells were grown at 30°C, while Pph22F232S mutant cells 
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were grown at the restrictive temperature of 37°C. Cells were harvested and 
fixed every 20 minutes for one cell cycle and after 120 minutes following -
factor release (t = 0) (Fig. 25E, Fig. 26C). Fixed cells were hybridized to 
mRNA probes and CLB2, ACT1 and poly(A) mRNA were quantified and 
compared to wildtype strain (Fig. 25F). We observed that the Dbf2N305A 
mutant strain failed to accumulate CLB2 transcript even in the absence of 
rapamycin treatment. In contrast, the Pph22F232S mutant strain grown at the 
restrictive temperature accumulated CLB2 mRNA quantities comparable to the 
wildtype strain treated with vehicle throughout all of the cell cycle. 
Interestingly, the Pph22F232S mutant strain resumed accumulating CLB2 
mRNA when treated with rapamycin. 
 
2.4.13.Failure to accumulate CLB2 mRNA correlates with early M-phase 
progression delay 
 
 We envisioned that failure to accumulate CLB2 mRNA would affect 
normal cell cycle progression. We analyzed the DNA content in synchronized 
strains treated with rapamycin or vehicle added 20 minutes after α-factors 
release. We used cdc15-2 mutant strain background and the same mutant strains 
that express genomic mutations Hmt1S9E, Hmt1S9A, Dbf2N305A or 
Pph22F232S at restrictive temperatures (i.e., limiting cell cycle from G1 to 
telophase, the point of arrest of cdc15-2 mutants), fixed them and stained either 
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DNA, with propidium iodide (PI), or mitotic spindle, with Tub1 specific 
immunostaining [135]. Cells were analyzed for the onset of budding (Fig. 27A-
B) and subsequent spindle dynamics (Fig. 27C-F). The DNA content of cells 
were studied by FACS for integral PI intensities per cell (Fig. 27G). We 
observed a 30 minute early M-phase transition delay in the rapamycin-treated 
cdc15-2 mutant background strain, hindering metaphase-anaphase spindle 
emergence in comparison to vehicle-treated cells. In contrast, spindle assembly 
was accelerated in Hmt1S9E whether or not the strain was treated with 
rapamycin. Both Dbf2N305A and Hmt1S9A exhibited delayed progression 
through early M-phase after both rapamycin and vehicle treatments. The 
rapamycin-treated Pph22F232S strain progressed through mitosis with 
comparable rates to the vehicle-treated cdc15-2 background strain. 
 
2.5.Discussion 
 
 Our understanding of cell cycle regulation have advanced recently due 
to careful dissection of cell populations into those having different lengths of 
mitotic phases (e.g. newborn daughter versus mother cells) and applications of 
fluorescent reporters and single cell analysis to define specific regulatory cues 
in time [105, 136].  
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Figure 27: Hmt1 regulations are necessary for M phase progression and induced early M phase 
delayed in rapamycin treated cells. 
 Temperature sensitive strains cdc15-2 endogenously expressing Hmt1wt, 
Hmt1S9E, Hmt1S9A, Dbf2N305A and Pph22F232S were arrested in G1 phase 
by alpha-factor and released in cell cycle. Synchronized cultures were treated 
with rapamycin (200 nM) or ethanol vehicle 20 minutes after alpha-factor 
released to prevent premature rapamycin induced G1 arrest. Cells were harvest, 
fixed and the proportion of budded cells (A-B), cells with metaphase spindles 
(C-D), anaphase/telophase spindles (E-F) and cells DNA content was stained 
with propidium iodide (PI) (G) measured by FACS analysis.  
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Equally, the need to understand the role of mRNA regulation in general and cell 
cycle progression specifically has been advanced by measurement of the spatial 
and temporal dynamics of single molecules of mRNA following transcription 
[93]. These developments have set the stage for dissecting regulatory pathways 
that may control cell cycle progression by regulating mRNA dynamics.  
 
 Here we demonstrate a strategy to identify proteins that regulate 
oscillating mRNAs during mitosis based on proteome-wide measurements of 
changes in protein-protein interactions in vivo [132, 134]. The same strategy 
could be applied to identify proteins involved in any cellular process. Here we 
first used the strategy to screen for interactions of Hmt1 with kinases and 
phosphatases by treating cells with rapamycin, a compound known to delay the 
cell division in early M-phase. These efforts resulted in our identification of 
Dbf2 and Pph22. We then characterized the dynamics of Hmt1 assembly and 
activation. Next, since asynchrony in the cell population would prevent us from 
detecting small differences in the dynamics of CLB2 transcript degradation, we 
measured mRNA decay in single cells and extended the methods to allow us to 
study mRNA dynamics in large populations of cells [93]. Results of these 
efforts allow us to propose a general model by which normal progression or 
stress-dependent delay of early M-phase is mediated by phosphorylation, 
oligomerization and activation of the arginine methyltransferase Hmt1 (Fig. 
28A).  
142 
 
 
Figure 28:Proposed Models 
(A) Model of mechanism regulating CLB2 mRNA accumulation during early 
M-phase. (B) Model of phospho-dependent Hmt1 cooperative assembly.  
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 Our model predicts that during early M-phase Dbf2 kinase 
phosphorylates Hmt1 and induces its cooperative assembly and activation. 
Active Hmt1 then methylates hnRNP components, which transport and stabilize 
nascent message of the cyclin CLB2. A positive feedback loop is propagated by 
CLB2 mRNA being translated into cyclin B2, thus associating with Cdk1 to 
promote entry into mitosis. Cdk1-Clb2 upregulates Cdc5 kinase activity [137, 
138]. The activated polo-kinase, Cdc5, phosphorylates and activates Cdc15 
kinase and both kinases phosphorylate Dbf2-Mob1, increasing Dbf2 kinase 
activity during early M-phase and as a result increasing Hmt1 activity [139-
144]. Feedback is abolished by proteasome-mediated proteolysis of Clb2 
through activation of the APC complex at the end of M-phase. Simultaneously, 
activated PP2A dephosphorylates Hmt1, leading to reduction in CLB2 mRNA 
stability [145]. As discussed below, however, given the cooperative activation 
of Hmt1 by Dbf2, versus graded deactivation by Pph22, constitutive Dbf2 
kinase activity could activate Hmt1 throughout the cell cycle if there were small 
decreases in Pph22 activity. This could provide a means by which progression 
of the cell cycle can be tuned. 
  
 In addition to proposing a mechanism for normal mitosis progression, 
our results can explain how early M-phase attenuation may occur in cells 
treated with rapamycin. It is known that PP2A is activated following release of 
its catalytic subunit Pph22 from the TAP42 complex when rapamycin-FKBP 
binds to TOR kinase during the mitosis transition and under a variety of stress 
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[84-87]. In our model, activated PP2A would shift Hmt1 equilibrium from its 
active hexameric form to its inactive monomeric state, resulting ultimately in 
destabilization of CLB2 mRNA and therefore attenuation of entry into M-phase. 
This basic circuit could also potentially be the target of a variety of stress-
responsive kinases and phosphatases. Our genome-wide screen for Hmt1 
revealed protein-protein interactions with alternative kinases and phosphatase 
including the MAP kinases Pkh2 and Pkh3, which are implicated in cell wall 
integrity [146]. These enzymes have been directly implicated in mRNA decay 
and mRNA inclusion in P-bodies [147]. Both of these phenomena may be 
mediated, at least in part, by concerted Pkh2 and Pkh3 association with Hmt1 
and ribonucleoprotein complexes during their transport and stabilization. 
Furthermore, we observed an interaction between Hmt1 and Nem1, a 
phosphatase implicated in nuclear membrane biogenesis, conserved from yeast 
to humans and required for sporulation in yeast [148]. A connection between 
these two processes remains to be discovered. It would also be interesting to 
investigate whether Nem1 dephosphorylation of Hmt1 is required for 
sporulation [149]. 
 
 Our findings are consistent with recent evidence for roles of Dbf2 in 
stabilizing CLB2 transcripts during early M-phase, the associations of Dbf2, 
Hmt1 and hnRNP components with gene loci and the functions of hnRNP 
proteins in nuclear export and stabilization of mRNA in the cytoplasm [93, 96]. 
It was suggested by Trcek, et al. that Dbf2 kinase activity is dispensable to 
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CLB2 transcript stability, which appears contradictory to our results. We can 
resolve this discrepancy. Trcek, et al. performed their experiments by using 
another mutation of the “kinase-dead” Dbf2 mutant. It has, however, been 
reported that this mutant has residual kinase activity in vitro [133, 150]. Our 
experiments were performed with the kinase dead mutation of Dbf2 integrated 
into the genome and therefore expressed at endogenous levels. We know that 
the activity of Dbf2 during early M-phase is minimal, not reaching a peak until 
later in M phase [139-141]. We thus argue that the conclusions of Trcek, et al. 
are correct in that Dbf2 does bind to the CLB2 locus and regulates mRNA 
accumulation, but Dbf2 activity is not dispensable to regulation of mRNA 
stability by hnRNPs.  
 
 Our observation that inactivation of Hmt1 activity does not lead to the 
retention of CLB2 mRNAs in the nucleus, but to a failure to accumulate in the 
cytoplasm, indicates that Hmt1 methylation of hnRNP proteins does not 
primarily regulate CLB2 mRNA nuclear export, but rather, primes the mRNA 
for regulation in the cytoplasm (e.g. degradation). Consistent with these 
observations, two studies have shown that arginine methylation by Htm1 acts as 
a signal for the co-transcriptional assembly and maturation of mRNPs [96, 
151]. Nuclear priming of later mRNA regulatory events by co-transcriptional 
assembly of hnRNP components is a common step prior to, as examples, the 
deposition of the exon-exon junction complex for cytoplasmic mRNA quality 
control or in assembling mRNPs for cytoplasmic mRNA localization [152, 
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153]. Presently, we do not know the protein composition of a CLB2 mRNP 
complex, but it is likely that its composition changes as a result of Htm1 
methylation. Consistent with our observation that different hnRNP components 
fail to accumulate in the cytoplasm when Hmt1 is inhibited, the lack of 
methylation of Nab2, Npl3 and Hrp1 may prevent their binding to CLB2 
mRNA. Alternatively, it is possible that the association of other proteins to 
CLB2 mRNA is dependent on their methylation by Hmt1. Interestingly, a recent 
study showed that Htm1 activity is required for the association of the Nab2 and 
Hpr1 with the Ccr4-Not complex, a multiprotein complex implicated in 
transcription as well as cytoplasmic mRNA degradation and, therefore, a prime 
candidate to be actively involved in the regulated degradation of CLB2 mRNA 
[128]. Further studies will show which of the components on the CLB2 mRNP 
are actively implicated in regulated degradation of CLB2 mRNA in the 
cytoplasm.  
 
 We demonstrated that Ser 9 is required for Hmt1 phosphorylation and 
that dimerization rapidly nucleates unphosphorylated subunits, resulting in 
generation of the active hexameric Hmt1 complex (Fig. 28B). Thus, only one of 
two subunits needs to be phosphorylated in order to induce dimers and 
tetramers. Our results suggest that the phospho-dependent dimerization 
interface allows phosphorylated Hmt1 to assemble into a dimer. The Hmt1 
dimer subsequently assembles with non-phosphorylated subunits, resulting in a 
hexameric complex through a second, phospho-independent interaction 
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interface. Our observations are consistent with gel filtration data showing 
higher stability of Hmt1 in its dimeric and hexameric forms [103]. Although the 
canonical consensus sequence for Dbf2 kinase (R-X-X-S) is not consistent with 
the sequence preceding Ser 9, the pattern is similar to the consensus for Dbf2 
human homologs, which can accommodate both a R and K at position -3 [154]. 
Alternatively, another serine could be phosphorylated by Dbf2 in a Ser 9-
dependant manner [133]. There is, however, only one Dbf2 kinase consensus 
sequence in Hmt1, Ser 45, and based on examination of the crystal structure, 
the side chain of this residue is buried and therefore inaccessible [103].  
 
 Recent studies have demonstrated that the sharpness and coherence of 
cell cycle transitions are regulated by transcriptional and biochemical positive 
feedback loops and notably those in which at least one step in the loop is 
ultrasensitive can result in bistable transitions [106, 136, 155-158]. The model 
we describe is a positive feedback loop in which Dbf2-mediates cooperative 
assembly and activation of Hmt1, contributing to the control of the early M-
phase transition and exit from mitosis. The ultrasensitivity was evident in 
rapamycin-induced disassembly of Dbf2-Hmt1 and Hmt1-Hmt1 complexes. 
This regulatory design enables a sharp tunable response to stresses that delay 
the cell cycle, while maintaining to a near constant, the requirement for a 
threshold level of active Clb2-Cdk1 complexes to allow cell cycle progression. 
The Hmt1 phosphorylation-dependent cooperative assembly adjusts the rate of 
development of Clb2-Cdk1 activity in response to both stress and cell cycle 
148 
 
cues by restraining CLB2 mRNA availability. These predictions are consistent 
with the accelerated early M-phase cycling transitions in CLB2 mRNA in the 
constitutively active Hmt1S9E expressing mutant strain. The constitutively 
inactive Hmt1S9A mutant simply showed no or very low levels of CLB2 
mRNA, resulting in a dramatic disruption of early M-phase transition. The 
effect of the Pph22 phosphatase inactive mutant resulted in recovery of the 
sharpness of early M-phase transition in rapamycin-treated cells. These results 
are consistent with the non-cooperative behavior of the Pph22-Hmt1 interaction 
that we observed. This model does not exclude the possibility that Hmt1 can be 
dephosphorylated by other phosphatases.  
 
 Our results suggests that the competition between Pph22 and Dbf2 for 
Hmt1 phosphosite could easily happen without any change in the quantities of 
these enzymes as occurs for Dbf2 during M phase. Specifically, we showed that 
first, Hmt1 oligomerization and activation involves substoichiometric quantities 
of Hmt1. Only one subunit of Hmt1 need be phosphorylated in order to 
generate an active hexamer. Second, the self-oligomerization of Hmt1 and 
binding to Dbf2 is highly cooperative. In contrast, the association of Pph22 
with Hmt1 is simply graded. This means that a small change in Pph22 activity 
would lead to a large shift in the equilibrium of Hmt1 towards the 
phosphorylated state. Any small perturbation of Pph22, such as via inhibition of 
the TOR pathway by rapamycin, can induce a dramatic decrease in Hmt1 
activity and thus mRNA stabilization.  
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 Finally, our results suggest that yeast have evolved a mechanism to 
adapt to a nutrient limited environment, mimicked by rapamycin-induced TOR 
inhibitions, by controlling the stability of mRNAs. Specifically, it is notable 
that cells respond to rapamycin without delaying cell cycle progression in the 
Pph22 phosphatase dead mutant strain supporting our model for early M-phase 
attenuation by rapamycin. Thus, the dephosphorylation of Hmt1 by Pph22 
dominantly leads to a decrease in the rate of early M-phase progression. The 
cells thus benefit from an extended early M-phase transition, allowing them to 
adapt to starvation by having the time to synthesize the necessary materials to 
generate viable daughter cells. We know that the stabilization of many RNAs 
by hnRNPs are under the control of Hmt1 including ribosomal and other cyclin 
and signalling protein mRNAs [96, 124, 159]. The current model for G1 arrest 
in rapamycin-treated and nutrient starved yeast, implicating Cln3 and CLN3 
mRNA down-regulations, is consistent with our Hmt1 regulation of mRNA 
stabilisation by hnRNPs. In fact, there are no convincing observations that 
would place the G1-cyclin tuning outside of a post-transcriptional regulation. 
However, there are ample evidences that both the G1-cyclin mRNA and 
ribosome rRNAs are regulated through their stability upon rapamycin-induced 
TOR inhibition and nitrogen starvation [124, 125, 159]. It is, also, described 
that untranslated regions, such as 5'UTR, play a role as switching for more 
stable 5'UTR stabilized the transcripts, that would be predicted by our hnRNP-
dependant model [124]. Synthesis of ribosomal RNA is a limiting factor in 
150 
 
regulation of growth and cyclins and signalling proteins regulate responses to 
nutritional and other stresses. It is conceivable and worth investigating whether 
the Pph22-Dbf2 competition could be modulated under different conditions and 
at different phases of the cell cycle. Pph22 and Dbf2 are conserved from yeast 
to humans and thus it would be interesting to explore whether the same 
mechanism of cell cycle control is also conserved. 
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2.7.Experimental Procedures 
2.7.1.Yeast strains, plasmids, growth conditions and buffers 
Growth conditions 
 
 All strains used in this study (Table S3) were derived from BY4741, 
BY4742, BY4743 and D754 genotypes. Each of the strains from the GFP 
library and TAP tagged library were grown overnight at 30°C in 400 μl SC-His. 
The GFP strains were mated to BY4742 harbouring endogenously expressed 
Nup49-dtTomato in YPD for 6 hours and resulting diploids were selected on 
agar containing SC-His + G418 plates. The TAP-tagged strains were mated to 
BY4742 harbouring endogenously expressed DHFR F[3] tagged protein in 
YPD for 6 hours and resulting diploids were selected on agar containing SC-
His + hygromycin B plates. Cells auto-fluorescence and non specific protein 
affinity to IgG resin was measured using BY4743 diploid strain. The onset of 
budding and spindle formation was compared between cdc15-2 background 
strain and other mutant strains, as previously described in [160]. Unless 
otherwise specified, strains were grown in YPD supplemented with 200 nM 
rapamycin (2 mM rapamycin stock solution in ethanol, Bioshop) or ethanol 
vehicle (001 % v/v) for 6 hrs. 
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Cell using α-factor 
 
 Cell synchronization in G1 was obtained by treatment of exponentially 
growing Mata cells with 10 µM α-factor mating pheromone for 2 h in acidified 
YPD (pH 3.5). The G1-arrested cells were washed with distilled water three 
times, released into fresh YPD. Cells were treated with 200 nM rapamycin or 
ethanol vehicle (Control) 20 minutes after -factor release to prevent 
rapamycin induced G1 arrest [107]. Cells were collected at the indicated times 
after α-factor release for subsequent assay. 
 
Plasmids generation by gateway system and mutated by site-directed 
mutagenesis 
 
Hmt1, Dbf2, and Pph22 expression vectors were created using Gateway cloning 
technology. The BP reaction was performed on Hmt1, Dbf2 and Pph22 
expression clone of yeast expression Gateway collection (YSC3867, 
OpenBiosystems). The expression clones (100 ng) were mix to the entry vector 
(100 ng). The BP reaction between the two plasmids were carried out in TRIS-
EDTA buffer (pH 8) with one unit of BP clonase II mix (Invitrogen) at room 
temperature for a hour. A 2 L aliquot was transform in DH5. The HMT1, 
DBF2 and PPH22 entry clone transformants were selected on kanamycin-
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containing broth (LB) agar plates. The entry clones were used in the LR 
reaction with the p413GPDpromoter–TAP destination vector [161]. The entry 
clones (100 ng) were mix to the destination vector (100 ng). The LR reaction 
between the two plasmids was carried out in TRIS-EDTA buffer (pH 8) with 
one unit of LR clonase II mix (Invitrogen) at room temperature for an hour. A 2 
L aliquot was transform in DH5. The Hmt1wt, Dbf2 and Pph22 expression 
clone transformants were selected on ampicillin-containing broth (LB) agar 
plates. To create the Hmt1S9E, Hmt1S9A, Dbf2N305A and Pph22F232S 
mutant expression vector, site-directed mutagenesis was carried out by using 
standard site-directed mutagenesis protocol (Quick Change Site-Directed 
Mutagenesis Kit- Stratagene # 200519) following the manufacturer instructions 
on the p413GPDpromoter-ORF-TAP expression clone. The presence of correct 
mutation was verified by sequencing. Hmt1wt and Hmt1S9E expression vectors 
were transformed as describe in [59], and transformants were selected on agar-
containing SC-His plates. 
 
Homologous recombination generated strains 
 
 The strains BY4741 (MATa his3 leu2 met15 ura3), BY4742 
(MAThis3 leu2 lys2 ura3) and D754 (MATa his3Δ leu2Δ met15Δ 
ura3Δ ade2Δ trp1Δ can1Δ rad5Δ ade1 [PSI+] cdc15-2) were transformed as 
described in [59] with PCR products amplified from the templates described in 
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[132, 134] to create specific homologous recombination DNA fragments 
required to generate Rluc PCA fragments and DHFR F[3] tagged strains 
(Suppl. Table S3). Whereas hmt1∆, dbf2∆ and pph22∆ and strains were 
transformed with the lithium acetate protocol with PCR products amplified 
from template Hmt1, Dbf2 and Pph22 mutant fused to TAP cDNA expression 
vector (Suppl. Table S3), respectively, to create specific homologous 
recombination DNA cassettes required to replace KANMX locus by mutated 
ORF-TAP. The transformation protocol was adapted to miniaturized volume as 
follows: 8 l of PCR product was mixed with 20 l of chemically-competent 
yeast, mixed with 72 l polyethyleneglycol (PEG) buffer and incubated for 30 
minutes at room temperature. Cells were then heat shocked with 10 µL DMSO 
for 15 minutes at 42C in a water bath. The transformation buffer was replaced 
with 250 l YPD and cells were left to recover for 4 hours at 30°C. 
Transformants were selected on antibiotic containing YPD agar plates, for PCA 
fragments homologous recombination, or on SC-His agar plates, for mutant 
ORF-TAP replacement of KANMX locus, and allowed to grow for 4 days at 
30°C. In all cases the BY4741 (MATa) strain was transformed with the Rluc 
F[1]-NAT1 cassettes and BY4742 (MAT) with the DHFR F[3]-HPH or Rluc 
F[2] cassettes. The transformed strains were grown on YPD agar plates plus 
appropriate antibiotic agar plates (100 g/mL nourseothricin for MATa 
transformed strains (WERNER BioAgents, Jena, Germany) or 250 g/mL 
hygromycin B for MATtransformed strains (Wisent Corporation, Quebec, 
Canada). Identification of successfully recombinant clones was performed as 
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follows: Putative recombinant clones were picked by hand, cell lysis was 
performed by heat treatment and confirmation of the correct location of a 
genome insertion was determined by PCR using the cassette 3' diagnostic 
primers described in (Suppl. Table S4). The yeast lysates were placed in PCR 
tubes and mixed with the ORF specific and cassette specific diagnostic primers. 
Annealing of the diagnostic primers was performed at 56C and 35 PCR cycles 
were carried out with the regular Taq DNA polymerase (Bioshop Canada, 
Montreal, Canada), with elongation cycles of 1.5 minutes at 72C, in a 50 l 
total reaction volume. Aliquots of 30 l from each PCR product were mixed 
with brilliant blue tainted glycerol and gel electrophoresed on ethidium bromide 
stained 1% agarose gels. Correct recombination was confirmed based on sizes 
of PCR products. The confirmed strains were glycerol-stocked in pre-assigned 
positions of 96-well plates and stored at -80°C. 
 
2.7.2.FISH probes and procedures 
 
 Probes are described in Suppl. Table S5. For each gene, 5 probes were 
used, where each probe was labelled with > 90% labelling efficiency. Design, 
synthesis and labelling of probes were performed as described previously 
(Femino et al., 2003; Zenklusen et al., 2008). ACT1 and CLB2 mRNA were 
quantified by counting individual FISH revealed mRNA foci after subtracting 
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background intensities and four time single probe intensity and applying hat 
kernel to increase contrast. 
 
2.7.3.Strains, plasmids, growth conditions, buffers and primers 
 
 Suppl. Table 3 and 4 describe strains, plasmids, media and buffers used 
in this study, their synchronization protocols and growth conditions. Primers 
used to generate strains and diagnostic primers are listed in Suppl. Table 5. 
 
2.7.4.Single cell, single molecule Fluorescence in situ Hybridization (FISH) 
 
 Suppl. Table 5 describes FISH probes used in this study and the FISH 
procedures. 
 
2.7.5.Fluorescence-Activated Cell Sorter (FACS) analysis of strains 
expressing GFP-tagged proteins 
 
 Proteins were quantified by fluorescence activated cell sorting (FACS) 
fluorometry from strains harboring a protein fused to GFP as described 
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previously [37]. GFP-tagged yeast cells were illuminated using a 488 nm laser 
(Coherent Sapphire, solid state, 20 mW, 488 nm, Becton Dickinson, San Jose, 
CA, USA), and fluorescence was collected through a 505 nm long-pass and 
HQ530/30 nm band-pass filters and 550 nm long-pass and HQ 575/26 nm 
band-pass filters (Becton Dickinson, San Jose, CA, USA) on a LSR-II 
cytometer. Thresholds of 20,000 and 15,000 for the FSC and SSC gates 
(FlowJo software, Tree Star; Ashland, OR), using HQ488/10 nm band-pass 
filters (Dickinson, San Jose, CA, USA), respectively, were used to exclude 
cellular debris. Cells were collected at a flow rate of 1,000-1,500 cells s
-1
 with a 
total accumulation of 30,000 cells run
-1
. Rapamycin (Bioshop) was used at a 
final concentration of 200 ng/ml and added to cells, growing in SC medium 
containing all amino acids at 30°C with shaking at OD600 = 0.05, 6 hrs before 
analysis. 
 
 
2.7.6.Fluorescence-Activated Cell Sorter (FACS) analysis of cell DNA 
content 
 
 For FACS analysis of DNA content, cells were synchronized and fixed 
at 20 minute intervals with ethanol for 1 h, washed with 50 mM sodium citrate 
in 50 mM Tris-HCl pH 7.5, and suspended in 50 mM Tris-HCl pH 7.5. Cells 
were treated with 1 mg/ml of RNaseA at 37°C for 1 h, then treated with 40 
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µg/ml of proteinase K at 55°C for 1 h, and washed and suspended in PBS 
buffer. The resulting cells were stained with 100 µg/ml propidium iodide (PI) at 
room temperature for 1 h. The DNA content of cells was measured on a BD 
LSR II flow cytometer. PI-stained yeast cells were illuminated using a 488 nm 
laser (Coherent Sapphire, solid state, 20 mW, 488 nm, Becton Dickinson, San 
Jose, CA, USA), and fluorescence was collected through HQ630/30 nm band-
pass filters (Becton Dickinson, San Jose,CA, USA) on the LSR-II cytometer. 
Rapamycin (Bioshop) was used at a final concentration of 200 ng/ml. 
 
 
2.7.7.Fluorescent protein localization 
 
 Diploid yeast cells endogenously expressing GFP-tagged protein and 
Nup49-dtTomato, as nuclear membrane marker, were grown overnight in SC-
His + G418, centrifuged and diluted in SC with all amino acids supplemented 
with 200 nM rapamycin or ethanol (vehicle) to OD600 = 0.01. Cells were 
allowed to grow for 6 hours at 30°C with shaking and were transferred to a 
ConA-coated glass-bottom plate, gently centrifuged at 1500 rpm for 5 min and 
imaged. 
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2.7.8.Microscopy 
 
 All microscopy was carried out using filters from Chroma Technology 
for GFP- (41001), dtTomato- (49008), DAPI- (31000V2), cy3.0- (SP102V1), 
cy3.5- (SP103V1) and cy 5.0- (49006) specific excitation and emission spectra. 
Sample visualisations were made on a fully robotized Nikon TE2000E 
epifluorescence-inverted microscope equipped with a high-resolution coolsnap 
HQ2 camera (Photometrics). Sample illumination was accomplished with a X-
cite XL120Q mercury lamp (X-cite) and magnified by an oil immersion violet 
corrected 60x objective (VC60XH, Nikon) and 1.5x internal optic 
magnification included on TE2000E for a 90x total magnification. Images were 
capture and analyzed using NIS-elements V3.1 (Nikon). 
 
2.7.9.Hmt1 DHFR PCA large-scale screen 
 
 The DHFR screen procedures are described in previous literature [132]. 
To test for Hmt1 differential protein interactions (rapamycin versus ethanol 
vehicle control), each of 5,250 MATα strains harbouring ORF-DHFR 
F[3]::HPH fusions were individually mated with the MATa strain endogenously 
expressing the Hmt1-DHFR F[1,2]::NAT1 fusion, on YPD plates. Diploid 
strains were selected on SC-Lys-Met for 48 hours at 30°C. These diploid strains 
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were printed on SC+MTX with a sublethal rapamycin concentration (2 nM) or 
ethanol (vehicle) to select for positive DHFR PCA reconstitution in each 
condition. Colonies were allowed to grow for 21 days at 30°C. Individual plates 
were photographed with a high-resolution (4 Mega pixel, Canon) digital camera 
and resulting images were converted to 8-bit grayscale images and analyzed 
with ImageJ 1.36b software (National Institutes of Health, USA), measuring 
pixel intensities of the colonies over a constant area.. 
 
2.7.10.TAP-tagged protein immunoprecipitation 
 
 Asynchronous cell cultures were grown to log phase before 
centrifugation, zymolase treatment and cell lysis in immunoprecipitation (IP) 
buffer, containing protease inhibitors. Immunoprecipitation was performed with 
2 mL of rabbit IgG sepharose beads (Sigma). Samples were rotated for 1 hour 
at 4°C followed by 3 washing steps with 2 mL IP buffer and elution after 
AcTEV protease (Invitrogen) cleavage at room temperature for 1 hour. Next, 
the samples were resolved by SDS-PAGE and detected by immunoblot analysis 
with rabbit-generated anti-C-terminal-DHFR antibodies (Sigma) for DHFR 
F[3] epitope recognition and rabbit-generated anti-calmodulin binding protein 
antibodies (Upstate) for TAP-tagged epitope visualisation. For alkaline 
phosphatase experiments, cell extracts and immunoprecipitates were prepared 
as described above. Before elution, immunoprecipitates were either treated with 
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alkaline phosphatase (New England Biolabs) or simultaneously treated with 
sodium vanadate (10 mM, Bioshop) and alkaline phosphatase in 2 mL IP buffer 
supplemented with NEBuffer 3 for 1 hour at 30°C and washed a third time with 
IP buffer. The elution and immunoblot was performed as described above. 
 
2.7.11.Hmt1 methyltransferase assay 
 
 Methyltransferase activity assays were performed in a 15 µl reaction of 
1x methyltransferase buffer in addition to enzyme and substrate proteins. For 
the methylation of Nab2-TAP and Npl3-TAP by wildtype Hmt1, S9E mutant 
Hmt1 or S9A mutant Hmt1, reactions were performed in the reaction mix 
described above with approximately 0.7 µM substrate and with 0.01 µM 
enzyme, as quantified from lysate resolved by SDS-PAGE and coomassie 
stained. Reactions were incubated at 30°C for 1 hour. All reactions were 
terminated by the addition of SDS-PAGE sample buffer and boiling. Samples 
were resolved by 12% SDS-PAGE followed by fluorography. Autoradiographs 
were exposed for 2 weeks at -80 °C. 
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2.7.12.Rluc PCA luminescence detection 
 
 Rluc PCA signals were directly acquired in reporter cell cultures at 
OD600 = 0.6. Cells were grown overnight in SC-Met-Lys to make a pre-culture. 
From the pre-culture, fresh cultures were started at an OD600 of 0.05 and 
allowed to grow up to 0.2 OD600 at 30°C with shaking. For each sample, 
rapamycin dilutions (or equivalent ethanol volumes) were prepared and added 
to each culture to grow 6 hrs at 30°C with shaking. For each sample, cells 
equivalent to 0.6 OD600 were centrifuged, supernatant was discarded and cells 
were resuspended in 180 μl of fresh SC-Met-Lys medium with rapamycin 
dilution (or equivalent ethanol volume) and transferred into white 96-well flat 
bottom plates (Greiner bio-one # 655075). The luciferase substrate benzyl-
coelenterazine (Nanolight #301) was diluted from the stock (2 mM in absolute 
ethanol) using PBS at pH 7.2 containing 1 mM EDTA. An LMax II
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Luminometer (Molecular Devices, Sunnyvale, CA, USA) was used to measure 
the protein-protein interaction signal. Using the internal injectors of the 
Luminometer, 20 μl was added to each sample of substrate (to a final 
concentration of 10 μM) and incubated for 60 seconds. After incubations, the 
Rluc PCA signal was integrated for 10 seconds. 
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2.7.13.Purification of Dbf2-Mob1 kinase complex 
 
 FlagHis6HA3Dbf2 (Dbf2) was co-immunoprecipitated with 
His6Mob1TEVmyc9 (Mob1) from Hi5 insect cells as previously described 
[143]. To activate Dbf2-Mob1, the protein complex bound to anti-FLAG M2 
beads (Sigma) was incubated with baculovirus-expressed Cdc15His6 in the 
presence of Cdc15 kinase buffer for 30 min at room temperature. The beads 
were washed three times with Cdc15 washing buffer to remove ATP and 
Cdc15His6. Dbf2-Mob1 was then eluted from the beads with 1 μg/ml FLAG 
peptide (Sigma) in Dbf2 kinase buffer (DKB) for four hours at 4°C. The same 
procedure was used to produce Dbf2N305A-Mob1, the kinase-inactive mutant 
of Dbf2. The eluted active or inactive Dbf2-Mob1 was used for subsequent 
assays. 
 
2.7.14.Protein kinase assay 
 
 TAP-tagged Hmt1wt, Hmt1S9E and Hmt1S9A, bound to 20 μl of beads, 
were dialyzed with DKB and incubated with Dbf2-Mob1 or Dbf2N305A-Mob1 
(~13 ng of Dbf2) and 2 μCi [γ-32P]ATP for 30 min at room temperature. Kinase 
reactions were stopped by addition of SDS-PAGE sample buffer, fractionated 
on SDS-PAGE and detected by autoradiography.  
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3.Chapter 3: Discussion 
 In studying the protein interactome of S. cerevisiae, we have discovered 
unexplored functional territories that allowed me to systematically elucidate 
some of the basic underlying mechanisms that allow the cell cycle to adapt to 
changing nutrient conditions. The course I took provides a new avenue to 
identify key regulators in adaptation to stress conditions or indeed any cellular 
process. Further, our findings reveal how a cell has evolved to delay and arrest 
cell cycle progression by supervising propagation of complex mRNA post-
transcriptional regulation. 
3.1.Implications and future directions 
 Most protein interaction screens performed, so far, have provided only 
static views of the PPI network. Some attempts to describe dynamic behavior of 
such networks have been described but allow one only to address a restricted 
number of genes at a time and only those already known to be involved in a 
specific cellular adaptation [162]. In our case study, we performed an unbiased 
PPI screen of Hmt1 for all reporter strains in our collection in cells treated with 
rapamycin. In absence of other information about potential kinases, 
phosphatases or regulators of these events, a biased set of reporters I would 
hardly have had any chance of success in identifying the rapamycin-induced 
regulators of Hmt1 Ser9 phosphorylation. In one fell swoop, my strategy 
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identified a potential set of regulators, potential kinases and phosphatases, 
along with proteins responsible for RNA export, maturation and turnover. 
 
 Interestingly, following our discovery of the interaction of Hmt1 with 
Dbf2, this same kinase was discovered to play a role in stabilizing CLB2 
transcripts during entry into M phase. Further, we knew that Dbf2, Hmt1 and 
hnRNP components associate with specific gene loci, including that of CLB2 
and the functions of hnRNP proteins in nuclear export and stabilization of 
mRNA in the cytoplasm [93, 96]. We know that the activity of Dbf2 in entry 
into M phase is minimal, not reaching a peak until later in M phase [139, 140]. 
We were thus able to argue that Dbf2 activity is not dispensable to regulation of 
mRNA stability by hnRNPs. It is known, furthermore, that PP2A is activated 
following release of its catalytic subunit Pph22 from the TAP42 complex when 
rapamycin-FKBP binds to TOR kinase and upon starvation [84]. In our model, 
activated PP2A dephosphorylates and shifts Hmt1 equilibrium from its active 
hexameric form to its inactive monomeric state, resulting ultimately in 
destabilization of CLB2 mRNA and therefore attenuation of entry into M phase. 
 
 Rapamycin-induced inhibition of TOR kinase and afferent signalling 
pathways has been subjects of great interest because of its potent 
immunosuppresive and antineoplasic potentials. Until recently, all therapeutic 
activities of rapamycin were attributed to translational regulation, through S6K 
and S6 proteins, necessary for efficient cap-dependant translation, and other 
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afferent signalling pathways [81, 163-166]. Our results suggest a novel 
mechanism of rapamycin action, the Dbf2/Pph22 competition for Hmt1 
phosphorylation state, implicated in regulating transcript stabilities upon TOR 
kinase inhibitions. The Dbf2 kinase is cell cycle regulated, with basal activity 
throughout the cell cycle and was shown to bind mRNA co-transcriptionally, 
such as CLB2 transcripts [93]. Likewise, we demonstrated that a Pph22 
phosphatase dead mutant strain treated with rapamycin contains phosphorylated 
and activated Hmt1 hexamers. Pph22 could be one of the several phosphatases 
that act on Hmt1 [84, 167]. The basic circuit of Hmt1 control could potentially 
be the target of drug design, since both the Dbf2 and Hmt1 have human 
homologs as does Pph22 and other phosphatases that may act on Hmt1 
homologs. It is conceivable that compounds targeting these enzymes could 
illicit similar consequences to cell cycle progression upon inhibition as 
rapamycin, but with less pleiotropic effects. 
 
 We know little about both the type and extent of the re-organization the 
protein interactome undergoes in response to different environmental changes. 
This lack of knowledge is mainly due to the colossal size of the interaction 
space and the proportional efforts needed to map it. For example, in order to 
discover interactions among the ~6,000 S. cerevisiae proteins, one needs to 
screen a space of 36,000,000 possible interactions. Thus, in order to tackle this 
problem we must reduce the size of the search space. On one hand, even 
measuring the dynamics of one interaction, Hmt1 homo-oligomerization, 
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provided information about the spectrum of protein network adaptations to 
rapamycin. On the other hand, a proteome-wide analysis of self-interactions 
under different conditions could reveal whole spaces of cellular processes never 
imagined. This also provides a solution to the problem of the size of a dynamic 
interactome screen of hetero-interactions. If we measure only self-interactions, 
the size of the space to probe scales linearly - not exponentially - with the 
number of proteins involved. In other words, we could probe the inner 
variability of the nodes in the network to identify the regions that change most 
under a specific set of conditions. We expect that self-interactions can be used to 
probes such changes, because the quantity of a self-interaction integrates 
information about both: (i) protein effective concentration (the higher the 
concentration of a protein the more it prone to self-interacts), and (ii) protein 
structural state (a structural change or a post-translational modification inducing 
a change in oligomeric state would result in a change in signal). Importantly 
also, we would expect this strategy to cover a significant part of the proteome. 
We indeed know that up to at least 50% of proteins form homo-oligomers under 
one condition [168, 169] and it has been known for several decades that 
allosteric as well as homo-oligomeric changes are frequently used to control 
protein function [170]. Therefore, about 50% or more of proteins probed could 
theoretically yield a self-interaction signal, and most importantly a change in 
such a signal. These interaction dynamics data could be combined with 
transcriptomic, protein turnover and protein localization information, potentially 
revealing new insights into protein regulatory networks. This approach could be 
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generalized to identify and mechanistically link genes, including those of 
unknown function, to any cellular process.  
 Post-transcriptional regulation of mRNA stability is a vast field of 
unexplored potential mechanisms for regulating specific cellular response. 
Recent results of the Encyclopedia of DNA Elements (ENCODE) project have 
shown that human genome produces a considerable amount of non-coding 
RNA. It is conceivable that RNA molecules have the capacity to regulate gene 
expression, transcript availability for translation and protein functions [171-
173]. To explore this new continent, it will be necessary to design new 
approaches to systematically detect protein-RNA and RNA-RNA interactions 
in intact cells to better understand the role of transcription regulation and non-
coding RNA in adaptation to intrinsic and extrinsic stresses and indeed all 
cellular processes. I hope that the strategy I have laid out in this thesis proves 
useful to all those prepared to explore this new world. 
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